细胞株Cell Lines 22-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
- 价 格：¥19200
- 货 号：Cell Line CV22
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines
BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
Email:biovector@163.com
ID GaMe-LF1
AC CVCL_Z117
RX PubMed=16618204;
CC Group: Insect cell line.
OX NCBI_TaxID=7137; ! Galleria mellonella
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID GaMG
AC CVCL_1226
SY GaMg; GAMG; GA-MG
DR BTO; BTO:0004860
DR CLO; CLO_0003450
DR CLDB; cl1441
DR BioSample; SAMN03473386
DR CCLE; GAMG_CENTRAL_NERVOUS_SYSTEM
DR ChEMBL-Cells; CHEMBL3308734
DR ChEMBL-Targets; CHEMBL1075447
DR Cosmic; 687567
DR Cosmic; 906868
DR Cosmic; 1175810
DR Cosmic; 1746947
DR Cosmic; 2302330
DR Cosmic; 2367525
DR Cosmic-CLP; 906868
DR DSMZ; ACC-242
DR GDSC; 906868
DR GEO; GSM326237
DR GEO; GSM887020
DR GEO; GSM888089
DR GEO; GSM1669804
DR Lonza; 1009
DR PRIDE; PXD002395
RX PubMed=3178168;
RX PubMed=8239502;
RX PubMed=22278370;
RX PubMed=22460905;
RX PubMed=24618588;
RX PubMed=27397505;
WW http://141.61.102.20/mxdb/project/show/9191407937500
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~40-50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using proteomics.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 10,11
ST D7S820: 9,10
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 14,19
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID gamma2-11.1
AC CVCL_6F34
SY gamma 2-11.1
DR ATCC; HB-8699
RX Patent=US4681848;
CC Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-242.
CC Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID gamma3-11.1
AC CVCL_2770
SY gamma 3-11.1
DR CLO; CLO_0009737
DR ATCC; HB-8700
RX Patent=US4681848;
CC Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-243.
CC Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID Gan-BL
AC CVCL_7194
SY Gan
RX PubMed=9882297;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GAP 8.3
AC CVCL_G651
DR CLO; CLO_0003451
DR ATCC; HB-12
RX PubMed=6975769;
CC Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID GAP A3
AC CVCL_G652
DR CLO; CLO_0003452
DR ATCC; HB-122
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Gap Per
AC CVCL_3312
DR CLO; CLO_0003453
DR ATCC; CRL-1335
DR BioSample; SAMN03471352
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 10,12
ST D5S818: 11,13
ST D7S820: 10,11
ST TH01: 6
ST TPOX: 8,10
ST vWA: 16,20
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Gard
AC CVCL_V418
RX PubMed=22552293;
RX PubMed=22893632;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Garvin-1
AC CVCL_Y588
RX PubMed=6546671;
RX PubMed=23665679;
RX PubMed=23882450;
CC Miscellaneous: Cell line name is not official. Was assigned by PubMed=23665679.
DI NCIt; C3749; Alveolar rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID GASH
AC CVCL_M709
SY Gash
RX CelloPub=CLPUB00041;
DI NCIt; C7402; Hairy cell leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GATAGM-96
AC CVCL_W350
SY Gulhane Askeri Tip Akademisi-Glioblastoma Multiforme-96
RX PubMed=9595044;
CC Doubling time: 38-42 hours (PubMed=9595044).
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GAY2911
AC CVCL_7956
DR Cosmic; 1522762
DR GEO; GSM726263
RX PubMed=21642991;
CC Omics: SNP array analysis.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GB
AC CVCL_S928
SY Grouper Brain
RX DOI=10.1046/j.1365-2761.2001.00303.x;
CC Group: Fish cell line.
OX NCBI_TaxID=152218; ! Epinephelus awoara
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID GB-1
AC CVCL_1227
SY GB1
DR BioSample; SAMN03470918
DR CCLE; GB1_CENTRAL_NERVOUS_SYSTEM
DR CGH-DB; 141-1
DR ChEMBL-Cells; CHEMBL3308166
DR ChEMBL-Targets; CHEMBL2366292
DR Cosmic; 687568
DR Cosmic; 2367526
DR Cosmic; 2516017
DR Cosmic-CLP; 687568
DR GDSC; 687568
DR GEO; GSM888090
DR GEO; GSM1669805
DR IFO; IFO50489
RX PubMed=2754458;
RX PubMed=4056904;
RX PubMed=16232199;
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 36 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 9
ST D18S51: 13,14
ST D19S433: 13,15.2
ST D21S11: 30
ST D2S1338: 20,22
ST D3S1358: 15,16
ST D5S818: 10,13
ST D7S820: 11,12
ST D8S1179: 16
ST FGA: 23.2
ST Penta D: 9,13
ST Penta E: 15,21
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GB-2
AC CVCL_S826
SY GB2
RX PubMed=2754458;
RX PubMed=3777953;
RX PubMed=4056904;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GB-3
AC CVCL_S827
SY GB3
RX PubMed=4056904;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GB-CL-1
AC CVCL_M732
DR Cosmic; 927194
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GB-d1
AC CVCL_H705
SY GB-D1; GBD-1; GBD1
RX PubMed=7559084;
RX PubMed=9502079;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GB-d2
AC CVCL_H706
SY GB-D2
RX PubMed=9502079;
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GB-h3
AC CVCL_H707
SY GB-H3; GBH-3; GBH3; GBh3
RX PubMed=9502079;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GB60
AC CVCL_M021
SY GB 60
RX PubMed=16961149;
RX PubMed=20461036;
RX PubMed=21253487;
CC Problematic cell line: Misidentified. Originally thought to be a chordoma cell line but is either contaminated or established from nonchordoma cells (PubMed=21253487).
CC Misspelling: 'GP 60' in PubMed=20461036.
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GBC-SD
AC CVCL_6903
SY GBCSD
DR BTO; BTO:0004112
DR CCRID; 3131C0001000700016
DR KCB; KCB 201187YJ
RX CelloPub=CLPUB00378;
RX PubMed=17064616;
RX PubMed=23802572;
CC Doubling time: 21.4 hours (CelloPub=CLPUB00378).
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GBC-SD/ATO
AC CVCL_M738
RX DOI=10.1007/s10330-009-0173-9;
CC Selected for resistance to: ChEBI; CHEBI:30621; Diarsenic trioxide (ATO; As2O3).
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6903 ! GBC-SD
CA Cancer cell line
//
ID GBC-SD/HL
AC CVCL_M739
RX PubMed=22093790;
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6903 ! GBC-SD
CA Cancer cell line
//
ID GBC-SD/M
AC CVCL_IU74
RX PubMed=17064616;
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6903 ! GBC-SD
CA Cancer cell line
//
ID GBC-SD/M3
AC CVCL_M740
RX PubMed=22093790;
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6903 ! GBC-SD
CA Cancer cell line
//
ID GBC1
AC CVCL_R900
SY Grouper Brain Clone 1
RX DOI=10.1016/j.aquaculture.2008.03.020;
CC Group: Fish cell line.
OX NCBI_TaxID=94232; ! Epinephelus coioides
OI CVCL_R901 ! GBC4
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID GBC4
AC CVCL_R901
SY Grouper Brain Clone 4
RX DOI=10.1016/j.aquaculture.2008.03.020;
RX PubMed=19248839;
CC Group: Fish cell line.
OX NCBI_TaxID=94232; ! Epinephelus coioides
OI CVCL_R900 ! GBC1
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Gbeta2AR13
AC CVCL_6631
RX PubMed=8961254;
RX PubMed=11064152;
RX PubMed=15541573;
CC Transfected with: HGNC; 5173; HRAS (with V-12).
CC Transfected with: HGNC; 286; ADRB2.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Transformed cell line
//
ID GBK-1
AC CVCL_M736
RX PubMed=3082828;
CC Doubling time: 43 hours (PubMed=3082828).
DI NCIt; C9167; Undifferentiated gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID GBL-HU12
AC CVCL_7195
RX PubMed=1320358;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GBM-18
AC CVCL_S551
SY G-7
RX PubMed=1653364;
RX PubMed=2839097;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GBM-18-A3
AC CVCL_S552
SY GBM-18-A3 (MDR)
RX PubMed=1317362;
RX PubMed=1653364;
CC Selected for resistance to: ChEBI; CHEBI:23359; Colchicine.
CC Transfected with: HGNC; 40; ABCB1.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S551 ! GBM-18
CA Cancer cell line
//
ID GBM-18-B3
AC CVCL_S553
SY GBM-18-B3 (MDR)
RX PubMed=1317362;
RX PubMed=1653364;
CC Selected for resistance to: ChEBI; CHEBI:23359; Colchicine.
CC Transfected with: HGNC; 40; ABCB1.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S551 ! GBM-18
CA Cancer cell line
//
ID GBM-HSF
AC CVCL_W351
RX PubMed=24390806;
CC Doubling time: ~51 hours (PubMed=24390806).
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID GBM1
AC CVCL_DG57
SY GBM 1
RX PubMed=19147502;
CC Group: Cancer stem cell line.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GBM2
AC CVCL_DG58
SY GBM 2
DR GEO; GSM1026856
RX PubMed=19147502;
RX PubMed=23468990;
CC Group: Cancer stem cell line.
CC Omics: Array-based CGH.
CC Omics: DNA methylation analysis.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GBM2603
AC CVCL_4W89
SY GBM 2603
RX PubMed=11351043;
CC Omics: Array-based CGH.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GBM3
AC CVCL_DG59
SY GBM 3
RX PubMed=19147502;
CC Group: Cancer stem cell line.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GBM4
AC CVCL_DG60
SY GBM 4
RX PubMed=19147502;
CC Group: Cancer stem cell line.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GBM5
AC CVCL_DG61
SY GBM 5
RX PubMed=19147502;
CC Group: Cancer stem cell line.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GBM6
AC CVCL_DG62
SY GBM 6
RX PubMed=19147502;
CC Group: Cancer stem cell line.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GBM6840
AC CVCL_B050
SY GBM 6840
RX PubMed=10736064;
RX PubMed=11351043;
CC Omics: Array-based CGH.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID GBM7
AC CVCL_DG63
SY GBM 7
DR GEO; GSM1026857
RX PubMed=19147502;
RX PubMed=23468990;
CC Group: Cancer stem cell line.
CC Omics: Array-based CGH.
CC Omics: DNA methylation analysis.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GBM8401
AC CVCL_B051
SY GBM-8401; GBM 8401; GBM8401/TSGH,NDMC
DR BTO; BTO:0003879
DR BCRC; 60163
DR Cosmic; 1237539
RX PubMed=2839737;
ST Source(s): BCRC
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 8,9
ST D16S539: 12,13
ST D5S818: 11,13
ST D7S820: 11,12
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 17,18
ST D7S820: 11,12
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B052 ! GBM8901
SX Female
CA Cancer cell line
//
ID GBM8901
AC CVCL_B052
SY GBM-8901; GBM 8901
DR BCRC; 60164
ST Source(s): BCRC
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 8,9
ST D16S539: 12,13
ST D5S818: 11,13
ST D7S820: 11,12
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 17,18
ST D7S820: 11,12
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B051 ! GBM8401
SX Female
CA Cancer cell line
//
ID GBS-1
AC CVCL_M818
RX PubMed=11862471;
DI NCIt; C4247; Unclassified pleomorphic sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GC-1 spg
AC CVCL_8872
SY GC-1spg; GC-1; GC1-SPG
DR CLO; CLO_0003457
DR ATCC; CRL-2053
DR BCRC; 60312
DR NCBI_Iran; C164
DR PRIDE; PXD002593
RX PubMed=1322317;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID GC-2spd(ts)
AC CVCL_6633
SY GC-2
DR CLO; CLO_0003459
DR ATCC; CRL-2196
DR BCRC; 60313
RX PubMed=7736662;
RX PubMed=8202522;
CC Transfected with: HGNC; 11998; TP53 (with V-135).
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Conditionally immortalized cell line
//
ID GC-3spc(ts)
AC CVCL_9V31
RX PubMed=8202522;
CC Transfected with: HGNC; 11998; TP53 (with V-135).
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Conditionally immortalized cell line
//
ID GC-BJAB
AC CVCL_5758
RX PubMed=170210;
RX PubMed=171663;
CC Characteristics: EBV-negative.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5711 ! BJAB
SX Female
CA Cancer cell line
//
ID GC1a
AC CVCL_6632
RX PubMed=15541573;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GC3/Cl
AC CVCL_1B34
SY GC3/cl
DR ChEMBL-Cells; CHEMBL3307788
DR ChEMBL-Cells; CHEMBL3308634
DR ChEMBL-Targets; CHEMBL614728
DR ChEMBL-Targets; CHEMBL612252
RX PubMed=1378304;
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1B32 ! GC3/M
SX Male
CA Cancer cell line
//
ID GC3/M
AC CVCL_1B32
DR ChEMBL-Cells; CHEMBL3308591
DR ChEMBL-Targets; CHEMBL614500
RX PubMed=1378304;
RX PubMed=3829001;
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y076 ! HxGC3
SX Male
CA Cancer cell line
//
ID GC3/M TK-
AC CVCL_1B33
SY GC3/MTK-
DR ChEMBL-Cells; CHEMBL3307886
DR ChEMBL-Targets; CHEMBL614157
RX PubMed=3829001;
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1B32 ! GC3/M
SX Male
CA Cancer cell line
//
ID GC48C
AC CVCL_6634
RX PubMed=221196;
RX PubMed=15541573;
CC Breed/subspecies: Holtzman Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_6620 ! DC3 [Rat granulosa]
SX Female
CA Transformed cell line
//
ID GC7
AC CVCL_5757
SY GC-7
DR BTO; BTO:0003459
RX PubMed=167187;
RX PubMed=4039633;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
CA Spontaneously immortalized cell line
//
ID GC9811-P
AC CVCL_0U28
RX PubMed=17404872;
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0U26 ! XGC9811
CA Cancer cell line
//
ID GCC-SV(c)
AC CVCL_GS26
SY GCC-SV(C); GCC-SV
RX PubMed=6582512;
RX PubMed=6956527;
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GCCOT-1
AC CVCL_U178
RX PubMed=15010838;
DI NCIt; C40212; Cervical adenosquamous carcinoma, glassy cell variant
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID GCCRK
AC CVCL_U179
RX PubMed=15010838;
DI NCIt; C40212; Cervical adenosquamous carcinoma, glassy cell variant
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID GCF
AC CVCL_R973
SY Grass Carp Fin
RX PubMed=2108122;
CC Group: Fish cell line.
OX NCBI_TaxID=7959; ! Ctenopharyngodon idella
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID GCH-1
AC CVCL_W852
RX CelloPub=CLPUB00141;
RX CelloPub=CLPUB00142;
RX PubMed=6167351;
RX PubMed=11014955;
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID GCH-1:RI
AC CVCL_W855
SY GCH-1 : RI
RX PubMed=6542580;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W852 ! GCH-1
SX Female
CA Cancer cell line
//
ID GCH-1:RII
AC CVCL_W856
SY GCH-1 : RII
RX PubMed=6542580;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W852 ! GCH-1
SX Female
CA Cancer cell line
//
ID GCH-1m
AC CVCL_W854
SY GCH-1(m); GCH-1 (m)
RX PubMed=2520787;
RX PubMed=3585108;
RX PubMed=11014955;
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W852 ! GCH-1
SX Female
CA Cancer cell line
//
ID GCH-2
AC CVCL_W853
RX CelloPub=CLPUB00142;
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GCH-nu
AC CVCL_AR87
RX CelloPub=CLPUB00317;
RX DOI=10.5795/jjscc.21.160;
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID GCH-nu-YS
AC CVCL_2910
DR BioSample; SAMN03470917
DR BioSample; SAMN03472434
DR JCRB; JCRB1201
DR JCRB; NIHS0409
RX CelloPub=CLPUB00317;
CC Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
CC Discontinued: JCRB; NIHS0409; true.
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 9,11
ST D13S317: 11,13
ST D16S539: 9
ST D18S51: 15,16,17
ST D19S433: 13.2,16.2
ST D21S11: 28,29,31
ST D2S1338: 17,18,19
ST D3S1358: 14,17,18
ST D5S818: 11,12,14
ST D7S820: 8
ST D8S1179: 16,17,18
ST FGA: 19,20
ST Penta D: 9,9.1,11
ST Penta E: 11,12
ST TH01: 6
ST TPOX: 8
ST vWA: 17,18,19 (JCRB)
ST vWA: 17,18,19,20 (PubMed=25877200)
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_AR87 ! GCH-nu
SX Female
CA Cancer cell line
//
ID GCIY
AC CVCL_1228
DR CLO; CLO_0050793
DR BioSample; SAMN03472290
DR CCLE; GCIY_STOMACH
DR ChEMBL-Cells; CHEMBL3308825
DR ChEMBL-Targets; CHEMBL2366234
DR Cosmic; 889110
DR Cosmic; 906869
DR Cosmic; 983729
DR Cosmic; 1001652
DR Cosmic; 1187272
DR Cosmic-CLP; 906869
DR GDSC; 906869
DR GEO; GSM887021
DR GEO; GSM888091
DR GEO; GSM1669806
DR RCB; RCB0555
DR TKG; TKG 0405
RX PubMed=1653599;
RX PubMed=9290701;
RX PubMed=15767549;
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR45 cancer cell line panel.
CC Doubling time: 60 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; RCB
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 9
ST D16S539: 13
ST D5S818: 10,12
ST D7S820: 8,12
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID GCN2-KO-DR
AC CVCL_B049
DR ATCC; CRL-2978
RX PubMed=11106749;
CC Knockout cell: Method=KO mouse; MGI; MGI:1353427; Eif2ak4.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID GCS-2
AC CVCL_R974
SY Grass Carp Snout-2
RX PubMed=2108122;
CC Group: Fish cell line.
OX NCBI_TaxID=7959; ! Ctenopharyngodon idella
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID GCSB
AC CVCL_R975
SY Grass Carp Swim Bladder
RX PubMed=2108122;
CC Group: Fish cell line.
OX NCBI_TaxID=7959; ! Ctenopharyngodon idella
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID GCSR1
AC CVCL_HF51
RX PubMed=25892440;
CC Doubling time: ~67.65 hours (PubMed=25892440).
DI NCIt; C5250; Signet ring cell gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GCT
AC CVCL_1229
SY Giant cell tumor
DR CLO; CLO_0003464
DR EFO; EFO_0002182
DR CLDB; cl1445
DR ATCC; TIB-223
DR BCRC; 60474
DR BioSample; SAMN03471887
DR CCLE; GCT_SOFT_TISSUE
DR ChEMBL-Cells; CHEMBL3308471
DR ChEMBL-Targets; CHEMBL1075448
DR CLS; 300155/p780_GCT
DR Cosmic; 684227
DR Cosmic; 906999
DR Cosmic-CLP; 906999
DR GDSC; 906999
DR GEO; GSM184402
DR GEO; GSM184403
DR GEO; GSM827496
DR GEO; GSM887022
DR GEO; GSM888092
DR GEO; GSM1669807
DR IGRhCellID; GCT
DR IZSLER; BS TCL 94
RX PubMed=7689482;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; CLS; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 9
ST D18S51: 17,19
ST D21S11: 28
ST D3S1358: 16,17
ST D5S818: 13,15
ST D7S820: 11,12
ST FGA: 21
ST Penta D: 12
ST Penta E: 12,13
ST TH01: 8,9.3
ST TPOX: 8,9
ST vWA: 16,18
DI NCIt; C4247; Unclassified pleomorphic sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GCT 27
AC CVCL_A344
SY GCT-27; GCT27
DR Cosmic; 971771
DR Cosmic; 2077190
DR DSMZ; ACC-743
DR GEO; GSM863897
RX PubMed=2442105;
CC Doubling time: ~35-40 hours (DSMZ).
ST Source(s): DSMZ; PubMed=11416159
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 9,11
ST D16S539: 13
ST D21S11: 30
ST D5S818: 13
ST D7S820: 10
ST D8S1179: 16
ST TH01: 8
ST TPOX: 10,12
ST vWA: 17 (DSMZ)
ST vWA: 15,17 (PubMed=11416159)
DI NCIt; C3877; Testicular teratoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GCT 35
AC CVCL_A345
SY GCT35
RX PubMed=2442105;
DI NCIt; C3877; Testicular teratoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GCT 44
AC CVCL_A346
SY GCT44
DR Cosmic; 971772
RX PubMed=2442105;
DI NCIt; C3877; Testicular teratoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GCT 46
AC CVCL_A347
SY GCT46
RX PubMed=2442105;
DI NCIt; C3877; Testicular teratoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GCT 48
AC CVCL_A348
SY GCT48
RX PubMed=2442105;
DI NCIt; C3877; Testicular teratoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GCT 72
AC CVCL_A349
SY GCT72
RX PubMed=2442105;
DI NCIt; C3877; Testicular teratoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GD-iPS1
AC CVCL_C948
SY GD-IPS1
DR ISCR; 24
RX Patent=US20110151447;
RX PubMed=18691744;
WW http://harvard.eagle-i.net/i/00000144-08d3-7c3d-0803-96bd80000000
CC From: Children's Hospital Boston; Boston; USA.
DI NCIt; C61268; Gaucher disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8515 ! GM00852
SX Male
CA Induced pluripotent stem cell
//
ID GD-iPS3
AC CVCL_C949
SY GD-IPS3
DR ISCR; 25
RX Patent=US20110151447;
RX PubMed=18691744;
CC From: Children's Hospital Boston; Boston; USA.
DI NCIt; C61268; Gaucher disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8515 ! GM00852
SX Male
CA Induced pluripotent stem cell
//
ID GD1I
AC CVCL_S929
RX DOI=10.1139/f81-125;
RX Patent=US4219543;
CC Group: Fish cell line.
OX NCBI_TaxID=59899; ! Clarias batrachus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Gd1T
AC CVCL_5479
DR CLO; CLO_0003465
DR ATCC; CRL-6180
CC Group: Bird cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6180; true.
OX NCBI_TaxID=9031; ! Gallus gallus
OI CVCL_3690 ! Gd1WE
SX Sex undetermined
CA Undefined cell line type
//
ID Gd1WE
AC CVCL_3690
DR CLO; CLO_0003466
DR ATCC; CRL-6181
CC Group: Bird cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6181; true.
OX NCBI_TaxID=9031; ! Gallus gallus
OI CVCL_5479 ! Gd1T
SX Sex undetermined
CA Finite cell line
//
ID GD25
AC CVCL_7264
DR Lonza; 256
RX PubMed=7533171;
RX PubMed=8567726;
RX PubMed=10574722;
RX PubMed=10601344;
WW http://bioinfoweb.com/CLDB-GD25.htm
CC Knockout cell: Method=Gene trap; MGI; MGI:96610; Itgb1.
CC Breed/subspecies: 129S2/SvPas.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_E078 ! G-201
SX Male
CA Transformed cell line
//
ID GD25T
AC CVCL_GR75
DR TOKU-E; 4081
RX PubMed=10574722;
CC Knockout cell: Method=Gene trap; MGI; MGI:96610; Itgb1.
CC Breed/subspecies: 129S2/SvPas.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_7264 ! GD25
SX Male
CA Transformed cell line
//
ID GDM-1
AC CVCL_1230
SY GDM1
DR CLO; CLO_0003467
DR EFO; EFO_0002183
DR CLDB; cl1446
DR CLDB; cl5541
DR ATCC; CRL-2627
DR BioSample; SAMN03473160
DR CCLE; GDM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR CGH-DB; 9221-4
DR ChEMBL-Cells; CHEMBL3308198
DR ChEMBL-Targets; CHEMBL2366157
DR Cosmic; 787430
DR Cosmic; 906870
DR Cosmic; 975249
DR Cosmic; 999777
DR Cosmic; 1012067
DR Cosmic; 1177802
DR Cosmic; 1197932
DR Cosmic; 1281313
DR Cosmic; 2089666
DR Cosmic; 2131537
DR Cosmic; 2306196
DR Cosmic-CLP; 906870
DR DSMZ; ACC-87
DR GDSC; 906870
DR GEO; GSM887023
DR GEO; GSM888093
DR GEO; GSM1669808
DR ICLC; HTL01008
DR IGRhCellID; GDM1
RX PubMed=6296552;
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=23955599;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~40-50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'GMD-1' in Cosmic 2131537.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 12
ST D18S51: 12,13
ST D21S11: 29
ST D3S1358: 14,15
ST D5S818: 13
ST D7S820: 11,12
ST D8S1179: 14,16
ST FGA: 22,23
ST Penta D: 8,11
ST Penta E: 15,20
ST TH01: 6
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID GE
AC CVCL_S930
SY Grouper Eye
RX PubMed=12962209;
CC Group: Fish cell line.
OX NCBI_TaxID=152218; ! Epinephelus awoara
OI CVCL_S931 ! GF
OI CVCL_S932 ! GH [Grouper]
OI CVCL_S934 ! GSB
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Ge Mar
AC CVCL_4J64
DR ATCC; CRL-1103
CC Discontinued: ATCC; CRL-1103; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID GE-1
AC CVCL_T724
SY Gekko Embryo-1
RX PubMed=4365679;
CC Group: Reptilian cell line.
OX NCBI_TaxID=481883; ! Eublepharis macularius
CA Spontaneously immortalized cell line
//
ID GE1
AC CVCL_E112
SY GE 1
DR CLO; CLO_0050207
DR RCB; RCB1709
RX PubMed=11334466;
RX PubMed=11520047;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Conditionally immortalized cell line
//
ID Ge1
AC CVCL_DD92
SY Ge-1
DR ATCC; HB-8574
RX Patent=US4695538;
CC Discontinued: ATCC; HB-8574; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8119 ! HMy.2 B
CA Hybridoma
//
ID GE11
AC CVCL_8873
SY GE-11
DR BTO; BTO:0003325
RX PubMed=10601344;
WW http://bioinfoweb.com/CLDB-GE11.htm
CC Knockout cell: Method=Gene trap; MGI; MGI:96610; Itgb1.
CC Breed/subspecies: 129S2/SvPas.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_E078 ! G-201
SX Male
CA Transformed cell line
//
ID GE47192
AC CVCL_F552
SY TER354
DR IMGT/HLA; 10607
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GE6
AC CVCL_E113
SY GE 6
RX PubMed=11334466;
RX PubMed=11520047;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID GEE018
AC CVCL_E672
DR dbMHC; 48867
DR ECACC; 94050329
DR IHW; IHW9255
DR IMGT/HLA; 10608
WW http://bioinformatics.hsanmartino.it/ecbr/cl255.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID GEEP
AC CVCL_3823
DR CLO; CLO_0003470
DR CLDB; cl1449
DR ECACC; 92062401
OX NCBI_TaxID=9925; ! Capra hircus
OX NCBI_TaxID=9940; ! Ovis aries
CA Hybrid cell line
//
ID GEK
AC CVCL_GU03
SY Goat Embryonic Kidney
RX CelloPub=CLPUB00354;
CC Group: Vaccine production cell line.
CC Doubling time: ~49.5 hours (CelloPub=CLPUB00354).
CC Breed/subspecies: Matou.
OX NCBI_TaxID=9925; ! Capra hircus
CA Spontaneously immortalized cell line
//
ID GeLu
AC CVCL_3313
SY Gerbil Lung
DR CLO; CLO_0003472
DR CLDB; cl1450
DR ATCC; CCL-100
DR ECACC; 90102534
RX PubMed=7065527;
WW http://fluoview.magnet.fsu.edu/gallery/cells/gelu/gelucells.html
CC Discontinued: ECACC; 90102534; probable.
OX NCBI_TaxID=10047; ! Meriones unguiculatus
SX Female
CA Finite cell line
//
ID GEM-199
AC CVCL_4204
SY GEM 199; GEM199; Goldfish Erythrophoroma-199
DR CLO; CLO_0051589
DR RCB; RCB1175
RX PubMed=6408467;
CC Group: Fish cell line.
OX NCBI_TaxID=7957; ! Carassius auratus
SX Sex undetermined
CA Cancer cell line
//
ID GEM-218
AC CVCL_4205
SY GEM 218; GEM218; Goldfish Erythrophoroma-218
DR CLO; CLO_0051590
DR RCB; RCB1176
CC Group: Fish cell line.
OX NCBI_TaxID=7957; ! Carassius auratus
SX Sex undetermined
CA Cancer cell line
//
ID GEM-81
AC CVCL_4206
SY GEM 81; GEM81; Goldfish Erythrophoroma-81
DR CLO; CLO_0051592
DR RCB; RCB1174
RX PubMed=2793781;
RX PubMed=6928999;
CC Group: Fish cell line.
OX NCBI_TaxID=7957; ! Carassius auratus
SX Sex undetermined
CA Cancer cell line
//
ID GEM-81 clone P15
AC CVCL_6G55
SY P15
RX PubMed=2514977;
RX PubMed=2793781;
CC Group: Fish cell line.
OX NCBI_TaxID=7957; ! Carassius auratus
HI CVCL_4206 ! GEM-81
SX Sex undetermined
CA Cancer cell line
//
ID GEM-81 clone P15D
AC CVCL_6G56
SY P15D
RX PubMed=2514977;
RX PubMed=2793781;
CC Group: Fish cell line.
OX NCBI_TaxID=7957; ! Carassius auratus
HI CVCL_6G55 ! GEM-81 clone P15
SX Sex undetermined
CA Cancer cell line
//
ID GEM-81 clone P15DI
AC CVCL_6G57
SY P15DI
RX PubMed=2514977;
RX PubMed=2793781;
CC Group: Fish cell line.
OX NCBI_TaxID=7957; ! Carassius auratus
HI CVCL_6G56 ! GEM-81 clone P15D
SX Sex undetermined
CA Cancer cell line
//
ID GEM-MIA PaCa-2
AC CVCL_HA89
SY GEM,MIA PaCa-2
RX PubMed=14508125;
CC Selected for resistance to: ChEBI; CHEBI:175901; Gemcitabine (Gemzar).
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0428 ! MIA PaCa-2
SX Male
CA Cancer cell line
//
ID GEN2.2
AC CVCL_5G44
SY Gen2.2; GEN 2.2; Gen 2.2; HLA-A*0201+ pDC line
RX Patent=US7341870;
RX PubMed=16365416;
RX PubMed=22696054;
WW http://www.clg.niigata-u.ac.jp/~matak/eng/resmat12.pdf
CC Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2938.
DI NCIt; C7203; Blastic plasmacytoid dendritic cell neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5G45 ! GEN3
SX Male
CA Cancer cell line
//
ID GEN3
AC CVCL_5G45
SY GEN 3
RX Patent=US7341870;
CC Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-3110.
DI NCIt; C7203; Blastic plasmacytoid dendritic cell neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5G44 ! GEN2.2
SX Male
CA Cancer cell line
//
ID GENEA001
AC CVCL_9010
SY SIVF001; SIVF-01; SIVF01; GENEAe001-A
DR hPSCreg; GENEAe001-A
DR ISCR; 1162
RX PubMed=20198447;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=827
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0370.
CC Registration: Swiss research registry; BAG-hES-IMP-0025.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA002
AC CVCL_9011
SY Genea002; SIVF002; SIVF-02; SIVF02
DR ISCR; 1163
RX PubMed=20198447;
RX PubMed=25316320;
RX PubMed=27217344;
RX PubMed=27345802;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=500
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0151.
CC Registration: Swiss research registry; BAG-hES-IMP-0026.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-38.
CC Miscellaneous: Sibling to GENEA048 (CVCL_9057).
ST Source(s): PubMed=27345802
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 11,12
ST D18S51: 13,16
ST D19S433: 13,14
ST D21S11: 28,30
ST D2S1338: 23
ST D3S1358: 14,17
ST D5S818: 11,12
ST D7S820: 8,10
ST D8S1179: 12,14
ST FGA: 19,21
ST TH01: 6
ST TPOX: 8
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA003
AC CVCL_9012
SY SIVF003; SIVF03; GENEAe002-A
DR hPSCreg; GENEAe002-A
DR ISCR; 1165
RX PubMed=18386991;
CC From: Genea Biocells, Ltd; Australia.
DI NCIt; C37866; Trisomy 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA004
AC CVCL_9013
SY SIVF004; SIVF04; GENEAe003-A
DR hPSCreg; GENEAe003-A
DR ISCR; 1166
RX PubMed=18386991;
CC From: Genea Biocells, Ltd; Australia.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA005
AC CVCL_9014
SY SIVF005; SIVF05; GENEAe004-A
DR hPSCreg; GENEAe004-A
DR ISCR; 1167
RX PubMed=18386991;
CC From: Genea Biocells, Ltd; Australia.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA006
AC CVCL_9015
SY SIVF006; SIVF06; GENEAe005-A
DR hPSCreg; GENEAe005-A
DR ISCR; 1168
RX PubMed=18386991;
CC From: Genea Biocells, Ltd; Australia.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA007
AC CVCL_9016
SY SIVF007; SIVF07; GENEAe006-A
DR hPSCreg; GENEAe006-A
DR ISCR; 1169
RX PubMed=18386991;
CC From: Genea Biocells, Ltd; Australia.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA008
AC CVCL_9017
SY SIVF008; SIVF08; GENEAe007-A
DR hPSCreg; GENEAe007-A
DR ISCR; 1170
RX PubMed=18386991;
CC From: Genea Biocells, Ltd; Australia.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA009
AC CVCL_9018
SY SIVF009; SIVF09; GENEAe008-A
DR hPSCreg; GENEAe008-A
DR ISCR; 1171
RX PubMed=18386991;
CC From: Genea Biocells, Ltd; Australia.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA010
AC CVCL_9019
SY SIVF010; SIVF10; GENEAe009-A
DR hPSCreg; GENEAe009-A
DR ISCR; 1172
RX PubMed=18386991;
CC From: Genea Biocells, Ltd; Australia.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA011
AC CVCL_9020
SY SIVF011; SIVF11; GENEAe010-A
DR hPSCreg; GENEAe010-A
DR ISCR; 1173
RX PubMed=18386991;
CC From: Genea Biocells, Ltd; Australia.
DI NCIt; C36433; Trisomy 5
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA012
AC CVCL_9021
SY SIVF012; SIVF12; GENEAe011-A
DR hPSCreg; GENEAe011-A
DR ISCR; 1174
RX PubMed=18386991;
CC From: Genea Biocells, Ltd; Australia.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA013
AC CVCL_9022
SY SIVF013; SIVF13; GENEAe012-A
DR hPSCreg; GENEAe012-A
DR ISCR; 1175
RX PubMed=18386991;
CC From: Genea Biocells, Ltd; Australia.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA014
AC CVCL_9023
SY SIVF014
DR ISCR; 1164
RX PubMed=20198447;
CC From: Genea Biocells, Ltd; Australia.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA015
AC CVCL_9024
SY Genea015; SIVF015
DR ISCR; 1177
RX PubMed=27217344;
RX PubMed=27346028;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=613
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0228.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-37.
CC Miscellaneous: Sibling to GENEA016 (CVCL_9025).
ST Source(s): PubMed=27346028
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 10,11
ST D18S51: 14,15
ST D19S433: 15,16.2
ST D21S11: 29,31.2
ST D2S1338: 18,23
ST D3S1358: 16,19
ST D5S818: 11,13
ST D7S820: 10,11
ST D8S1179: 13,14
ST FGA: 21,23
ST TH01: 6,8
ST TPOX: 8,12
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA016
AC CVCL_9025
SY Genea016; SIVF016
DR ISCR; 1178
RX PubMed=27345780;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=614
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0229.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-37.
CC Miscellaneous: Sibling to GENEA015 (CVCL_9024).
ST Source(s): PubMed=27345780
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10,11
ST D16S539: 10,12
ST D18S51: 13,19
ST D19S433: 15,16.2
ST D21S11: 28,29
ST D2S1338: 18,19
ST D3S1358: 16,19
ST D5S818: 12,13
ST D7S820: 10,11
ST D8S1179: 13,14
ST FGA: 21,24
ST TH01: 6,8
ST TPOX: 8,12
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA017-HD
AC CVCL_9026
SY GENEA017; Genea017; SIVF017; SIVF017-HD; SIV017
DR ISCR; 1179
RX PubMed=20649476;
RX PubMed=25316320;
RX PubMed=27346022;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=502
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0166.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-44.
ST Source(s): PubMed=27346022
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,14
ST D16S539: 11,12
ST D18S51: 15,18
ST D19S433: 14,15
ST D21S11: 29
ST D2S1338: 17,18
ST D3S1358: 14,18
ST D5S818: 12,13
ST D7S820: 10,12
ST D8S1179: 13,15
ST FGA: 21,23
ST TH01: 9
ST TPOX: 8,11
ST vWA: 15,18
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA018-HD
AC CVCL_9027
SY GENEA018; Genea018; SIVF018; SIVF018-HD; SIV018
DR ISCR; 1180
RX PubMed=20649476;
RX PubMed=25316320;
RX PubMed=27346005;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=505
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0169.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-45.
ST Source(s): PubMed=27346005
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 13
ST D16S539: 11,13
ST D18S51: 14,17
ST D19S433: 13,15.2
ST D21S11: 29
ST D2S1338: 17,25
ST D3S1358: 16,17
ST D5S818: 12,13
ST D7S820: 10,12
ST D8S1179: 11,14
ST FGA: 24,25
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA019
AC CVCL_9028
SY Genea019; GENEAe020-A; SIVF019; SIV019
DR BioSamples; SAMEA104013010
DR hPSCreg; GENEAe020-A
DR ISCR; 1181
RX PubMed=20649476;
RX PubMed=25316320;
RX PubMed=27217344;
RX PubMed=27346002;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC From: Genea Biocells, Ltd; Australia.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-62.
CC Omics: Proteome analysis.
CC Miscellaneous: Sibling to GENEA020 (CVCL_9029).
ST Source(s): PubMed=27346002
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 11
ST D18S51: 12,18
ST D19S433: 13,14
ST D21S11: 29,30
ST D2S1338: 18,23
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 7,8
ST D8S1179: 12,13
ST FGA: 22,23
ST TH01: 9.3,10
ST TPOX: 11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA020
AC CVCL_9029
SY GENEA020-HD; Genea020; GENEAe015-A; SIVF020; SIVF020-HD; SIV020
DR BioSamples; SAMEA104012534
DR hPSCreg; GENEAe015-A
DR ISCR; 1182
RX PubMed=20649476;
RX PubMed=25316320;
RX PubMed=27346007;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC From: Genea Biocells, Ltd; Australia.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-62.
CC Miscellaneous: Sibling to GENEA019 (CVCL_9028).
ST Source(s): PubMed=27346007
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 10,12
ST D16S539: 11
ST D18S51: 14,15
ST D19S433: 13,16.2
ST D21S11: 30,33.2
ST D2S1338: 24
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 8
ST D8S1179: 12,13
ST FGA: 19,20
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA021
AC CVCL_9030
SY Genea021; GEN021; SIVF021; SIVF-021
DR ISCR; 1183
RX PubMed=25645121;
RX PubMed=27346003;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC From: Genea Biocells, Ltd; Australia.
CC Registration: Swiss research registry; BAG-hES-IMP-0027.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-60.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Miscellaneous: Sibling to GENEA022 (CVCL_9031) and GENEA023 (CVCL_9032).
ST Source(s): PubMed=27346003
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 11,12
ST D16S539: 11,13
ST D18S51: 13,19
ST D19S433: 14.2,15
ST D21S11: 29,30,32.2
ST D2S1338: 17,24
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 11,13
ST D8S1179: 13,14
ST FGA: 22,24
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA022
AC CVCL_9031
SY Genea022; GEN022; SIVF022; SIVF-022
DR ISCR; 1184
RX PubMed=25316320;
RX PubMed=25645121;
RX PubMed=27346017;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC From: Genea Biocells, Ltd; Australia.
CC Registration: Swiss research registry; BAG-hES-IMP-0028.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-60.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Miscellaneous: Sibling to GENEA021 (CVCL_9030) and GENEA023 (CVCL_9032).
ST Source(s): PubMed=27346017
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 12
ST D16S539: 10,13
ST D18S51: 14,16
ST D19S433: 13,14
ST D21S11: 28,29
ST D2S1338: 17,18
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 10,13
ST D8S1179: 12,13
ST FGA: 20,22
ST TH01: 6
ST TPOX: 8,11
ST vWA: 15,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA023
AC CVCL_9032
SY Genea023; GEN023; SIVF023; SIVF-023
DR ISCR; 1185
RX PubMed=25316320;
RX PubMed=25645121;
RX PubMed=27346015;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC From: Genea Biocells, Ltd; Australia.
CC Registration: Swiss research registry; BAG-hES-IMP-0029.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-60.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Miscellaneous: Sibling to GENEA021 (CVCL_9030) and GENEA022 (CVCL_9031).
ST Source(s): PubMed=27346015
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 11
ST D16S539: 11,13
ST D18S51: 13,16
ST D19S433: 13,14
ST D21S11: 30,32.2
ST D2S1338: 17,24
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 11,13
ST D8S1179: 14
ST FGA: 22,24
ST TPOX: 8,9
ST vWA: 14,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA024
AC CVCL_9033
SY SIVF024
DR ISCR; 1186
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=506
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0170.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-45.
DI NCIt; C84704; Facioscapulohumeral muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA025
AC CVCL_9034
SY SIVF025
DR ISCR; 1187
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC From: Genea Biocells, Ltd; Australia.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA026
AC CVCL_9035
SY SIVF026
DR ISCR; 1188
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC From: Genea Biocells, Ltd; Australia.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA027
AC CVCL_9036
SY SIVF027
DR ISCR; 1189
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC From: Genea Biocells, Ltd; Australia.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA028
AC CVCL_9037
SY SIVF028
DR ISCR; 1190
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC From: Genea Biocells, Ltd; Australia.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA029
AC CVCL_9038
SY SIVF029
DR ISCR; 1191
RX PubMed=25316320;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC From: Genea Biocells, Ltd; Australia.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-60.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA030
AC CVCL_9039
SY SIVF030
DR ISCR; 1192
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC From: Genea Biocells, Ltd; Australia.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-63.
CC Discontinued: ISCR; 1192; probable.
DI NCIt; C84685; Emery-Dreifuss muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA031
AC CVCL_9040
SY SIVF031
DR ISCR; 2061
WW http://www.geneastemcells.com.au/Our-Products/Stem-Cell-Lines/GENEA031
WW http://grants.nih.gov/stem_cells/registry/draft_intent.htm
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; draft request for approval.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
CC Miscellaneous: Sibling to GENEA032 (CVCL_9041) and GENEA033 (CVCL_9042).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA032
AC CVCL_9041
SY SIVF032
DR ISCR; 2062
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/draft_intent.htm
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; draft request for approval.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
CC Miscellaneous: Sibling to GENEA031 (CVCL_9040) and GENEA033 (CVCL_9042).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA033
AC CVCL_9042
SY SIVF033
DR ISCR; 2064
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/draft_intent.htm
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; draft request for approval.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
CC Miscellaneous: Sibling to GENEA031 (CVCL_9040) and GENEA032 (CVCL_9041).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA034
AC CVCL_9043
DR ISCR; 1196
CC From: Genea Biocells, Ltd; Australia.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-63.
CC Discontinued: ISCR; 1196; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID GENEA035
AC CVCL_9044
DR ISCR; 1197
CC From: Genea Biocells, Ltd; Australia.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
CC Discontinued: ISCR; 1197; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID GENEA036
AC CVCL_9045
DR ISCR; 1198
CC From: Genea Biocells, Ltd; Australia.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
CC Discontinued: ISCR; 1198; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID GENEA037
AC CVCL_9046
DR ISCR; 1199
CC From: Genea Biocells, Ltd; Australia.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
CC Discontinued: ISCR; 1199; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID GENEA038
AC CVCL_9047
DR ISCR; 1200
CC From: Genea Biocells, Ltd; Australia.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
CC Discontinued: ISCR; 1200; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID GENEA039
AC CVCL_9048
DR ISCR; 1201
CC From: Genea Biocells, Ltd; Australia.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
CC Discontinued: ISCR; 1201; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID GENEA040
AC CVCL_9049
SY SIVF040
DR ISCR; 1202
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=507
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0171.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-45.
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA041
AC CVCL_9050
SY SIVF041
DR ISCR; 1203
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=503
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0167.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-44.
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA042
AC CVCL_9051
SY Genea042; SIVF042
DR ISCR; 1204
RX PubMed=27345994;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=615
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0231.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-40.
ST Source(s): PubMed=27345994
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,13
ST D16S539: 11,13
ST D18S51: 15,16
ST D19S433: 13,14
ST D21S11: 30
ST D2S1338: 16,23
ST D3S1358: 14,18
ST D5S818: 11,13
ST D7S820: 8,10
ST D8S1179: 13,14
ST FGA: 20,25
ST TH01: 6,7
ST TPOX: 8
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA043
AC CVCL_9052
SY Genea043; SIVF043
DR ISCR; 1205
RX PubMed=27345801;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=616
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0232.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-40.
ST Source(s): PubMed=27345801
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,13
ST D16S539: 11
ST D18S51: 15,16
ST D19S433: 13,14
ST D21S11: 30,30.2
ST D2S1338: 16,18
ST D3S1358: 16,17
ST D5S818: 11,13
ST D7S820: 8,10
ST D8S1179: 13,14
ST FGA: 23
ST TH01: 7,8
ST TPOX: 8
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA044
AC CVCL_9053
SY SIVF044
DR ISCR; 1206
CC From: Genea Biocells, Ltd; Australia.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA045
AC CVCL_9054
SY SIVF045
DR ISCR; 1207
CC From: Genea Biocells, Ltd; Australia.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA046-HD
AC CVCL_9055
SY GENEA046; Genea046; SIVF046; SIVF046-HD
DR ISCR; 1208
RX PubMed=20649476;
RX PubMed=25316320;
RX PubMed=27346012;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=511
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0180.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-46.
CC Omics: Proteome analysis.
ST Source(s): PubMed=27346012
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,10
ST D16S539: 11,12
ST D18S51: 14,18
ST D19S433: 13.2,14
ST D21S11: 29,30
ST D2S1338: 18,24
ST D3S1358: 15,18
ST D5S818: 11,12
ST D7S820: 7,11
ST D8S1179: 10,14
ST FGA: 20,25
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA047
AC CVCL_9056
SY Genea047; SIVF047
DR ISCR; 1209
RX PubMed=27345995;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=617
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0230.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-41.
ST Source(s): PubMed=27345995
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11,13
ST D18S51: 12,14
ST D19S433: 13,14
ST D21S11: 30
ST D2S1338: 17,23
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 8
ST D8S1179: 10,13
ST FGA: 20,22
ST TH01: 6,9
ST TPOX: 8
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA048
AC CVCL_9057
SY SIVF048
DR ISCR; 1210
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=501
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0152.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-38.
CC Miscellaneous: Sibling to GENEA002 (CVCL_9011).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA049
AC CVCL_9058
SY Genea049; SIVF049
DR ISCR; 1211
RX PubMed=27217344;
RX PubMed=27346016;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=512
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0183.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-54.
CC Miscellaneous: Sibling to GENEA050 (CVCL_9059).
ST Source(s): PubMed=27346016
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 10,11
ST D16S539: 11
ST D18S51: 15,21
ST D19S433: 13,15
ST D21S11: 28,30
ST D2S1338: 20,23
ST D3S1358: 16,17
ST D5S818: 11,13
ST D7S820: 9
ST D8S1179: 13
ST FGA: 20,23
ST TH01: 6,7
ST TPOX: 9,11
ST vWA: 17,18
DI NCIt; C84704; Facioscapulohumeral muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA050
AC CVCL_9059
SY Genea050; SIVF050
DR ISCR; 1212
RX PubMed=27217344;
RX PubMed=27346025;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=513
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0184.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-54.
CC Miscellaneous: Sibling to GENEA049 (CVCL_9058).
ST Source(s): PubMed=27346025
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 11
ST D18S51: 11,15
ST D19S433: 14,15
ST D21S11: 28,30
ST D2S1338: 20,25
ST D3S1358: 15,17
ST D5S818: 11
ST D7S820: 8,11
ST D8S1179: 13
ST FGA: 21,22
ST TH01: 6.8
ST TPOX: 9,11
ST vWA: 17,18
DI NCIt; C84704; Facioscapulohumeral muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA051
AC CVCL_9060
DR ISCR; 1213
CC From: Genea Biocells, Ltd; Australia.
CC Discontinued: ISCR; 1213; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID GENEA052
AC CVCL_9061
SY Genea052; SIVF052
DR ISCR; 1214
RX PubMed=27345996;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=637
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0234.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-36.
ST Source(s): PubMed=27345996
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,10
ST D16S539: 9,12
ST D18S51: 15,16
ST D19S433: 14
ST D21S11: 27,32.2
ST D2S1338: 19,24
ST D3S1358: 16,18
ST D5S818: 10,11
ST D7S820: 9,11
ST D8S1179: 10,13
ST FGA: 22,23
ST TH01: 6
ST TPOX: 9,11
ST vWA: 15,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA053
AC CVCL_9062
SY Genea053; GEN053; SIVF053
DR ISCR; 1215
RX PubMed=25645121;
RX PubMed=27346024;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC From: Genea Biocells, Ltd; Australia.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-63.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=27346024
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,11
ST D16S539: 9,12
ST D18S51: 14,16
ST D19S433: 13,15
ST D21S11: 29,30
ST D2S1338: 19,24
ST D3S1358: 15,17
ST D5S818: 12,13
ST D7S820: 10,12
ST D8S1179: 13,15
ST FGA: 20,23
ST TH01: 9
ST TPOX: 10,11
ST vWA: 15,17
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA054
AC CVCL_9063
DR ISCR; 1216
CC From: Genea Biocells, Ltd; Australia.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-63.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID GENEA055
AC CVCL_9064
SY SIVF055
DR ISCR; 1217
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC From: Genea Biocells, Ltd; Australia.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
DI NCIt; C114765; Trisomy 22
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA056
AC CVCL_9065
DR ISCR; 1218
CC From: Genea Biocells, Ltd; Australia.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-63.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID GENEA057
AC CVCL_9066
SY Genea057; SIVF057
DR ISCR; 1219
RX PubMed=27345782;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=636
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0233.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-39.
ST Source(s): PubMed=27345782
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,10
ST D16S539: 10,12
ST D18S51: 14,15
ST D19S433: 14,15
ST D21S11: 28,31
ST D2S1338: 17,23
ST D3S1358: 15,16
ST D5S818: 10,11
ST D7S820: 10
ST D8S1179: 13,14
ST FGA: 21,25
ST TH01: 7
ST TPOX: 8
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA058
AC CVCL_9067
SY SIVF058
DR ISCR; 1220
RX PubMed=27217344;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=514
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0199.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-47.
DI NCIt; C84587; Becker's muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA059
AC CVCL_9068
SY SIVF059
DR ISCR; 1221
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=517
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0175.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
DI NCIt; C36100; BRCA1 syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA060
AC CVCL_9069
SY SIVF060
DR ISCR; 1843
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=508
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0172.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-49.
CC Miscellaneous: Sibling to GENEA061 (CVCL_9070).
DI NCIt; C3105; Von Hippel-Lindau syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA061
AC CVCL_9070
SY SIVF061
DR ISCR; 1844
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=509
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0173.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-49.
CC Miscellaneous: Sibling to GENEA060 (CVCL_9069).
DI NCIt; C3105; Von Hippel-Lindau syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA062
AC CVCL_9071
SY SIVF062
DR ISCR; 1845
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=519
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0187.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
CC Miscellaneous: Sibling to GENEA063 (CVCL_9072).
DI NCIt; C75468; Charcot-Marie-Tooth disease type 1A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA063
AC CVCL_9072
SY SIVF063
DR ISCR; 1846
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=520
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0188.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
CC Miscellaneous: Sibling to GENEA062 (CVCL_9071).
DI NCIt; C75468; Charcot-Marie-Tooth disease type 1A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA064
AC CVCL_9073
SY SIVF064
DR ISCR; 1847
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=510
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0174.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-49.
DI NCIt; C118782; Charcot-Marie-Tooth disease type 1B
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA065
AC CVCL_9074
SY SIVF065
DR ISCR; 1848
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=518
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0200.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-48.
DI NCIt; C84927; Infantile neuroaxonal dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA066
AC CVCL_9075
SY Genea066; SIVF066
DR ISCR; 1849
RX PubMed=27346023;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=521
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0189.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
ST Source(s): PubMed=27346023
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,9
ST D16S539: 10,11
ST D18S51: 16,17
ST D19S433: 14,14.2
ST D21S11: 28,32.2
ST D2S1338: 19,24
ST D3S1358: 16
ST D5S818: 10,12
ST D7S820: 12
ST D8S1179: 14,15
ST FGA: 20,22
ST TH01: 6
ST TPOX: 11,12
ST vWA: 15,18
DI NCIt; C84680; Dystrophia myotonica 2
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA067
AC CVCL_9076
SY Genea067; SIVF067
DR ISCR; 1850
RX PubMed=27346009;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=522
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0190.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
ST Source(s): PubMed=27346009
ST Amelogenin: X,Y
ST CSF1PO: 13,14
ST D13S317: 11
ST D16S539: 9,12
ST D18S51: 17,18
ST D19S433: 13
ST D21S11: 28,30
ST D2S1338: 17,20
ST D3S1358: 16,18
ST D5S818: 11,13
ST D7S820: 8,10
ST D8S1179: 13,15
ST FGA: 20,23
ST TH01: 6,9.3
ST TPOX: 9,11
ST vWA: 16
DI NCIt; C84679; Dystrophia myotonica 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA068
AC CVCL_9077
SY SIVF068
DR ISCR; 1851
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=504
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0168.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-44.
DI NCIt; C40407; Renal Wilms tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA069
AC CVCL_9078
SY SIVF069
DR ISCR; 1852
RX CelloPub=CLPUB00370;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=515
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0181.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-51.
CC Characteristics: Has a BEST1 p.Phe305Ser mutation.
CC Miscellaneous: Sibling to GENEA070 (CVCL_9079).
DI NCIt; C118788; Vitelliform macular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA070
AC CVCL_9079
SY SIVF070
DR ISCR; 1853
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=516
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0182.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-51.
CC Miscellaneous: Sibling to GENEA069 (CVCL_9078).
DI NCIt; C118788; Vitelliform macular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA071
AC CVCL_9080
SY SIVF071
DR ISCR; 1854
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=523
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0191.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
DI NCIt; C84787; Incontinentia pigmenti
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA072
AC CVCL_9081
SY SIVF072
DR ISCR; 1855
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=524
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0192.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
DI NCIt; C75483; Juvenile X-linked retinoschisis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA073
AC CVCL_9082
SY SIVF073
DR ISCR; 1856
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=525
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0193.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
DI NCIt; C34368; Alpha thalassemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA074
AC CVCL_9083
SY SIVF074
DR ISCR; 1857
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=526
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0194.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
DI NCIt; C118780; Autosomal dominant torsion dystonia 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA075
AC CVCL_B883
SY SIVF075
DR ISCR; 1858
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC From: Genea Biocells, Ltd; Australia.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-64.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA076
AC CVCL_B884
SY SIVF076
DR ISCR; 1859
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC From: Genea Biocells, Ltd; Australia.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-64.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA077
AC CVCL_B885
SY SIVF077
DR ISCR; 1860
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=635
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0261.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-55.
DI NCIt; C118697; Hypochondroplasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA078
AC CVCL_B886
SY Genea078; SIVF078
DR ISCR; 1861
RX PubMed=27346006;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=626
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0252.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
CC Miscellaneous: Sibling to GENEA079 (CVCL_B887) and GENEA080 (CVCL_B888).
ST Source(s): PubMed=27346006
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 12
ST D18S51: 12,13
ST D19S433: 14,15
ST D21S11: 28,30
ST D2S1338: 17,24
ST D3S1358: 15
ST D5S818: 12,13
ST D7S820: 8,10
ST D8S1179: 11,13
ST FGA: 22,23
ST TH01: 6
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C118784; Nemaline myopathy 2
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA079
AC CVCL_B887
SY Genea079; SIVF079
DR ISCR; 1862
RX PubMed=27346010;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=627
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0253.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
CC Miscellaneous: Sibling to GENEA078 (CVCL_B886) and GENEA080 (CVCL_B888).
ST Source(s): PubMed=27346010
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 12
ST D18S51: 13,17
ST D19S433: 14,15
ST D21S11: 29,30.2
ST D2S1338: 17,20
ST D3S1358: 15,17
ST D5S818: 11
ST D7S820: 10,12
ST D8S1179: 11,13
ST FGA: 20,23
ST TH01: 6,8
ST TPOX: 8
ST vWA: 15,16
DI NCIt; C118784; Nemaline myopathy 2
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA080
AC CVCL_B888
SY Genea080; SIVF080
DR ISCR; 1863
RX PubMed=27346011;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=628
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0254.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
CC Miscellaneous: Sibling to GENEA078 (CVCL_B886) and GENEA079 (CVCL_B887).
ST Source(s): PubMed=27346011
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 9,12
ST D18S51: 12,13
ST D19S433: 14,14.3
ST D21S11: 28,30.2
ST D2S1338: 17,20
ST D3S1358: 15,16
ST D5S818: 12,13
ST D7S820: 8,12
ST D8S1179: 11,13
ST FGA: 22,24
ST TH01: 8,9.3
ST TPOX: 8,9
ST vWA: 15,17
DI NCIt; C118784; Nemaline myopathy 2
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA081
AC CVCL_B889
SY SIVF081
DR ISCR; 1864
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=629
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0255.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
DI NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA082
AC CVCL_B890
SY SIVF082
DR ISCR; 1865
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=625
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0251.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-56.
DI NCIt; C67383; Epidermolysis bullosa
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA083
AC CVCL_M234
DR ISCR; 2041
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=630
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0256.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-52.
CC Miscellaneous: Sibling to GENEA084 (CVCL_M235).
DI NCIt; C114768; Loeys-Dietz syndrome type 2
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA084
AC CVCL_M235
DR ISCR; 2042
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=631
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0257.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-53.
CC Miscellaneous: Sibling to GENEA083 (CVCL_M234).
DI NCIt; C114768; Loeys-Dietz syndrome type 2
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA085
AC CVCL_M236
DR ISCR; 2043
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=624
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0250.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-53.
DI NCIt; C85045; Retinitis pigmentosa
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA086
AC CVCL_M237
DR ISCR; 2044
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=632
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0258.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
CC Miscellaneous: Sibling to GENEA087 (CVCL_M238).
DI NCIt; C75331; Tuberous sclerosis 2
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA087
AC CVCL_M238
DR ISCR; 2045
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=633
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0259.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
CC Miscellaneous: Sibling to GENEA086 (CVCL_M237).
DI NCIt; C75331; Tuberous sclerosis 2
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA088
AC CVCL_M239
DR ISCR; 2046
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=634
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0260.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
DI NCIt; C118787; Simpson Golabi Behmel syndrome type 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA089
AC CVCL_M240
SY Genea089; SIVF089
DR ISCR; 2047
RX PubMed=25316320;
RX PubMed=27346008;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=621
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0247.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-47.
CC Miscellaneous: Sibling to GENEA090 (CVCL_M241) and GENEA091 (CVCL_M242).
ST Source(s): PubMed=27346008
ST Amelogenin: X
ST CSF1PO: 11,15
ST D13S317: 8,11
ST D16S539: 12
ST D18S51: 15
ST D19S433: 13,14
ST D21S11: 29,31
ST D2S1338: 17,19
ST D3S1358: 17,18
ST D5S818: 10,12
ST D7S820: 10
ST D8S1179: 14,15
ST FGA: 23,24
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 18,19
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA090
AC CVCL_M241
SY Genea090
DR ISCR; 2048
RX PubMed=25316320;
RX PubMed=27346026;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=619
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0245.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-49.
CC Miscellaneous: Sibling to GENEA089 (CVCL_M240) and GENEA091 (CVCL_M242).
ST Source(s): PubMed=27346026
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,11
ST D16S539: 11,12
ST D18S51: 14
ST D19S433: 12,13
ST D21S11: 29,30
ST D2S1338: 17,19
ST D3S1358: 17,18
ST D5S818: 10,11
ST D7S820: 11,12
ST D8S1179: 13,15
ST FGA: 23
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 18,19
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA091
AC CVCL_M242
SY Genea091
DR ISCR; 2049
RX PubMed=25316320;
RX PubMed=27346013;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=620
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0246.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-49.
CC Miscellaneous: Sibling to GENEA089 (CVCL_M240) and GENEA090 (CVCL_M241).
ST Source(s): PubMed=27346013
ST Amelogenin: X
ST CSF1PO: 12,14
ST D13S317: 9,11
ST D16S539: 11,12
ST D18S51: 14
ST D19S433: 12,13
ST D21S11: 29,31
ST D2S1338: 17
ST D3S1358: 17
ST D5S818: 10,12
ST D7S820: 10,11
ST D8S1179: 13,15
ST FGA: 22,23
ST TH01: 6
ST TPOX: 9,11
ST vWA: 18,19
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA093
AC CVCL_V432
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=828
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0371.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-42.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA094
AC CVCL_V433
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=829
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0372.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-43.
CC Miscellaneous: Sibling to GENEA095 (CVCL_V434).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA095
AC CVCL_V434
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=830
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0373.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-43.
CC Miscellaneous: Sibling to GENEA094 (CVCL_V433).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA096
AC CVCL_M243
SY Genea096
DR ISCR; 2050
RX PubMed=27217344;
RX PubMed=27346027;
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=618
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0244.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-57.
ST Source(s): PubMed=27346027
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12,13
ST D16S539: 11
ST D18S51: 14,16
ST D19S433: 13,15
ST D21S11: 30,32.2
ST D2S1338: 17,23
ST D3S1358: 15,16
ST D5S818: 11
ST D7S820: 10
ST D8S1179: 10,11
ST FGA: 22
ST TH01: 8,9.3
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C84704; Facioscapulohumeral muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA097
AC CVCL_M244
DR ISCR; 2051
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=622
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0248.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-47.
CC Miscellaneous: Sibling to GENEA098 (CVCL_M245).
DI NCIt; C5183; Hereditary multiple exostoses
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA098
AC CVCL_M245
DR ISCR; 2052
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=623
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0249.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-47.
CC Miscellaneous: Sibling to GENEA097 (CVCL_M244).
DI NCIt; C5183; Hereditary multiple exostoses
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA099
AC CVCL_V737
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=835
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0378.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-58.
DI NCIt; C129981; Spastic paraplegia 4
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA100
AC CVCL_2G85
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=833
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0376.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-59.
DI NCIt; C75468; Charcot-Marie-Tooth disease type 1A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA101
AC CVCL_2G86
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=834
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0377.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-59.
DI NCIt; C75468; Charcot-Marie-Tooth disease type 1A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID GENEA104
AC CVCL_2G87
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=831
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0374.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID GENEA105
AC CVCL_2G88
WW http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=832
CC From: Genea Biocells, Ltd; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0375.
DI NCIt; C36425; Trisomy 3
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Genox 3.53
AC CVCL_K216
SY Genox3.53
DR CLO; CLO_0003473
DR ATCC; HB-103
DR IZSLER; BS Hy 62
RX PubMed=95015;
RX PubMed=6162228;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID GEO
AC CVCL_0271
SY Geo; HCT-GEO
DR BTO; BTO:0002892
DR MCCL; MCC:0000162
DR Cosmic; 738930
DR Cosmic; 889529
DR Cosmic; 1131685
DR Cosmic; 1479567
DR Cosmic; 1708407
DR Cosmic-CLP; 2164691
DR GEO; GSM1448176
RX PubMed=3349466;
RX PubMed=7329817;
RX PubMed=7761852;
RX PubMed=17363507;
RX PubMed=25926053;
CC Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC Omics: Deep exome analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GEOC4
AC CVCL_1Q48
RX PubMed=6686281;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1Q47 ! PCC4AO
CA Hybrid cell line
//
ID Ger
AC CVCL_8353
SY GER
DR BTO; BTO:0002865
DR Cosmic; 710856
RX PubMed=435363;
RX PubMed=11787853;
CC Doubling time: 36 hours, at 11th passage (PubMed=435363).
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID GES-1
AC CVCL_EQ22
SY GES1
DR GEO; GSM1152880
DR GEO; GSM1152881
DR GEO; GSM1152882
DR GEO; GSM1152883
DR GEO; GSM1152884
DR GEO; GSM1152885
DR GEO; GSM1923245
DR GEO; GSM1923246
DR GEO; GSM1923247
DR GEO; GSM1923248
DR GEO; GSM1923249
DR GEO; GSM1923250
RX PubMed=8033753;
RX PubMed=25633122;
RX PubMed=26690385;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID GEV
AC CVCL_E673
DR IHW; IHW0904
WW http://bioinformatics.hsanmartino.it/ecbr/cl376.html
CC Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID GF
AC CVCL_S931
SY Grouper Fin
RX PubMed=12962209;
CC Group: Fish cell line.
OX NCBI_TaxID=152218; ! Epinephelus awoara
OI CVCL_S930 ! GE
OI CVCL_S932 ! GH [Grouper]
OI CVCL_S934 ! GSB
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID GF-1
AC CVCL_J030
SY Grouper Fin-1
DR ATCC; PTA-859
RX DOI=10.1046/j.1365-2761.1999.00152.x;
RX Patent=US6566117;
CC Group: Fish cell line.
OX NCBI_TaxID=94232; ! Epinephelus coioides
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID GF-D8
AC CVCL_0272
SY GFD8
DR CLO; CLO_0003477
DR MCCL; MCC:0000163
DR CLDB; cl7058
DR BioSample; SAMN03473504
DR Cosmic; 787431
DR Cosmic; 975250
DR Cosmic; 1281314
DR Cosmic; 2306206
DR DSMZ; ACC-615
DR ICLC; HTL01009
RX PubMed=8443395;
RX PubMed=10451701;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=GF-D8
CC Characteristics: CSF2 or IL3 dependent.
CC Doubling time: ~48-72 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8,11
ST D16S539: 11,13
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 7
ST TPOX: 8,11
ST vWA: 15
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GF1053
AC CVCL_8W46
DR ECACC; 98061807
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GF1054
AC CVCL_8W47
DR ECACC; 98061808
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GFB3C-W1
AC CVCL_L019
RX CelloPub=CLPUB00251;
RX PubMed=21086187;
CC Group: Fish cell line.
OX NCBI_TaxID=7957; ! Carassius auratus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID GFKf
AC CVCL_6D93
SY GoldFish Kidney fibroblast
RX PubMed=26419476;
CC Group: Fish cell line.
OX NCBI_TaxID=7957; ! Carassius auratus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID GFM
AC CVCL_S161
SY GoldFish Muscle
RX PubMed=17972754;
CC Group: Fish cell line.
OX NCBI_TaxID=7957; ! Carassius auratus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID GFM1SV.25
AC CVCL_9U77
RX PubMed=27345796;
DI NCIt; C125663; Combined oxidative phosphorylation deficiency 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID GFP-CD16-F/F.NK-92
AC CVCL_W733
DR ATCC; PTA-8837
RX Patent=US8313943;
CC Transfected with: HGNC; 3619; FCGR3A.
CC Transfected with: UniProtKB; P42212; GFP.
DI NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2142 ! NK-92
SX Male
CA Cancer cell line
//
ID GFP-CD16-V/V.NK-92
AC CVCL_W734
DR ATCC; PTA-8836
RX Patent=US8313943;
CC Transfected with: HGNC; 3619; FCGR3A (with V-176).
CC Transfected with: UniProtKB; P42212; GFP.
DI NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2142 ! NK-92
SX Male
CA Cancer cell line
//
ID GFP-KSC4
AC CVCL_W142
DR ECACC; 11081701
DR Ximbio; 151713
RX PubMed=19907996;
CC Transfected with: UniProtKB; P42212; GFP.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID GFP+LJES1
AC CVCL_DF58
SY GFP(+)LJES1
RX PubMed=17136469;
CC Group: Fish cell line.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=8164; ! Lateolabrax japonicus
HI CVCL_M753 ! LJES1
SX Sex undetermined
CA Embryonic stem cell
//
ID GFPu-1
AC CVCL_5285
DR CLO; CLO_0003478
DR ATCC; CRL-2794
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 9,13
ST D5S818: 8
ST D7S820: 11,12
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID GFS
AC CVCL_L020
SY GoldFish Scale; GF-scale
RX DOI=10.1002/etc.5620100212;
CC Group: Fish cell line.
OX NCBI_TaxID=7957; ! Carassius auratus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID GFSB
AC CVCL_S162
SY GoldFish Swim Bladder
RX PubMed=17972754;
CC Group: Fish cell line.
OX NCBI_TaxID=7957; ! Carassius auratus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID GFSe
AC CVCL_6D94
SY GoldFish Snout epithelial
RX PubMed=26419476;
CC Group: Fish cell line.
OX NCBI_TaxID=7957; ! Carassius auratus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID GFSHR-17
AC CVCL_6635
SY GFSHR17
DR BTO; BTO:0002289
RX PubMed=8243796;
RX PubMed=8961254;
RX PubMed=15541573;
WW https://www.abmgood.com/Immortalized-Rat-Steroidogenic-Granulosa-Cells-stably-expressing-FSH-Receptor-(GFSHR-17)-T0605.html
CC Transfected with: HGNC; 5173; HRAS (with V-12).
CC Transfected with: RGD; 2632; Fshr.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Transformed cell line
//
ID GFSk-S1
AC CVCL_L021
SY GFSK-S1
RX PubMed=9088943;
CC Group: Fish cell line.
OX NCBI_TaxID=7957; ! Carassius auratus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID GFT
AC CVCL_S936
SY Guppy Fetal Tissue
RX DOI=10.1139/z85-427;
CC Group: Fish cell line.
OX NCBI_TaxID=8081; ! Poecilia reticulata
SX Female
CA Spontaneously immortalized cell line
//
ID GFTF
AC CVCL_R843
SY GoldFish Tail Fin
RX PubMed=21916901;
CC Group: Fish cell line.
OX NCBI_TaxID=7957; ! Carassius auratus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID GG-62
AC CVCL_9707
SY GG62
RX PubMed=12021921;
RX PubMed=12966428;
RX PubMed=15150091;
CC From: Van Valen F.; University of Munster; Germany.
DI NCIt; C3745; Clear cell sarcoma of soft tissue
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID GG2EE
AC CVCL_8602
RX PubMed=3119352;
RX PubMed=9039268;
WW http://www.infarktforschung.de/macrophages_cell_lines.html
CC Transformant: Recombinant retrovirus J2.
CC Breed/subspecies: C3H/HeJ.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID GG618-13
AC CVCL_IU57
SY GG618 clone 13
RX PubMed=6276755;
RX PubMed=6301144;
RX PubMed=6302703;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2676 ! P3HR-1
SX Male
CA Cancer cell line
//
ID GGD
AC CVCL_6G51
RX PubMed=2778838;
CC Transformant: Recombinant retrovirus J2.
CC Breed/subspecies: C57BL/6-Ly-5a.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID GGE-R
AC CVCL_0I70
DR CCLV; CCLV-RIE 0456
OX NCBI_TaxID=9913; ! Bos taurus
CA Finite cell line
//
ID GGO00326IN
AC CVCL_E162
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Sex undetermined
CA Transformed cell line
//
ID GGR41
AC CVCL_J985
DR CLO; CLO_0050337
DR RCB; RCB2021
RX PubMed=8221098;
CC Monoclonal antibody target: Gangliosides GQ1balpha.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID GGR51
AC CVCL_CW93
RX PubMed=7734848;
CC Monoclonal antibody target: ChEBI; CHEBI:90151; Ganglioside GM1b.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
CA Hybridoma
//
ID GH [Goldfish]
AC CVCL_IS36
SY Goldfish Heart
RX PubMed=28097494;
CC Group: Fish cell line.
OX NCBI_TaxID=7957; ! Carassius auratus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID GH [Grouper]
AC CVCL_S932
SY Grouper Heart
RX PubMed=12962209;
CC Group: Fish cell line.
OX NCBI_TaxID=152218; ! Epinephelus awoara
OI CVCL_S930 ! GE
OI CVCL_S931 ! GF
OI CVCL_S934 ! GSB
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID GH-1
AC CVCL_6C07
SY GH 1; GH1; Gekko Heart-1
RX PubMed=4314147;
RX PubMed=5659169;
CC Group: Reptilian cell line.
OX NCBI_TaxID=36310; ! Gecko gecko
OI CVCL_4207 ! GL-1 [Gecko]
SX Male
CA Spontaneously immortalized cell line
//
ID GH-2
AC CVCL_6C08
SY GH 2; GH2; Gekko Heart-2
RX PubMed=4314147;
RX PubMed=5659169;
CC Group: Reptilian cell line.
OX NCBI_TaxID=36310; ! Gecko gecko
SX Male
CA Spontaneously immortalized cell line
//
ID GH1
AC CVCL_0610
SY GH 1
DR CLO; CLO_0003481
DR CLO; CLO_0003483
DR CLO; CLO_0003486
DR CLDB; cl1453
DR CLDB; cl1454
DR ATCC; CCL-82
DR ECACC; 89072610
DR IFO; IFO50269
DR IZSLER; BS TCL 17
DR JCRB; JCRB9046
RX PubMed=4951281;
RX PubMed=15541569;
CC Breed/subspecies: Wistar Furth.
DI NCIt; C132194; Rat pituitary gland neoplasm
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_0273 ! GH3
OI CVCL_0275 ! GH4
SX Female
CA Cancer cell line
//
ID GH3
AC CVCL_0273
SY GH 3
DR BTO; BTO:0001410
DR CLO; CLO_0003482
DR CLO; CLO_0003484
DR CLO; CLO_0003487
DR MCCL; MCC:0000164
DR CLDB; cl1455
DR CLDB; cl1456
DR CLDB; cl1457
DR CLDB; cl1458
DR ATCC; CCL-82.1
DR BCRC; 60015
DR BCRJ; 0090
DR CCRID; 3111C0001CCC000008
DR ChEMBL-Cells; CHEMBL3307652
DR ChEMBL-Targets; CHEMBL614571
DR DSMZ; ACC-469
DR ECACC; 87012603
DR ICLC; ATL96003
DR IFO; IFO50105
DR IZSLER; BS TCL 18
DR JCRB; JCRB9047
DR KCLB; 10082.1
DR Lonza; 613
DR TOKU-E; 1327
RX PubMed=4951281;
RX PubMed=15541569;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/g/cell-lines-detail-288.html
CC Doubling time: ~60-90 hours (DSMZ).
CC Breed/subspecies: Wistar Furth.
DI NCIt; C132194; Rat pituitary gland neoplasm
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_0610 ! GH1
OI CVCL_0275 ! GH4
SX Female
CA Cancer cell line
//
ID GH3/GH-EYFP
AC CVCL_U370
RX PubMed=15923356;
CC Transfected with: RGD; 2686; Gh1.
CC Transfected with: UniProtKB; P42212; EYFP (modified GFP at L-46, 64-LG-65, L-68, A-72, T-153, A-163, G-175, Y-203 and L-231).
CC Breed/subspecies: Wistar Furth.
DI NCIt; C132194; Rat pituitary gland neoplasm
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0273 ! GH3
SX Female
CA Cancer cell line
//
ID GH329
AC CVCL_6395
SY GH-3-29
DR CLO; CLO_0003488
DR ATCC; CRL-13002
DR ATCC; PTA-803
RX Patent=US6365394;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Discontinued: ATCC; PTA-803; true.
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID GH354
AC CVCL_6396
SY GH-3-54
DR CLO; CLO_0003489
DR ATCC; CRL-13003
DR ATCC; PTA-3404
RX Patent=US6365394;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Discontinued: ATCC; PTA-3404; true.
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID GH364
AC CVCL_K171
SY GH-3-64
DR ATCC; CRL-13004
DR ATCC; PTA-3405
RX Patent=US6365394;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Discontinued: ATCC; CRL-13004; true.
CC Discontinued: ATCC; PTA-3405; true.
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID GH3B6
AC CVCL_0274
SY GH3.B6; GH3/B6
DR MCCL; MCC:0000165
DR BCRJ; 0091
DR NCBI_Iran; C610
CC Breed/subspecies: Wistar Furth.
DI NCIt; C132194; Rat pituitary gland neoplasm
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0273 ! GH3
SX Female
CA Cancer cell line
//
ID GH4
AC CVCL_0275
DR MCCL; MCC:0000166
DR TOKU-E; 3555
RX PubMed=15541569;
CC Breed/subspecies: Wistar Furth.
DI NCIt; C132194; Rat pituitary gland neoplasm
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_0610 ! GH1
OI CVCL_0273 ! GH3
SX Female
CA Cancer cell line
//
ID GH4C1
AC CVCL_0276
SY GH4 C 1; GH4-C1
DR BTO; BTO:0002767
DR CLO; CLO_0003485
DR CLO; CLO_0003490
DR MCCL; MCC:0000167
DR CLDB; cl1459
DR ATCC; CCL-82.2
DR ChEMBL-Cells; CHEMBL3307497
DR ChEMBL-Targets; CHEMBL614572
DR DSMZ; ACC-482
DR ICLC; ATL96006
RX PubMed=15541569;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/g/cell-lines-detail-289.html
CC Doubling time: ~60-80 hours (DSMZ).
CC Breed/subspecies: Wistar Furth.
DI NCIt; C132194; Rat pituitary gland neoplasm
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0273 ! GH3
SX Female
CA Cancer cell line
//
ID GH4I12
AC CVCL_8154
RX PubMed=8171043;
CC Transfected with: RGD; 2520; Drd2 (isoform long).
CC Breed/subspecies: Wistar Furth.
DI NCIt; C132194; Rat pituitary gland neoplasm
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0276 ! GH4C1
SX Female
CA Cancer cell line
//
ID GH4ZR7
AC CVCL_0277
DR MCCL; MCC:0000168
RX PubMed=1688845;
RX PubMed=8171043;
CC Transfected with: RGD; 2520; Drd2 (isoform short).
CC Breed/subspecies: Wistar Furth.
DI NCIt; C132194; Rat pituitary gland neoplasm
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0276 ! GH4C1
SX Female
CA Cancer cell line
//
ID GHBP116
AC CVCL_J277
DR JCRB; JCRB1226
RX PubMed=10443474;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID GHE
AC CVCL_8199
SY Glioblastome Humain E
DR BioSample; SAMN03151940
RX PubMed=10508494;
RX PubMed=18472955;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=10508494, PubMed=20143388). Originally thought to originate from an astrocytoma.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0554 ! T24
SX Female
CA Cancer cell line
//
ID GHE-L
AC CVCL_8153
RX PubMed=2181436;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
CA Spontaneously immortalized cell line
//
ID GHFT1-5
AC CVCL_J506
SY GHFT1
RX PubMed=8096199;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID GHINK-1
AC CVCL_W390
RX PubMed=15369136;
CC Transfected with: UniProtKB; P42212; GFP.
DI NCIt; C40407; Renal Wilms tumor
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8691 ! HFWT
SX Male
CA Cancer cell line
//
ID GHOST(3)
AC CVCL_S489
SY GHOST (3); GHOST Parental cells
DR NIH-ARP; 3679-234
WW http://www.nibsc.org/Default.aspx?pageid=597&ID=0082
CC Transfected with: UniProtKB; P42212; GFP.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0312 ! HOS
SX Female
CA Cancer cell line
//
ID GHOST(3).BOB/GPR15
AC CVCL_1E05
SY GHOST (3) BOB/GPR15; GHOST cell BOB/GPR15
DR NIH-ARP; 3686-240
WW http://www.nibsc.org/Default.aspx?pageid=597&ID=0080
CC Transfected with: UniProtKB; P42212; GFP.
CC Transfected with: HGNC; 4469; GPR15.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S489 ! GHOST(3)
SX Female
CA Cancer cell line
//
ID GHOST(3).CCR1
AC CVCL_1E06
SY GHOST (3) CCR1; GHOST cell CCR1
DR NIH-ARP; 3680-235
WW http://www.nibsc.org/Default.aspx?pageid=597&ID=0074
CC Transfected with: UniProtKB; P42212; GFP.
CC Transfected with: HGNC; 1602; CCR1.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S489 ! GHOST(3)
SX Female
CA Cancer cell line
//
ID GHOST(3).CCR2b
AC CVCL_1E07
SY GHOST (3) CCR2b; GHOST cell CCR2
DR NIH-ARP; 3681-236
WW http://www.nibsc.org/Default.aspx?pageid=597&ID=0075
CC Transfected with: UniProtKB; P42212; GFP.
CC Transfected with: HGNC; 1603; CCR2.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S489 ! GHOST(3)
SX Female
CA Cancer cell line
//
ID GHOST(3).CCR3
AC CVCL_S490
SY GHOST (3) CCR3; GHOST cell CCR3
DR NIH-ARP; 3682-237
RX PubMed=11878871;
RX PubMed=16061987;
WW http://www.nibsc.org/Default.aspx?pageid=597&ID=0076
CC Transfected with: UniProtKB; P42212; GFP.
CC Transfected with: HGNC; 1604; CCR3.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S489 ! GHOST(3)
SX Female
CA Cancer cell line
//
ID GHOST(3).CCR4
AC CVCL_S497
SY GHOST(3) CCR4; GHOST (3) CCR4; GHOST cell CCR4
DR NIH-ARP; 3683-238
WW http://www.nibsc.org/Default.aspx?pageid=597&ID=0077
CC Transfected with: UniProtKB; P42212; GFP.
CC Transfected with: HGNC; 1605; CCR4.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S489 ! GHOST(3)
SX Female
CA Cancer cell line
//
ID GHOST(3).CCR5
AC CVCL_S491
SY GHOST(3)-CCR5; GHOST CCR5; GHOST cell CCR5
DR ChEMBL-Cells; CHEMBL3308560
DR ChEMBL-Targets; CHEMBL614502
RX PubMed=11878871;
RX PubMed=16061987;
WW http://www.nibsc.org/Default.aspx?pageid=597&ID=0078
CC Transfected with: UniProtKB; P42212; GFP.
CC Transfected with: HGNC; 1606; CCR5.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S489 ! GHOST(3)
SX Female
CA Cancer cell line
//
ID GHOST(3).CCR8
AC CVCL_S494
SY GHOST (3) CCR8; GHOST(3) CCR8; GHOST cell CCR8
DR NIH-ARP; 3940-243
WW http://www.nibsc.org/Default.aspx?pageid=597&ID=0083
CC Transfected with: UniProtKB; P42212; GFP.
CC Transfected with: HGNC; 1609; CCR8.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S489 ! GHOST(3)
SX Female
CA Cancer cell line
//
ID GHOST(3).CXCR4
AC CVCL_S492
SY GHOST(3)-CXCR4; GHOST (3) CXCR4; GHOST(3) CXCR4; GHOST CXCR4; Ghost-CXCR4; GHOST cell CXCR4
DR ChEMBL-Cells; CHEMBL3307789
DR ChEMBL-Targets; CHEMBL612253
DR NIH-ARP; 3685-448
RX PubMed=11878871;
RX PubMed=16061987;
WW http://www.nibsc.org/Default.aspx?pageid=597&ID=0079
CC Transfected with: UniProtKB; P42212; GFP.
CC Transfected with: HGNC; 2561; CXCR4.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S489 ! GHOST(3)
SX Female
CA Cancer cell line
//
ID GHOST(3).CXCR6
AC CVCL_S493
SY GHOST (3) Bonzo/STRL33; GHOST cell BONZO/STRL33
DR NIH-ARP; 3687-241
RX PubMed=16061987;
WW http://www.nibsc.org/Default.aspx?pageid=597&ID=0081
CC Transfected with: UniProtKB; P42212; GFP.
CC Transfected with: HGNC; 16647; CXCR6.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S489 ! GHOST(3)
SX Female
CA Cancer cell line
//
ID GHOST(3).Hi-5
AC CVCL_1E17
SY GHOST (3) Hi-5; GHOST(3) Hi-5; GHOST(3) Hi5; GHOST-Hi5; Ghost-Hi5; GHOST Hi5; Ghost HI-5; GHOST cell Hi5
DR NIH-ARP; 3944-343
WW http://www.nibsc.org/Default.aspx?pageid=597&ID=0086
CC Transfected with: UniProtKB; P42212; GFP.
CC Transfected with: HGNC; 1606; CCR5.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S489 ! GHOST(3)
SX Female
CA Cancer cell line
//
ID GHOST(3).R3/X4/R5
AC CVCL_1E08
SY GHOST (3) R3/X4/R5; GHOST(3)R3/X4/R5; GHOST-R3/X4/R5; Ghost R3-X4-R5; Ghost-R5-X4-R3; GHOST cell R3/X4/R5
DR NIH-ARP; 3943-245
WW http://www.nibsc.org/Default.aspx?pageid=597&ID=0085
CC Transfected with: UniProtKB; P42212; GFP.
CC Transfected with: HGNC; 1604; CCR3.
CC Transfected with: HGNC; 1606; CCR5.
CC Transfected with: HGNC; 2561; CXCR4.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S489 ! GHOST(3)
SX Female
CA Cancer cell line
//
ID GHOST(3).V28/CX3CR1
AC CVCL_1E09
SY GHOST (3) V28/CX3CR1; GHOST cell V28 CXCR1
DR NIH-ARP; 3939-242
WW http://www.nibsc.org/Default.aspx?pageid=597&ID=0087
CC Transfected with: UniProtKB; P42212; GFP.
CC Transfected with: HGNC; 2558; CX3CR1.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S489 ! GHOST(3)
SX Female
CA Cancer cell line
//
ID GHOST(3).X4/R5
AC CVCL_1E10
SY GHOST (3) X4/R5; GHOST cell X4/R5
DR NIH-ARP; 3942-394
WW http://www.nibsc.org/Default.aspx?pageid=597&ID=0084
CC Transfected with: UniProtKB; P42212; GFP.
CC Transfected with: HGNC; 1606; CCR5.
CC Transfected with: HGNC; 2561; CXCR4.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S489 ! GHOST(3)
SX Female
CA Cancer cell line
//
ID GI-1
AC CVCL_1231
DR CLO; CLO_0050634
DR BioSample; SAMN03470902
DR CCLE; GI1_CENTRAL_NERVOUS_SYSTEM
DR ChEMBL-Cells; CHEMBL3308167
DR ChEMBL-Targets; CHEMBL2366272
DR Cosmic; 687569
DR Cosmic; 906871
DR Cosmic; 2367527
DR Cosmic-CLP; 906871
DR GDSC; 906871
DR GEO; GSM887024
DR GEO; GSM888094
DR GEO; GSM1669809
DR RCB; RCB0763
RX PubMed=1545891;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; PubMed=25877200; RCB
ST Amelogenin: X,Y
ST CSF1PO: 9
ST D13S317: 8
ST D16S539: 9,10
ST D18S51: 13
ST D19S433: 13,14
ST D21S11: 29,30
ST D2S1338: 16,18
ST D3S1358: 15,18
ST D5S818: 11
ST D7S820: 11
ST D8S1179: 10,16
ST FGA: 23,24
ST Penta D: 11,12
ST Penta E: 12,15
ST TH01: 9
ST TPOX: 8,12
ST vWA: 17
DI NCIt; C3796; Gliosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GI-101A
AC CVCL_0278
AS CVCL_5214
SY GI101A; GI 101A; GI-101; GI 101; GI101
DR MCCL; MCC:0000169
DR Cosmic; 687469
DR GEO; GSM217569
RX Patent=US6037520;
RX PubMed=10328849;
RX PubMed=12800145;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/GI%20101.html
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID GI-102
AC CVCL_D589
DR BTO; BTO:0005302
RX PubMed=12601555;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID GI-103
AC CVCL_D616
RX PubMed=12601555;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GI-112
AC CVCL_D617
RX PubMed=12601555;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID GI-117
AC CVCL_D618
RX PubMed=12601555;
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID GI-CA-N
AC CVCL_3369
SY Gi-CA-N; GICAN; Gaslini Institute-CA-Neuroblastoma
DR CLO; CLO_0003492
DR CLDB; cl1460
DR ICLC; HTL96025
RX DOI=10.1007/0-306-46872-7_2;
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=2307545;
RX PubMed=3204111;
CC Discontinued: ICLC; HTL96025; true.
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GI-LA-N
AC CVCL_8874
SY GILAN; Gaslini Institute-LA-Neuroblastoma
DR BTO; BTO:0005807
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=3422578;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GI-LI-N
AC CVCL_3370
SY Gi-Li-N; GILIN; Gaslini Institute-LI-Neuroblastoma
DR CLO; CLO_0003493
DR CLDB; cl1462
DR Cosmic; 753617
DR ICLC; HTL96013
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=3204111;
CC Discontinued: ICLC; HTL96013; true.
CC Derived from metastatic site: Peripheral blood.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GI-ME-N
AC CVCL_1232
SY Gi-ME-N; GIMEN; Gimen; Gimen1; Gaslini Institute-ME-Neuroblastoma
DR BTO; BTO:0005808
DR CLO; CLO_0003494
DR CLDB; cl1464
DR CLDB; cl4931
DR BioSample; SAMN03473467
DR ChEMBL-Cells; CHEMBL3308868
DR ChEMBL-Targets; CHEMBL2366074
DR CLS; 300179/p640_Gimen
DR Cosmic; 755616
DR Cosmic; 906872
DR Cosmic; 1167992
DR Cosmic; 1518065
DR Cosmic; 1526625
DR Cosmic; 1543771
DR Cosmic; 2239471
DR Cosmic-CLP; 906872
DR DSMZ; ACC-654
DR GDSC; 906872
DR GEO; GSM692856
DR GEO; GSM1669810
DR ICLC; HTL98011
RX DOI=10.1007/0-306-46872-7_2;
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=2296463;
RX PubMed=2535035;
RX PubMed=2917605;
RX PubMed=3204111;
RX PubMed=3406012;
RX PubMed=3422578;
RX PubMed=3615018;
RX PubMed=7838528;
RX PubMed=9516836;
RX PubMed=11550280;
RX PubMed=22213050;
RX PubMed=27397505;
CC Doubling time: ~24 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): CLS; Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12 (CLS)
ST D13S317: 8,12 (Cosmic-CLP; DSMZ)
ST D16S539: 9,12
ST D18S51: 12,17
ST D21S11: 31
ST D3S1358: 14
ST D5S818: 12
ST D7S820: 10,11
ST D8S1179: 10,14
ST FGA: 19,22
ST Penta D: 9,13
ST Penta E: 15,20
ST TH01: 6,7
ST TPOX: 11
ST vWA: 16,19
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID GI0001
AC CVCL_8W48
DR ECACC; 95081041
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID GI0002
AC CVCL_8W49
DR ECACC; 95081042
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID GiCB
AC CVCL_CW64
SY Gibel Carp Brain
RX Patent=US20160017284;
RX PubMed=25912023;
CC Group: Fish cell line.
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C2013179.
OX NCBI_TaxID=101364; ! Carassius gibelio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID GICIN-1
AC CVCL_9476
SY GI-CI-N-1
DR Cosmic; 1526624
RX PubMed=10640144;
CC Misspelling: 'GICIN' in Cosmic 1526624.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Gie-No3B11
AC CVCL_6A81
SY MCNr3B11
RX PubMed=18771458;
WW https://www.abmgood.com/Immortalized-Gingival-Keratinocytes-(Gie-No3B11)-T0049.html
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
CC Miscellaneous: Cell line recommanded name and gender from author direct submission.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GILM1
AC CVCL_D255
RX PubMed=14598885;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0278 ! GI-101A
SX Female
CA Cancer cell line
//
ID GILM2
AC CVCL_D256
RX PubMed=14598885;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D255 ! GILM1
SX Female
CA Cancer cell line
//
ID GILM3
AC CVCL_S917
RX PubMed=14598885;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D256 ! GILM2
SX Female
CA Cancer cell line
//
ID Gin-1
AC CVCL_F842
SY GIN-1; Gin 1
DR ATCC; CRL-1292
CC Discontinued: ATCC; CRL-1292; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GingF12
AC CVCL_L241
WW http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L231 ! OKG12
SX Male
CA Finite cell line
//
ID Girardi Heart
AC CVCL_2254
SY Girardi heart; GIRARDI HEART
DR CLO; CLO_0003495
DR CLDB; cl1466
DR CLDB; cl1467
DR CLDB; cl1468
DR ATCC; CCL-27
DR BioSample; SAMN03151697
DR ECACC; 93120822
DR IZSLER; BS CL 47
RX DOI=10.1007/978-1-4757-1647-4_13;
RX PubMed=566722;
RX PubMed=1246601;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=566722, PubMed=1246601, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Discontinued: ATCC; CCL-27; true.
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID Girardi Heart clone 2
AC CVCL_1815
SY GIRARDI HEART C2; GHc2
DR CLO; CLO_0003496
DR CLDB; cl1469
DR DSMZ; ACC-116
RX PubMed=20143388;
CC Problematic cell line: Contaminated. Parent cell line (Girardi Heart) has been shown to be a HeLa derivative (PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12,13.3
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2254 ! Girardi Heart
SX Female
CA Cancer cell line
//
ID Girardi Heart clone 7
AC CVCL_1816
SY GIRARDI HEART C7; GHc7
DR CLO; CLO_0003497
DR CLDB; cl1470
DR DSMZ; ACC-121
RX DOI=10.1007/BF03191992;
RX PubMed=20143388;
CC Problematic cell line: Contaminated. Parent cell line (Girardi Heart) has been shown to be a HeLa derivative (PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12,13.3
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2254 ! Girardi Heart
SX Female
CA Cancer cell line
//
ID GIST-DR
AC CVCL_M444
RX PubMed=15882927;
CC Breed/subspecies: Wistar.
DI NCIt; C60682; Rat digestive system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID GIST-H1
AC CVCL_M440
RX PubMed=21131734;
CC Doubling time: 47.5 hours (PubMed=21131734).
DI NCIt; C3868; Gastrointestinal stromal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GIST-T-1
AC CVCL_4976
SY GIST-T1
DR Cosmic; 1029465
DR Cosmic; 1873953
RX PubMed=12004007;
DI NCIt; C3868; Gastrointestinal stromal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GIST-T1/829
AC CVCL_S983
DR Cosmic; 1873952
RX PubMed=22665524;
CC Selected for resistance to: ChEBI; CHEBI:45783; Imatinib (Gleevec; STI571).
DI NCIt; C3868; Gastrointestinal stromal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4976 ! GIST-T-1
CA Cancer cell line
//
ID GIST430
AC CVCL_7040
SY GIST-430; GIST 430
DR Cosmic; 1180674
DR Cosmic; 1873951
DR GEO; GSM486233
RX PubMed=16982758;
DI NCIt; C3868; Gastrointestinal stromal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GIST48
AC CVCL_7041
SY GIST-48; GIST 48
DR Cosmic; 1180673
DR Cosmic; 1873950
DR GEO; GSM486229
RX PubMed=16982758;
RX PubMed=22294416;
DI NCIt; C3868; Gastrointestinal stromal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GIST48B
AC CVCL_M441
RX PubMed=19706776;
DI NCIt; C3868; Gastrointestinal stromal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7041 ! GIST48
CA Cancer cell line
//
ID GIST522
AC CVCL_7042
SY GIST-522
DR Cosmic; 1180676
DR GEO; GSM486231
RX PubMed=19706776;
DI NCIt; C3868; Gastrointestinal stromal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GIST62
AC CVCL_7043
SY GIST-62; GIST 62
DR Cosmic; 1180675
DR GEO; GSM486230
RX PubMed=16982758;
DI NCIt; C3868; Gastrointestinal stromal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GIST882
AC CVCL_7044
SY GIST-882; GIST 882
DR Cosmic; 1180672
DR Cosmic; 1217560
DR Cosmic; 1244759
DR Cosmic; 1477623
DR Cosmic; 1873949
DR GEO; GSM486234
DR Lonza; 694
RX PubMed=11526490;
RX PubMed=16982758;
DI NCIt; C3868; Gastrointestinal stromal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GJC
AC CVCL_Z598
RX PubMed=8943096;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Z599 ! GJR
SX Male
CA Cancer cell line
//
ID GJR
AC CVCL_Z599
RX PubMed=8943096;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Z598 ! GJC
SX Male
CA Cancer cell line
//
ID GK
AC CVCL_R902
SY Grouper Kidney
RX DOI=10.1046/j.1365-2761.2000.00247.x;
CC Group: Fish cell line.
OX NCBI_TaxID=152218; ! Epinephelus awoara
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID GK-5
AC CVCL_7265
DR CLO; CLO_0003499
DR ATCC; CRL-1834
CC Group: Hybridoma fusion partner cell line.
CC Problematic cell line: Misidentified. Grand-parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 11
ST D5S818: 10,12
ST D7S820: 10
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H616 ! GM1500-6TG-A12
SX Male
CA Transformed cell line
//
ID GK-7
AC CVCL_IV57
SY Grouper Kidney-7
RX DOI=10.4172/2155-9910.1000192;
CC Group: Fish cell line.
OX NCBI_TaxID=94232; ! Epinephelus coioides
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID GK0001
AC CVCL_8W50
DR ECACC; 95101919
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GK0002
AC CVCL_8W51
DR ECACC; 95101920
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GK0003
AC CVCL_8W52
DR ECACC; 95101921
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GK1.5
AC CVCL_4523
SY GK 1.5; GK-1.5
DR CLO; CLO_0003498
DR CLDB; cl5190
DR ATCC; TIB-207
DR BCRC; 60472
DR BCRJ; 0092
DR CCRID; 3131C0001000600043
DR IZSLER; BS Hy 25
DR KCLB; 40207
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID GK129
AC CVCL_5A07
SY GK-129; GK 129
RX PubMed=1604321;
CC Breed/subspecies: 129P2/OlaHsd.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID GK129/1
AC CVCL_5A08
CC Breed/subspecies: 129P2/OlaHsd.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5A07 ! GK129
SX Male
CA Embryonic stem cell
//
ID GK1C
AC CVCL_M442
RX PubMed=23619463;
DI NCIt; C3868; Gastrointestinal stromal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GK3C
AC CVCL_M443
RX PubMed=23619463;
DI NCIt; C3868; Gastrointestinal stromal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GKA
AC CVCL_6G36
RX PubMed=6690059;
RX PubMed=6825111;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID GKP2
AC CVCL_2G65
DR BCGO; BCGO_0000109
WW https://www.betacell.org/pdf/betacell-resource-1038.pdf
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C34053; Mouse insulinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID GKP4
AC CVCL_2G66
DR BCGO; BCGO_0000110
WW https://www.betacell.org/pdf/betacell-resource-1038.pdf
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C34053; Mouse insulinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID GL
AC CVCL_R903
SY Grouper Liver
RX DOI=10.1046/j.1365-2761.2000.00247.x;
CC Group: Fish cell line.
OX NCBI_TaxID=152218; ! Epinephelus awoara
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID GL-1 [Dog leukemia]
AC CVCL_L352
RX PubMed=8741612;
RX PubMed=22236332;
RX PubMed=23365669;
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
CC Breed/subspecies: German Shepherd.
DI NCIt; C128120; Canine leukemia
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID GL-1 [Gecko]
AC CVCL_4207
SY GL 1; GL1; Gekko Lung-1
DR CLO; CLO_0003471
DR CLO; CLO_0003500
DR CLDB; cl1471
DR ATCC; CCL-111
DR ECACC; 89072612
RX PubMed=4314147;
RX PubMed=5659169;
RX PubMed=6062904;
RX PubMed=7065527;
RX PubMed=23891577;
CC Group: Reptilian cell line.
OX NCBI_TaxID=36310; ! Gecko gecko
OI CVCL_6C07 ! GH-1
SX Male
CA Spontaneously immortalized cell line
//
ID GL-E
AC CVCL_0C11
DR Cosmic; 2239093
RX PubMed=7736387;
RX PubMed=9559344;
RX PubMed=9815546;
RX PubMed=10037197;
CC Derived from metastatic site: Pericardial effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GL-Mel
AC CVCL_M741
DR Cosmic; 1295334
CC From: Guadagni F.; Istituto Regina Elena; Roma; Italy.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GL-V3
AC CVCL_DC65
SY V3; Glaxo Laboratories - Vervet no. 3
DR ATCC; CRL-1433
RX PubMed=4043530;
RX PubMed=4318075;
CC Group: Non-human primate cell line.
CC Discontinued: ATCC; CRL-1433; true.
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
CA Spontaneously immortalized cell line
//
ID GL1
AC CVCL_9175
DR CLO; CLO_0003501
DR ATCC; HB-253
DR BCRC; 60291
DR NCBI_Iran; H136
CC Monoclonal antibody target: UniProtKB; P42082; Mouse Cd86.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID GL15
AC CVCL_5H95
SY GL-15
RX PubMed=1655272;
RX PubMed=8237465;
RX PubMed=8845742;
RX PubMed=10074188;
RX PubMed=16391870;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GL22
AC CVCL_5H96
RX PubMed=1655272;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GL261
AC CVCL_Y003
SY Glioma 261; GLIOMA 261; Glioma-261; GL-261
DR BCRJ; 0299
DR DSMZ; ACC-802
DR PRIDE; PXD000589
DR Wikidata; Q27547979
RX PubMed=16734735;
RX PubMed=25894527;
WW https://en.wikipedia.org/wiki/Glioma_261
CC Doubling time: ~100-120 hours (DSMZ).
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Omics: Cell surface proteome.
CC Misspelling: Occasionally 'GI261'.
CC Breed/subspecies: C57BL/6.
DI NCIt; C21600; Mouse neuroglia neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID GL261-luc2
AC CVCL_X986
WW http://web.archive.org/web/20150518034753/http://www.perkinelmer.com/catalog/product/id/134246
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Discontinued: PerkinElmer; Catalog number 134246.
CC Breed/subspecies: C57BL/6.
DI NCIt; C21600; Mouse neuroglia neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_Y003 ! GL261
CA Cancer cell line
//
ID GL261-Red-FLuc
AC CVCL_5I93
SY GL261 Red-FLuc
WW http://www.perkinelmer.com/Catalog/Product/ID/BW134246
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: C57BL/6.
DI NCIt; C21600; Mouse neuroglia neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_Y003 ! GL261
CA Cancer cell line
//
ID GL7
AC CVCL_9176
DR CLO; CLO_0003503
DR ATCC; HB-254
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID GLAG-66
AC CVCL_9918
RX PubMed=8330267;
RX PubMed=19087340;
DI NCIt; C4035; Thyroid gland papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GLC-1
AC CVCL_8200
SY GLC 1; GLC1; OC-Roi
DR Cosmic; 2239118
DR GEO; GSM986185
DR PRIDE; PXD000132
RX PubMed=2998591;
RX PubMed=9559344;
RX PubMed=10709110;
RX PubMed=23651173;
CC Omics: Proteome analysis by 2D-DE/MS.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GLC-1-M13
AC CVCL_8201
SY GLC1 M13; GLC1M13; GLC-1-13
DR PRIDE; PXD000132
RX PubMed=2998591;
RX PubMed=23651173;
CC Omics: Proteome analysis by 2D-DE/MS.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8200 ! GLC-1
SX Male
CA Cancer cell line
//
ID GLC-11
AC CVCL_8202
SY GLC 11; GLC11
RX PubMed=2838297;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GLC-12
AC CVCL_8203
SY GLC 12; GLC12
RX PubMed=1314232;
RX PubMed=2409557;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GLC-14
AC CVCL_8204
SY GLC 14; GLC14
DR Cosmic; 2239124
DR GEO; GSM554391
RX PubMed=1314232;
RX PubMed=2846164;
RX PubMed=9212023;
RX PubMed=9559344;
RX PubMed=9744504;
RX PubMed=10709110;
RX PubMed=12712436;
RX PubMed=20631050;
CC Omics: Array-based CGH.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Supraclavicular lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8205 ! GLC-16
OI CVCL_8206 ! GLC-19
SX Female
CA Cancer cell line
//
ID GLC-15
AC CVCL_6904
DR CCRID; 3153C0001000000009
DR KCB; KCB 90028YJ
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GLC-16
AC CVCL_8205
SY GLC 16; GLC16
RX PubMed=2574988;
RX PubMed=2846164;
RX PubMed=9212023;
RX PubMed=9744504;
RX PubMed=10709110;
RX PubMed=12712436;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8204 ! GLC-14
OI CVCL_8206 ! GLC-19
SX Female
CA Cancer cell line
//
ID GLC-19
AC CVCL_8206
SY GLC 19; GLC19
RX PubMed=2846164;
RX PubMed=9212023;
RX PubMed=9744504;
RX PubMed=10709110;
RX PubMed=12712436;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8204 ! GLC-14
OI CVCL_8205 ! GLC-16
SX Female
CA Cancer cell line
//
ID GLC-2
AC CVCL_8207
SY GLC 2; GLC2; OC-Ny; OC-NYH; NYH
DR BTO; BTO:0005499
DR Cosmic; 1759250
DR Cosmic; 2239119
DR GEO; GSM986182
RX PubMed=2574988;
RX PubMed=2998591;
RX PubMed=9212023;
RX PubMed=9559344;
RX PubMed=9744504;
RX PubMed=10709110;
RX PubMed=12712436;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GLC-20
AC CVCL_8208
SY GLC 20; GLC20
DR Cosmic; 877400
DR Cosmic; 2239125
RX PubMed=1314232;
RX PubMed=9559344;
RX PubMed=10709110;
CC Misspelling: '6LC20' in Cosmic 877400.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GLC-22
AC CVCL_8209
SY GLC 22; GLC22
RX PubMed=1314232;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GLC-26
AC CVCL_8210
SY GLC 26; GLC26
RX PubMed=8410137;
RX PubMed=9212023;
RX PubMed=9744504;
RX PubMed=12712436;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8211 ! GLC-28
CA Cancer cell line
//
ID GLC-28
AC CVCL_8211
SY GLC 28; GLC28
DR Cosmic; 2239126
RX PubMed=8410137;
RX PubMed=9212023;
RX PubMed=9559344;
RX PubMed=9744504;
RX PubMed=10709110;
RX PubMed=12712436;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8210 ! GLC-26
CA Cancer cell line
//
ID GLC-3
AC CVCL_8212
SY GLC 3; GLC3; OC-Tol; OC-TOL
DR Cosmic; 2239120
RX PubMed=1314232;
RX PubMed=2574988;
RX PubMed=2998591;
RX PubMed=9212023;
RX PubMed=9559344;
RX PubMed=9744504;
RX PubMed=12712436;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GLC-33
AC CVCL_8213
SY GLC 33; GLC33
RX PubMed=1314232;
CC Derived from metastatic site: Supraclavicular lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID GLC-34
AC CVCL_8214
SY GLC 34; GLC34
DR Cosmic; 2239127
RX PubMed=9559344;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GLC-35
AC CVCL_0B61
SY GLC35
DR Cosmic; 2239128
RX PubMed=9559344;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GLC-36
AC CVCL_8215
SY GLC 36; GLC36
DR Cosmic; 2239129
DR GEO; GSM986186
RX PubMed=9559344;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GLC-4
AC CVCL_0279
SY GLC 4; GLC4
DR BTO; BTO:0002385
DR MCCL; MCC:0000170
DR ChEMBL-Cells; CHEMBL3307807
DR ChEMBL-Targets; CHEMBL612707
DR Cosmic; 1429646
DR Cosmic; 1998274
DR Cosmic; 2239121
DR GEO; GSM536324
RX PubMed=1657425;
RX PubMed=3028613;
RX PubMed=9559344;
RX PubMed=10709110;
RX PubMed=15150577;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GLC-4/ADR
AC CVCL_4997
SY GLC4-Adr; GLC4/ADR; GLC(4)/ADR
DR BTO; BTO:0002386
RX PubMed=1657425;
RX PubMed=3028613;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0279 ! GLC-4
SX Male
CA Cancer cell line
//
ID GLC-4/AM3x
AC CVCL_Y299
SY GLC4/AM3x
RX PubMed=8980384;
CC Selected for resistance to: ChEBI; CHEBI:2687; Amsacrine.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0279 ! GLC-4
SX Male
CA Cancer cell line
//
ID GLC-4/CDDP
AC CVCL_4998
SY GLC4-CDDP; GLC4/CDDP; GLC4/cDDP
DR BTO; BTO:0002388
DR Cosmic; 1998275
DR GEO; GSM536325
RX PubMed=1657425;
RX PubMed=2163989;
RX PubMed=2846161;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0279 ! GLC-4
SX Male
CA Cancer cell line
//
ID GLC-4/CDDP11
AC CVCL_Y297
SY GLC4/CDDP11
RX PubMed=2163989;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0279 ! GLC-4
SX Male
CA Cancer cell line
//
ID GLC-4/CDDP3
AC CVCL_Y298
SY GLC4-CDDP3
RX PubMed=2163989;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0279 ! GLC-4
SX Male
CA Cancer cell line
//
ID GLC-4/MIT60x
AC CVCL_4999
AS CVCL_Y300
SY GLC4/MIT60X; GLC4-MITO; GLC4/MITO; GLC-4/MITO
DR BTO; BTO:0002387
RX PubMed=8980384;
RX PubMed=15150577;
CC Selected for resistance to: ChEBI; CHEBI:50729; Mitoxantrone.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0279 ! GLC-4
SX Male
CA Cancer cell line
//
ID GLC-4/VM20x
AC CVCL_Y301
SY GLC4/VM20x
RX PubMed=8980384;
CC Selected for resistance to: ChEBI; CHEBI:75988; Teniposide (VM-26).
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0279 ! GLC-4
SX Male
CA Cancer cell line
//
ID GLC-42
AC CVCL_8216
SY GLC 42; GLC42
DR Cosmic; 2239130
RX PubMed=9559344;
RX PubMed=10709110;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GLC-44
AC CVCL_0B62
SY GLC44
DR Cosmic; 2239131
RX PubMed=9559344;
RX PubMed=10709110;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GLC-45
AC CVCL_0B63
SY GLC45
DR Cosmic; 2239132
DR TOKU-E; 3618
RX PubMed=9559344;
RX PubMed=10709110;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GLC-7
AC CVCL_8217
SY GLC 7; GLC7
DR Cosmic; 2239122
RX PubMed=2409557;
RX PubMed=9559344;
RX PubMed=10709110;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GLC-8
AC CVCL_8218
SY GLC 8; GLC8
DR Cosmic; 2239123
DR GEO; GSM554390
DR GEO; GSM986183
RX PubMed=2838297;
RX PubMed=2409557;
RX PubMed=9559344;
RX PubMed=10709110;
RX PubMed=20631050;
CC Omics: Array-based CGH.
CC Omics: SNP array analysis.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GLC-82
AC CVCL_3371
SY Glc-82; GLC82; Gejiu Lung Carcinoma-82
DR BTO; BTO:0004113
DR CLO; CLO_0003505
DR CCRID; 3111C0001CCC000067
DR CCRID; 3153C0001000000010
DR Cosmic; 753557
DR ICLC; HTL98006
DR KCB; KCB 86017YJ
DR TOKU-E; 3607
RX PubMed=3471311;
RX PubMed=4006684;
CC Discontinued: ICLC; HTL98006; true.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID GLC-P1
AC CVCL_0B59
SY GLCP1
RX PubMed=10709110;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GLC-P2
AC CVCL_0B60
RX PubMed=10709110;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GLHR-15
AC CVCL_6636
SY GLHR15
DR BTO; BTO:0002288
RX PubMed=1328253;
RX PubMed=8961254;
RX PubMed=15541573;
WW https://www.abmgood.com/Immortalized-Rat-Steroidogenic-Granulosa-Cells-stably-expressing-LH/CG-Receptor-(GLHR-15)-T0606.html
CC Transfected with: HGNC; 5173; HRAS (with V-12).
CC Transfected with: RGD; 3007; Lhcgr.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Transformed cell line
//
ID Gli-6
AC CVCL_A600
SY Gli 6
DR Cosmic; 1175811
DR Cosmic; 1217679
RX PubMed=11153144;
RX PubMed=14605880;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GliNS2
AC CVCL_DG67
DR GEO; GSM1026860
RX PubMed=19497285;
RX PubMed=23468990;
CC Group: Cancer stem cell line.
CC Omics: Array-based CGH.
CC Omics: DNA methylation analysis.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GLL-1
AC CVCL_W996
RX PubMed=7600027;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GLL-19
AC CVCL_W181
SY GLL19
RX PubMed=2174414;
RX PubMed=6746112;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GLM-1
AC CVCL_X019
RX PubMed=16086234;
CC Derived from metastatic site: Liver.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GLM-2
AC CVCL_X020
RX PubMed=16086234;
CC Derived from metastatic site: Liver.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID GLM-3
AC CVCL_X021
RX PubMed=16086234;
CC Derived from metastatic site: Liver.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID glomotel
AC CVCL_3473
SY Glomotel
DR CLO; CLO_0003506
DR ATCC; CRL-2597
DR BioSample; SAMN03471686
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: ATCC; CRL-2597; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 10,12
ST D16S539: 11,13
ST D5S818: 11,13
ST D7S820: 11
ST TH01: 5,9.3
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C5350; Hereditary glomangioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Telomerase immortalized cell line
//
ID Glor-BL
AC CVCL_7196
SY Glor
RX PubMed=9882297;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Caution: Could be identical to QIMR-GOR (CVCL_M648).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GLUTag
AC CVCL_J406
DR TOKU-E; 3556
RX PubMed=1491697;
WW http://www.glucagon.com/glutagcells.html
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID GLY
AC CVCL_R733
SY Gly; HCT-GLY
RX PubMed=3349466;
RX PubMed=6437669;
RX PubMed=7329817;
RX PubMed=9000147;
RX PubMed=9000572;
CC Microsatellite instability: Stable (MSS) (PubMed=9000147).
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GM-20
AC CVCL_F939
SY MEC-1
RX PubMed=3053466;
RX PubMed=8146177;
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4772 ! MEB-4
SX Male
CA Cancer cell line
//
ID GM-490
AC CVCL_F263
SY GM 490
DR CLO; CLO_0003507
DR CLDB; cl1474
RX CelloPub=CLPUB00042;
RX PubMed=12357381;
RX PubMed=16222707;
DI NCIt; C3167; Acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID GM-70
AC CVCL_F940
SY MEC-2
RX PubMed=3053466;
RX PubMed=8146177;
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4772 ! MEB-4
SX Male
CA Cancer cell line
//
ID GM-89
AC CVCL_F941
SY MEC-3
RX PubMed=3053466;
RX PubMed=8146177;
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4772 ! MEB-4
SX Male
CA Cancer cell line
//
ID GM-95
AC CVCL_F938
SY GM95; MEC-4
DR BTO; BTO:0005962
DR CLO; CLO_0050760
DR RCB; RCB1026
RX PubMed=3053466;
RX PubMed=8146177;
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4772 ! MEB-4
SX Male
CA Cancer cell line
//
ID GM/SO
AC CVCL_6905
DR Cosmic; 787493
RX PubMed=2198961;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=GM%2FSO
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID GM00002
AC CVCL_CX31
SY GM-2
DR Coriell; GM00002
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00002; probable.
DI NCIt; C61261; Hurler syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00003
AC CVCL_H163
SY GM-3
DR CLO; CLO_0025207
DR Coriell; GM00003
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00004
AC CVCL_H555
SY GM-4
DR CLO; CLO_0025206
DR Coriell; GM00004
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00005
AC CVCL_H556
SY GM-5; GM005
DR CLO; CLO_0025205
DR Coriell; GM00005
RX PubMed=4780772;
RX PubMed=6293786;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00006
AC CVCL_W146
SY GM-6
DR CLO; CLO_0025202
DR Coriell; GM00006
RX CelloPub=CLPUB00290;
DI NCIt; C81315; Phenylketonuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00007
AC CVCL_Y930
SY GM-7
DR CLO; CLO_0025201
DR Coriell; GM00007
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00008
AC CVCL_W227
SY GM-8; GM 8; GM8
DR CLO; CLO_0025200
DR Coriell; GM00008
RX CelloPub=CLPUB00290;
RX PubMed=9792862;
DI NCIt; C129932; Nephropathic cystinosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00010
AC CVCL_7266
SY GM-10; GM 10; GM00010B
DR CLO; CLO_0025199
DR Coriell; GM00010
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7318 ! GM01380
SX Male
CA Finite cell line
//
ID GM00011
AC CVCL_7267
SY GM-11; GM 11; GM11; GM0011
DR CLO; CLO_0025204
DR Coriell; GM00011
DR GEO; GSM909336
DR GEO; GSM909337
RX PubMed=694721;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00013
AC CVCL_8514
SY GM-13; GM 13
DR CLO; CLO_0025203
DR Coriell; GM00013
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00016
AC CVCL_0P11
SY GM-16
DR CLO; CLO_0025194
DR Coriell; GM00016
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00017
AC CVCL_X222
SY GM-0017; GM0017; GM-17; GM 17; GM17
DR CLO; CLO_0025196
DR Coriell; GM00017
RX PubMed=4780773;
RX PubMed=6293786;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00018
AC CVCL_Y981
SY GM-18; GM 18
DR CLO; CLO_0025195
DR Coriell; GM00018
RX CelloPub=CLPUB00290;
RX PubMed=9792862;
DI NCIt; C129932; Nephropathic cystinosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00020
AC CVCL_Y982
SY GM-20
DR CLO; CLO_0025198
DR Coriell; GM00020
RX CelloPub=CLPUB00290;
DI NCIt; C129932; Nephropathic cystinosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00022
AC CVCL_W228
SY GM-22
DR CLO; CLO_0025197
DR Coriell; GM00022
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00023
AC CVCL_7268
DR CLO; CLO_0025190
DR Coriell; GM00023
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00024
AC CVCL_7269
DR CLO; CLO_0025189
DR Coriell; GM00024
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00025
AC CVCL_CX21
SY GM-25
DR Coriell; GM00025
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00025; probable.
DI NCIt; C122662; Glycogen storage disease type IX
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00028
AC CVCL_0U52
DR CLO; CLO_0025192
DR Coriell; GM00028
DI NCIt; C101328; Mitochondrial myopathy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00030
AC CVCL_F494
SY Le Mas; XP3BE
DR CLO; CLO_0025191
DR ATCC; CRL-1189
DR Coriell; GM00030
DR JCRB; KURB1056
CC Discontinued: ATCC; CRL-1189; true.
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F495 ! GM02248
SX Male
CA Finite cell line
//
ID GM00031
AC CVCL_W030
SY GM-31
DR CLO; CLO_0025193
DR Coriell; GM00031
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00032
AC CVCL_0P12
DR CLO; CLO_0025183
DR Coriell; GM00032
DI NCIt; C84756; Hepatolenticular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00033
AC CVCL_0P13
DR CLO; CLO_0025184
DR Coriell; GM00033
DI NCIt; C84756; Hepatolenticular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00034
AC CVCL_V527
SY GM-34; GM00034B
DR CLO; CLO_0025181
DR Coriell; GM00034
RX CelloPub=CLPUB00290;
DI NCIt; C61261; Hurler syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00035
AC CVCL_V047
DR CLO; CLO_0025182
DR Coriell; GM00035
DI NCIt; C34807; Marfan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00036
AC CVCL_V048
DR CLO; CLO_0025179
DR Coriell; GM00036
DI NCIt; C34807; Marfan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00037
AC CVCL_7270
SY GM-37; GM37; GM0037; GM00037A; GM17071
DR BTO; BTO:0003592
DR CLO; CLO_0014602
DR CLO; CLO_0025180
DR Coriell; GM00037
DR Coriell; GM17071
RX PubMed=694721;
CC Part of: Human variation panel.
CC Population: Puerto Rican.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00038
AC CVCL_7271
SY GM00038B; GM-38; GM38
DR CLO; CLO_0025187
DR EFO; EFO_0004921
DR Coriell; GM00038
DR GEO; GSM992926
DR GEO; GSM992927
RX PubMed=6843573;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00039
AC CVCL_W651
SY GM-39
DR CLO; CLO_0025188
DR Coriell; GM00039
RX CelloPub=CLPUB00290;
DI NCIt; C61260; Hunter syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00041
AC CVCL_7272
SY GM00041B; GM-41; GM 41; GM41; GM41A
DR CLO; CLO_0025185
DR Coriell; GM00041
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00042
AC CVCL_D340
SY GM-42
DR CLO; CLO_0025186
DR Coriell; GM00042
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00043
AC CVCL_7273
SY GM00043B; GM43
DR CLO; CLO_0025173
DR Coriell; GM00043
RX PubMed=694721;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00044
AC CVCL_H953
SY GM-0044; GM 0044; GM044; GM-44; GM 44
DR CLO; CLO_0025174
DR Coriell; GM00044
RX PubMed=1132253;
RX PubMed=6293786;
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H954 ! GM00633
SX Male
CA Finite cell line
//
ID GM00045
AC CVCL_W109
DR CLO; CLO_0025175
DR Coriell; GM00045
DI NCIt; C75016; Cornelia de Lange syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00046
AC CVCL_W234
SY GM-46; GM 46; GM46
DR CLO; CLO_0025169
DR Coriell; GM00046
RX CelloPub=CLPUB00290;
RX PubMed=9792862;
DI NCIt; C129932; Nephropathic cystinosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00047
AC CVCL_W652
SY GM-47
DR CLO; CLO_0025170
DR Coriell; GM00047
RX CelloPub=CLPUB00290;
DI NCIt; C61260; Hunter syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00048
AC CVCL_H952
DR CLO; CLO_0025171
DR Coriell; GM00048
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H951 ! GM00083
SX Female
CA Finite cell line
//
ID GM00054
AC CVCL_D342
SY GM-54; GM54
DR CLO; CLO_0025177
DR Coriell; GM00054
RX PubMed=694721;
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F026 ! GM01907
OI CVCL_F027 ! GM02795
SX Male
CA Finite cell line
//
ID GM00056
AC CVCL_2N22
SY GM-56
DR CLO; CLO_0025178
DR Coriell; GM00056
RX CelloPub=CLPUB00290;
DI NCIt; C85030; Propionic acidemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00057
AC CVCL_2N23
SY GM-57
DR CLO; CLO_0025161
DR Coriell; GM00057
RX CelloPub=CLPUB00290;
DI NCIt; C85030; Propionic acidemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00059
AC CVCL_0P14
DR CLO; CLO_0025162
DR Coriell; GM00059
RX PubMed=19815695;
DI NCIt; C84611; Canavan disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00060
AC CVCL_0P15
DR CLO; CLO_0025159
DR Coriell; GM00060
DI NCIt; C84611; Canavan disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00068
AC CVCL_L482
SY GM-68; GM 68
DR CLO; CLO_0025160
DR Coriell; GM00068
RX PubMed=180603;
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00072
AC CVCL_V746
SY GM-0072; GM-72; GM 72
DR CLO; CLO_0025166
DR Coriell; GM00072
RX PubMed=560288;
RX PubMed=6617268;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
DI NCIt; C35528; Wolf-Hirschhorn syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00073
AC CVCL_H955
SY GM073; GM-73; GM 0073
DR CLO; CLO_0025163
DR Coriell; GM00073
RX PubMed=4796242;
RX PubMed=6293786;
RX PubMed=6947233;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H956 ! GM10073
SX Female
CA Finite cell line
//
ID GM00074
AC CVCL_H957
SY GM-0074; GM-74; GM 74
DR CLO; CLO_0025164
DR Coriell; GM00074
RX PubMed=4752868;
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H958 ! GM10074
SX Male
CA Finite cell line
//
ID GM00077
AC CVCL_U380
SY GM-77
DR CLO; CLO_0025167
DR Coriell; GM00077
RX CelloPub=CLPUB00290;
DI NCIt; C85184; Tay-Sachs disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00078
AC CVCL_6B30
SY GM-78; GM 78
DR CLO; CLO_0025168
DR Coriell; GM00078
RX CelloPub=CLPUB00290;
RX PubMed=36611;
CC Discontinued: Coriell; GM00078; probable.
DI NCIt; C61251; Metachromatic leukodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00080
AC CVCL_9Q85
SY GM-80
DR CLO; CLO_0025149
DR Coriell; GM00080
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00081
AC CVCL_9Q86
SY GM-81
DR CLO; CLO_0025150
DR Coriell; GM00081
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00082
AC CVCL_L495
SY GM-82; GM82
DR CLO; CLO_0025151
DR Coriell; GM00082
DR JCRB; KURB1026
RX PubMed=1372102;
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00083
AC CVCL_H951
DR CLO; CLO_0025152
DR Coriell; GM00083
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H952 ! GM00048
SX Female
CA Finite cell line
//
ID GM00084
AC CVCL_V547
SY GM-0084; GM-84; GM 84; GM84
DR CLO; CLO_0025153
DR Coriell; GM00084
RX PubMed=6661932;
RX PubMed=7329430;
RX PubMed=7471105;
DI NCIt; C114765; Trisomy 22
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00085
AC CVCL_H950
SY GM-0085; GM-85; GM 85; GM85
DR CLO; CLO_0025154
DR Coriell; GM00085
RX PubMed=6661932;
RX PubMed=7329430;
RX PubMed=7471105;
DI NCIt; C36529; Trisomy 13
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00087
AC CVCL_CX24
SY GM-87
DR Coriell; GM00087
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00087; probable.
DI NCIt; C61270; I-cell disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_CX25 ! GM00521
SX Male
CA Finite cell line
//
ID GM00088
AC CVCL_X224
SY GM-0088; GM-88; GM 88
DR CLO; CLO_0025156
DR Coriell; GM00088
RX PubMed=4780774;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
DI NCIt; C26900; Turner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00089
AC CVCL_F600
SY GM0089; GM089
DR CLO; CLO_0025157
DR Coriell; GM00089
RX PubMed=6293786;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00090
AC CVCL_H959
SY GM-90; GM 90
DR CLO; CLO_0025158
DR Coriell; GM00090
RX CelloPub=CLPUB00290;
RX PubMed=9792862;
RX PubMed=23665875;
CC Omics: CNV analysis.
DI NCIt; C129932; Nephropathic cystinosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_CW96 ! GM00093
OI CVCL_H960 ! GM00304
SX Male
CA Finite cell line
//
ID GM00093
AC CVCL_CW96
SY GM-93
DR Coriell; GM00093
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00093; probable.
DI NCIt; C129932; Nephropathic cystinosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H959 ! GM00090
OI CVCL_H960 ! GM00304
SX Male
CA Finite cell line
//
ID GM00097
AC CVCL_V747
SY GM-97; GM0097; GM 0097
DR CLO; CLO_0025819
DR Coriell; GM00097
RX PubMed=1679663;
RX PubMed=2498246;
RX PubMed=4139001;
DI NCIt; C118787; Simpson Golabi Behmel syndrome type 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00098
AC CVCL_V748
SY GM-0098; GM-98; GM 98
DR CLO; CLO_0025820
DR Coriell; GM00098
RX PubMed=1149496;
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00107
AC CVCL_0P99
SY GM-107; GM0107
DR CLO; CLO_0025822
DR Coriell; GM00107
RX CelloPub=CLPUB00290;
DI NCIt; C84701; Fabry disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00109
AC CVCL_4D75
DR CLO; CLO_0025821
DR Coriell; GM00109
DI NCIt; C3360; Supernumerary circular chromosome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00110
AC CVCL_W054
DR CLO; CLO_0025824
DR Coriell; GM00110
DI NCIt; C126864; Niemann-Pick disease, type C1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00111
AC CVCL_1F01
SY GM-111
DR CLO; CLO_0025823
DR Coriell; GM00111
RX CelloPub=CLPUB00290;
DI NCIt; C84736; Glycogen storage disease type III
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00112
AC CVCL_F268
SY GM-112; GM00112A
DR CLO; CLO_0003508
DR CLO; CLO_0025826
DR CLDB; cl1475
DR BioSamples; SAME43457
DR Coriell; GM00112
RX CelloPub=CLPUB00290;
RX PubMed=19815695;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Characteristics: Homozygous for the SMPD1 p.Leu302Pro mutation.
DI NCIt; C126561; Niemann-Pick disease, type A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00113
AC CVCL_9R60
SY GM-113
DR CLO; CLO_0025825
DR Coriell; GM00113
RX CelloPub=CLPUB00290;
DI NCIt; C125595; Mucolipidosis type IIIA
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00118
AC CVCL_V749
SY GM-0118; GM-118; GM 118
DR CLO; CLO_0025828
DR Coriell; GM00118
RX PubMed=1225503;
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00119
AC CVCL_V750
SY GM-119
DR CLO; CLO_0025827
DR Coriell; GM00119
RX PubMed=1132250;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00120
AC CVCL_4J08
SY GM-120
DR CLO; CLO_0025831
DR Coriell; GM00120
RX CelloPub=CLPUB00290;
RX PubMed=4502820;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00121
AC CVCL_V751
SY GM-121; GM00121A
DR CLO; CLO_0025829
DR Coriell; GM00121
RX CelloPub=CLPUB00290;
RX PubMed=817873;
DI NCIt; C84903; Sly syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00126
AC CVCL_V752
SY GM-126
DR CLO; CLO_0025830
DR Coriell; GM00126
RX PubMed=1132252;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00130
AC CVCL_7274
SY GM-130; GM 130; GM130; GM17201
DR CLO; CLO_0013839
DR CLO; CLO_0025838
DR Coriell; GM00130
DR Coriell; GM17201
DR GEO; GSM569492
DR GEO; GSM596265
DR GEO; GSM596627
RX PubMed=16244288;
RX PubMed=20889555;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM00131
AC CVCL_7275
SY GM-131; GM131; GM0131; GM17202
DR CLO; CLO_0013837
DR CLO; CLO_0025837
DR Coriell; GM00131
DR Coriell; GM17202
DR GEO; GSM569498
DR GEO; GSM596266
DR GEO; GSM596628
DR Lonza; 1323
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM00132
AC CVCL_6B31
SY GM-132
DR CLO; CLO_0025835
DR Coriell; GM00132
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00133
AC CVCL_CX52
SY GM-133
DR Coriell; GM00133
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00133; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00135
AC CVCL_R904
SY GM-135; GM 135; GM135
DR CLO; CLO_0025832
DR Coriell; GM00135
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00137
AC CVCL_X225
SY GM-0137; GM 137
DR CLO; CLO_0025846
DR Coriell; GM00137
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00140
AC CVCL_W653
SY GM-140
DR CLO; CLO_0025843
DR Coriell; GM00140
RX CelloPub=CLPUB00290;
DI NCIt; C61260; Hunter syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00142
AC CVCL_V204
DR CLO; CLO_0025841
DR Coriell; GM00142
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00143
AC CVCL_X226
SY GM-0143; GM 143; GM143
DR CLO; CLO_0025849
DR Coriell; GM00143
DR GEO; GSM795
RX PubMed=694721;
RX PubMed=6661932;
DI NCIt; C36626; Trisomy 18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00144
AC CVCL_V459
SY GM-0144; GM-144; GM 144
DR CLO; CLO_0025850
DR Coriell; GM00144
DR GEO; GSM426280
RX PubMed=4139000;
RX PubMed=6661932;
RX PubMed=19727395;
CC Omics: Transcriptome analysis.
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00148
AC CVCL_9Q63
SY GM148; GM 148
DR Coriell; GM00148
RX PubMed=1766867;
CC Discontinued: Coriell; GM00148; probable.
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID GM00149
AC CVCL_H557
DR CLO; CLO_0025851
DR Coriell; GM00149
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM00151
AC CVCL_Y523
SY GM-151
DR CLO; CLO_0025852
DR Coriell; GM00151
RX CelloPub=CLPUB00290;
DI NCIt; C84903; Sly syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00152
AC CVCL_L483
SY GM-152; GM 152
DR CLO; CLO_0025862
DR Coriell; GM00152
RX PubMed=180603;
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00156
AC CVCL_0L90
SY GM-156; GM 00156
DR CLO; CLO_0025860
DR Coriell; GM00156
RX CelloPub=CLPUB00290;
DI NCIt; C84898; Mucopolysaccharidosis type IIIB
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00157
AC CVCL_V753
SY GM-0157; GM-157; GM 157
DR CLO; CLO_0025866
DR Coriell; GM00157
RX PubMed=1132249;
RX PubMed=1183238;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00158
AC CVCL_V427
SY GM-158; GM 158
DR Coriell; GM00158
RX PubMed=180603;
CC Discontinued: Coriell; GM00158; probable.
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID GM00159
AC CVCL_L484
SY GM-159; GM 159
DR CLO; CLO_0025863
DR Coriell; GM00159
RX PubMed=180603;
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00164
AC CVCL_CX26
SY GM-164
DR Coriell; GM00164
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00164; probable.
DI NCIt; C61270; I-cell disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00165
AC CVCL_AX11
DR CLO; CLO_0025855
DR Coriell; GM00165
DI NCIt; C61269; Niemann-Pick disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00166
AC CVCL_V754
SY GM-166
DR CLO; CLO_0025853
DR Coriell; GM00166
RX PubMed=1183236;
DI NCIt; C3360; Supernumerary circular chromosome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00172
AC CVCL_CV48
SY GM 172
DR Coriell; GM00172
CC Discontinued: Coriell; GM00172; probable.
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID GM00194
AC CVCL_H961
SY GM-194; GM0194
DR CLO; CLO_0025667
DR Coriell; GM00194
RX PubMed=1225501;
RX PubMed=2498246;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H962 ! GM02899
SX Female
CA Finite cell line
//
ID GM00196
AC CVCL_6B32
SY GM-196
DR CLO; CLO_0025668
DR Coriell; GM00196
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00197
AC CVCL_6B33
SY GM-197; GM 197
DR CLO; CLO_0025661
DR Coriell; GM00197
RX CelloPub=CLPUB00290;
RX PubMed=36611;
DI NCIt; C61251; Metachromatic leukodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00200
AC CVCL_6B34
SY GM-200
DR CLO; CLO_0025662
DR Coriell; GM00200
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00201
AC CVCL_V460
SY GM-0201; GM-201; GM 201; GM201; GM00201A
DR CLO; CLO_0025659
DR Coriell; GM00201
RX PubMed=1132251;
RX PubMed=6293786;
RX PubMed=6661932;
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00203
AC CVCL_1Y40
SY GM-203; GM 203; GM00203A
DR CLO; CLO_0025660
DR Coriell; GM00203
RX CelloPub=CLPUB00290;
RX PubMed=3017984;
DI NCIt; C85052; Sandhoff disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00204
AC CVCL_1Y41
SY GM-204
DR CLO; CLO_0025665
DR Coriell; GM00204
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00212
AC CVCL_0D82
SY GM-212
DR CLO; CLO_0025666
DR Coriell; GM00212
RX CelloPub=CLPUB00290;
DI NCIt; C98986; Methylmalonic acidemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00213
AC CVCL_V755
SY GM-213
DR CLO; CLO_0025663
DR Coriell; GM00213
RX PubMed=124242;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00214
AC CVCL_V756
SY GM-0214; GM0214; GM-214; GM 214
DR CLO; CLO_0025664
DR Coriell; GM00214
RX PubMed=436455;
RX PubMed=6617268;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00216
AC CVCL_V757
SY GM-216
DR CLO; CLO_0025500
DR Coriell; GM00216
RX PubMed=1132254;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00217
AC CVCL_V758
SY GM-0217; GM-217; GM 217
DR Coriell; GM00217
RX PubMed=1132255;
RX PubMed=6661932;
CC Discontinued: Coriell; GM00217; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00218
AC CVCL_CX17
SY GM-218
DR Coriell; GM00218
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00218; probable.
DI NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00220
AC CVCL_H963
DR CLO; CLO_0025499
DR Coriell; GM00220
DI NCIt; C75486; Menkes disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00221
AC CVCL_U381
SY GM-221
DR CLO; CLO_0025508
DR Coriell; GM00221
RX CelloPub=CLPUB00290;
DI NCIt; C85184; Tay-Sachs disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00226
AC CVCL_1F02
SY GM-226
DR CLO; CLO_0025507
DR Coriell; GM00226
RX CelloPub=CLPUB00290;
DI NCIt; C84736; Glycogen storage disease type III
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00228
AC CVCL_W725
DR CLO; CLO_0025506
DR Coriell; GM00228
DI NCIt; C85239; Zellweger syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00229
AC CVCL_CV37
DR CLO; CLO_0025505
DR Coriell; GM00229
DI NCIt; C34466; Cartilage development disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00230
AC CVCL_X227
SY GM-0230; GM 230
DR CLO; CLO_0025504
DR Coriell; GM00230
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00232
AC CVCL_Y965
DR CLO; CLO_0025503
DR Coriell; GM00232
DI NCIt; C98670; Werdnig-Hoffmann disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00235
AC CVCL_J103
SY GM-235; GM235
DR CLO; CLO_0025502
DR Coriell; GM00235
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84639; Citrullinemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM00241
AC CVCL_1F03
DR CLO; CLO_0025490
DR Coriell; GM00241
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00242
AC CVCL_W229
DR CLO; CLO_0025489
DR Coriell; GM00242
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00243
AC CVCL_6B35
SY GM-243
DR CLO; CLO_0025492
DR Coriell; GM00243
RX CelloPub=CLPUB00290;
DI NCIt; C61251; Metachromatic leukodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00244
AC CVCL_M920
SY GM-244; GM17061
DR CLO; CLO_0014562
DR CLO; CLO_0025491
DR Coriell; GM00244
DR Coriell; GM17061
RX CelloPub=CLPUB00290;
RX PubMed=26621101;
CC Part of: Human variation panel.
CC Population: Mexican.
ST Source(s): PubMed=11416159
ST Amelogenin: X
ST D18S51: 14,16
ST D21S11: 28,33.2
ST D8S1179: 13,14
ST FGA: 24
ST TH01: 7,9.3
ST vWA: 19,20
DI NCIt; C84734; Glycogen storage disease type II
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00245
AC CVCL_W623
DR CLO; CLO_0025496
DR Coriell; GM00245
DI NCIt; C75486; Menkes disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00248
AC CVCL_1K46
SY GM-248
DR CLO; CLO_0025495
DR Coriell; GM00248
RX CelloPub=CLPUB00290;
DI NCIt; C84734; Glycogen storage disease type II
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00254
AC CVCL_7276
SY GM 00254; GM 254
DR CLO; CLO_0025498
DR Coriell; GM00254
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00257
AC CVCL_V759
SY GM-257
DR CLO; CLO_0025497
DR Coriell; GM00257
RX PubMed=1149497;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00260
AC CVCL_L934
SY GM-0260; GM 260; GM00069
DR CLO; CLO_0025494
DR Coriell; GM00069
DR Coriell; GM00260
RX PubMed=6661932;
CC Discontinued: Coriell; GM00069; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00264
AC CVCL_CX16
SY GM-264
DR Coriell; GM00264
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00264; probable.
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00267
AC CVCL_2Z45
SY GM-267
DR CLO; CLO_0025493
DR Coriell; GM00267
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00268
AC CVCL_2Z46
SY GM-268
DR CLO; CLO_0025519
DR Coriell; GM00268
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00269
AC CVCL_9R17
DR CLO; CLO_0025523
DR Coriell; GM00269
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00271
AC CVCL_V760
SY GM-271
DR CLO; CLO_0025522
DR Coriell; GM00271
RX PubMed=1169138;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00275
AC CVCL_9W73
SY GM275
DR CLO; CLO_0025521
DR Coriell; GM00275
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00282
AC CVCL_L935
SY GM-282; GM00061
DR CLO; CLO_0025520
DR Coriell; GM00061
DR Coriell; GM00282
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00061; true.
DI NCIt; C128119; Fructose-1,6-bisphosphatase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00283
AC CVCL_L936
SY GM-283; GM00102
DR CLO; CLO_0025527
DR Coriell; GM00102
DR Coriell; GM00283
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00102; true.
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00285
AC CVCL_4D76
DR CLO; CLO_0025526
DR Coriell; GM00285
DI NCIt; C3360; Supernumerary circular chromosome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00286
AC CVCL_L937
SY GM-286; GM00058
DR CLO; CLO_0025525
DR Coriell; GM00058
DR Coriell; GM00286
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00058; true.
DI NCIt; C98641; Type I tyrosinemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00288
AC CVCL_L938
SY GM00095
DR CLO; CLO_0025524
DR Coriell; GM00095
DR Coriell; GM00288
CC Discontinued: Coriell; GM00095; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00289
AC CVCL_V761
SY GM-289
DR CLO; CLO_0025528
DR Coriell; GM00289
RX CelloPub=CLPUB00290;
RX PubMed=1192845;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V791 ! GM01023
SX Male
CA Finite cell line
//
ID GM00290
AC CVCL_V762
SY GM-290
DR CLO; CLO_0025510
DR Coriell; GM00290
RX CelloPub=CLPUB00290;
RX PubMed=1192845;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V794 ! GM01026
SX Female
CA Finite cell line
//
ID GM00291
AC CVCL_V763
SY GM-291
DR CLO; CLO_0025509
DR Coriell; GM00291
RX CelloPub=CLPUB00290;
RX PubMed=1192845;
DI NCIt; C61274; Fucosidosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V792 ! GM01024
SX Male
CA Finite cell line
//
ID GM00292
AC CVCL_V764
SY GM-292
DR CLO; CLO_0025512
DR Coriell; GM00292
RX CelloPub=CLPUB00290;
RX PubMed=1192845;
DI NCIt; C61274; Fucosidosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V793 ! GM01025
SX Male
CA Finite cell line
//
ID GM00294
AC CVCL_1Y42
SY GM-294; GM 294
DR CLO; CLO_0025511
DR Coriell; GM00294
RX CelloPub=CLPUB00290;
RX PubMed=3017984;
DI NCIt; C85052; Sandhoff disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00296
AC CVCL_W230
SY GM-296
DR CLO; CLO_0025514
DR Coriell; GM00296
RX CelloPub=CLPUB00290;
DI NCIt; C34806; Maple syrup urine disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00297
AC CVCL_W231
SY GM-297
DR CLO; CLO_0025513
DR Coriell; GM00297
RX CelloPub=CLPUB00290;
DI NCIt; C34806; Maple syrup urine disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00298
AC CVCL_W654
SY GM-298
DR CLO; CLO_0025516
DR Coriell; GM00298
RX CelloPub=CLPUB00290;
DI NCIt; C61260; Hunter syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00302
AC CVCL_7277
SY GM-302; GM 302; GM302A; GM 302A; GM00075
DR CLO; CLO_0025515
DR Coriell; GM00075
DR Coriell; GM00302
RX PubMed=180603;
RX PubMed=3745952;
CC Discontinued: Coriell; GM00075; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00303
AC CVCL_J995
SY GM-303; GM00055
DR CLO; CLO_0025518
DR Coriell; GM00055
DR Coriell; GM00303
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00055; true.
DI NCIt; C84736; Glycogen storage disease type III
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00304
AC CVCL_H960
SY GM-304; GM 304; GM00091; GM-91
DR CLO; CLO_0025517
DR Coriell; GM00091
DR Coriell; GM00304
RX CelloPub=CLPUB00290;
RX PubMed=9792862;
CC Discontinued: Coriell; GM00091; true.
DI NCIt; C129932; Nephropathic cystinosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H959 ! GM00090
OI CVCL_CW96 ! GM00093
SX Male
CA Finite cell line
//
ID GM00305
AC CVCL_L939
SY GM00305A; GM00094
DR CLO; CLO_0025548
DR Coriell; GM00094
DR Coriell; GM00305
CC Discontinued: Coriell; GM00094; true.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00306
AC CVCL_L941
SY GM-306; GM00051
DR CLO; CLO_0025546
DR Coriell; GM00051
DR Coriell; GM00306
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00051; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00312
AC CVCL_0L91
SY GM-312
DR CLO; CLO_0025547
DR Coriell; GM00312
RX CelloPub=CLPUB00290;
DI NCIt; C84897; Mucopolysaccharidosis type IIIA
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00314
AC CVCL_X228
SY GM 314
DR CLO; CLO_0025544
DR Coriell; GM00314
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00316
AC CVCL_7278
SY GM00316B; GM-316; GM 316; GM316
DR CLO; CLO_0025545
DR Coriell; GM00316
RX PubMed=180603;
RX PubMed=2987007;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00317
AC CVCL_1Y43
SY GM-317; GM 317
DR CLO; CLO_0025542
DR Coriell; GM00317
RX CelloPub=CLPUB00290;
RX PubMed=3017984;
DI NCIt; C85052; Sandhoff disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00318
AC CVCL_L958
SY GM-318; GM00134; GM0134
DR CLO; CLO_0025543
DR Coriell; GM00134
DR Coriell; GM00318
CC Discontinued: Coriell; GM00134; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00321
AC CVCL_7279
SY DMPK CTG5; DMPK CTG(5)
DR CLO; CLO_0025540
DR Coriell; GM00321
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00323
AC CVCL_7280
SY GM00323A
DR CLO; CLO_0025541
DR Coriell; GM00323
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00324
AC CVCL_4J09
SY GM-324
DR CLO; CLO_0025539
DR Coriell; GM00324
RX CelloPub=CLPUB00290;
DI NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00325
AC CVCL_4J10
SY GM-325
DR CLO; CLO_0025535
DR Coriell; GM00325
RX CelloPub=CLPUB00290;
DI NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00326
AC CVCL_D341
SY GM00326B; GM-00326; GM 326
DR CLO; CLO_0025536
DR Coriell; GM00326
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00327
AC CVCL_V765
SY GM-327; GM327
DR CLO; CLO_0025537
DR Coriell; GM00327
RX PubMed=872631;
RX PubMed=6293786;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00333
AC CVCL_7281
SY GM-333; GM 333; GM18001
DR CLO; CLO_0015991
DR CLO; CLO_0025531
DR Coriell; GM00333
DR Coriell; GM18001
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM00334
AC CVCL_W232
SY GM-334; GM00334A
DR CLO; CLO_0025532
DR Coriell; GM00334
RX CelloPub=CLPUB00290;
DI NCIt; C114767; Galactokinase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00335
AC CVCL_W722
SY GM-335
DR CLO; CLO_0025533
DR Coriell; GM00335
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00336
AC CVCL_W723
SY GM-336
DR CLO; CLO_0025534
DR Coriell; GM00336
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00337
AC CVCL_9R18
DR CLO; CLO_0025529
DR Coriell; GM00337
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00338
AC CVCL_1K47
SY GM-338
DR CLO; CLO_0025530
DR Coriell; GM00338
RX CelloPub=CLPUB00290;
DI NCIt; C84734; Glycogen storage disease type II
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00339
AC CVCL_X229
SY GM 339
DR CLO; CLO_0025568
DR Coriell; GM00339
RX PubMed=6661932;
DI NCIt; C26900; Turner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00342
AC CVCL_W233
SY GM-342
DR CLO; CLO_0025562
DR Coriell; GM00342
RX CelloPub=CLPUB00290;
DI NCIt; C84765; Homocystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00343
AC CVCL_V766
SY GM 343
DR CLO; CLO_0025563
DR Coriell; GM00343
RX PubMed=6617268;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
DI NCIt; C35528; Wolf-Hirschhorn syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00344
AC CVCL_V767
SY GM-0344; GM-344; GM 344; GM344
DR CLO; CLO_0025560
DR Coriell; GM00344
RX PubMed=1225499;
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00357
AC CVCL_6B36
SY GM-357
DR CLO; CLO_0025565
DR Coriell; GM00357
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00359
AC CVCL_1N81
DR CLO; CLO_0025559
DR Coriell; GM00359
DI NCIt; C34415; Beckwith-Wiedemann syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00361
AC CVCL_V828
SY GM-361; GM00966; GM-966
DR Coriell; GM00361
DR Coriell; GM00966
RX PubMed=177249;
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00361; probable.
CC Discontinued: Coriell; GM00966; probable.
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00362
AC CVCL_Y316
DR CLO; CLO_0025558
DR Coriell; GM00362
DI NCIt; C3822; X-linked agammaglobulinemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00364
AC CVCL_2Z42
DR CLO; CLO_0025557
DR Coriell; GM00364
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00366
AC CVCL_X230
SY GM-0366; GM 366
DR CLO; CLO_0025549
DR Coriell; GM00366
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00367
AC CVCL_W055
SY GM 367
DR CLO; CLO_0025550
DR Coriell; GM00367
RX PubMed=865488;
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00368
AC CVCL_W056
SY GM 368
DR CLO; CLO_0025551
DR Coriell; GM00368
DI NCIt; C62505; Fanconi anemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00369
AC CVCL_W057
DR CLO; CLO_0025552
DR Coriell; GM00369
DI NCIt; C125702; Fanconi anemia, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00370
AC CVCL_W058
SY GM-370
DR CLO; CLO_0025553
DR Coriell; GM00370
RX CelloPub=CLPUB00290;
DI NCIt; C126561; Niemann-Pick disease, type A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00371
AC CVCL_2N24
SY GM-371
DR CLO; CLO_0025554
DR Coriell; GM00371
RX CelloPub=CLPUB00290;
DI NCIt; C85030; Propionic acidemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00372
AC CVCL_U478
SY GM-372; GM372
DR CLO; CLO_0025555
DR Coriell; GM00372
RX CelloPub=CLPUB00290;
RX PubMed=2464926;
DI NCIt; C61268; Gaucher disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00376
AC CVCL_L940
SY GM-376; GM00099
DR CLO; CLO_0025556
DR Coriell; GM00099
DR Coriell; GM00376
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00099; true.
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00377
AC CVCL_L481
SY GM 377; GM377; GM00029; GM-29; GM 29; GM29
DR CLO; CLO_0026289
DR Coriell; GM00029
DR Coriell; GM00377
CC Discontinued: Coriell; GM00029; true.
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00378
AC CVCL_Y983
SY GM-378
DR CLO; CLO_0026290
DR Coriell; GM00378
RX CelloPub=CLPUB00290;
DI NCIt; C129932; Nephropathic cystinosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00379
AC CVCL_Y984
SY GM-379
DR CLO; CLO_0026291
DR Coriell; GM00379
RX CelloPub=CLPUB00290;
DI NCIt; C129932; Nephropathic cystinosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00380
AC CVCL_V768
SY GM-380
DR CLO; CLO_0026293
DR Coriell; GM00380
RX PubMed=1149495;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V808 ! GM01561
SX Female
CA Finite cell line
//
ID GM00390
AC CVCL_J104
DR CLO; CLO_0026292
DR Coriell; GM00390
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM00392
AC CVCL_V769
SY GM-392
DR CLO; CLO_0026295
DR Coriell; GM00392
RX PubMed=1058758;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00403
AC CVCL_2N25
SY GM-403
DR CLO; CLO_0026294
DR Coriell; GM00403
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00405
AC CVCL_2N26
SY GM-405
DR CLO; CLO_0026297
DR Coriell; GM00405
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00406
AC CVCL_AX12
SY GM-406
DR CLO; CLO_0026296
DR Coriell; GM00406
RX CelloPub=CLPUB00290;
DI NCIt; C126561; Niemann-Pick disease, type A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00407
AC CVCL_V428
SY GM-407; GM 407
DR Coriell; GM00407
RX PubMed=180603;
CC Discontinued: Coriell; GM00407; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID GM00408
AC CVCL_U506
DR CLO; CLO_0026298
DR Coriell; GM00408
CC Discontinued: Coriell; GM00408; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00409
AC CVCL_7282
SY GM-409; GM 409
DR CLO; CLO_0026120
DR Coriell; GM00409
RX PubMed=180603;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00412
AC CVCL_4J11
SY GM-412
DR CLO; CLO_0026127
DR Coriell; GM00412
RX CelloPub=CLPUB00290;
DI NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00413
AC CVCL_4D77
DR CLO; CLO_0026128
DR Coriell; GM00413
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00414
AC CVCL_4D78
DR CLO; CLO_0026125
DR Coriell; GM00414
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00415
AC CVCL_V529
SY GM-415
DR CLO; CLO_0026126
DR Coriell; GM00415
RX CelloPub=CLPUB00290;
DI NCIt; C61261; Hurler syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00417
AC CVCL_0P58
SY GM-417
DR CLO; CLO_0026123
DR Coriell; GM00417
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00419
AC CVCL_X131
SY GM419
DR Coriell; GM00419
RX PubMed=694721;
CC Discontinued: Coriell; GM00419; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00422
AC CVCL_1Y19
SY GM-422; GM 422
DR CLO; CLO_0026124
DR Coriell; GM00422
RX CelloPub=CLPUB00290;
RX PubMed=1766867;
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00423
AC CVCL_2G95
SY GM-423; GM0423
DR CLO; CLO_0026121
DR Coriell; GM00423
RX CelloPub=CLPUB00290;
DI NCIt; C84765; Homocystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00424
AC CVCL_0D83
SY GM-424; GM0424A
DR CLO; CLO_0026122
DR Coriell; GM00424
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00424; probable.
DI NCIt; C84765; Homocystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00425
AC CVCL_7283
SY GM 425
DR CLO; CLO_0003510
DR CLO; CLO_0026109
DR CLDB; cl1477
DR Coriell; GM00425
RX PubMed=6617268;
RX PubMed=6661932;
DI NCIt; C36396; Trisomy 8
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00427
AC CVCL_CX06
SY GM-427
DR Coriell; GM00427
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00427; probable.
DI NCIt; C98964; Isovaleric acidemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00432
AC CVCL_CV38
DR CLO; CLO_0026110
DR Coriell; GM00432
DI NCIt; C34650; Gout
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00433
AC CVCL_1Y20
SY GM-433; GM 433
DR CLO; CLO_0026111
DR Coriell; GM00433
RX CelloPub=CLPUB00290;
RX PubMed=1766867;
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00434
AC CVCL_L754
SY GM0434; GM-434; GM434; XP3NE
DR CLO; CLO_0026112
DR Coriell; GM00434
RX PubMed=2987007;
RX PubMed=3003928;
RX PubMed=3030788;
DI NCIt; C3967; Xeroderma pigmentosum, complementation group D
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00435
AC CVCL_J996
SY GM-435; GM435; XP2NE
DR CLO; CLO_0026113
DR Coriell; GM00435
DR JCRB; KURB1073
DI NCIt; C3967; Xeroderma pigmentosum, complementation group D
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00436
AC CVCL_J997
SY GM-436; GM436; XP1NE
DR CLO; CLO_0026114
DR Coriell; GM00436
DI NCIt; C3967; Xeroderma pigmentosum, complementation group D
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00437
AC CVCL_X071
SY GM-0437; GM 437
DR CLO; CLO_0026115
DR Coriell; GM00437
RX PubMed=6617268;
RX PubMed=7329430;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00438
AC CVCL_V770
SY GM-438
DR CLO; CLO_0026116
DR Coriell; GM00438
RX CelloPub=CLPUB00290;
RX PubMed=181209;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00439
AC CVCL_V771
SY GM-439; GM0439
DR CLO; CLO_0026117
DR Coriell; GM00439
RX CelloPub=CLPUB00290;
RX PubMed=181209;
RX PubMed=2498246;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V795 ! GM01029
SX Female
CA Finite cell line
//
ID GM00440
AC CVCL_V430
SY GM-440
DR CLO; CLO_0026118
DR Coriell; GM00440
RX CelloPub=CLPUB00290;
RX PubMed=181209;
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V431 ! GM01028
SX Female
CA Finite cell line
//
ID GM00441
AC CVCL_L973
SY GM-441
DR CLO; CLO_0026119
DR Coriell; GM00441
RX CelloPub=CLPUB00290;
RX PubMed=181209;
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L972 ! GM02412
SX Male
CA Finite cell line
//
ID GM00442
AC CVCL_V772
SY GM-442
DR CLO; CLO_0026101
DR Coriell; GM00442
RX CelloPub=CLPUB00290;
RX PubMed=181209;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00443
AC CVCL_1K48
SY GM-443
DR CLO; CLO_0026099
DR Coriell; GM00443
RX CelloPub=CLPUB00290;
DI NCIt; C84734; Glycogen storage disease type II
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00444
AC CVCL_5M48
DR CLO; CLO_0026100
DR Coriell; GM00444
DI NCIt; C85040; Pyruvate carboxylase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00445
AC CVCL_X072
SY GM 445
DR CLO; CLO_0026104
DR Coriell; GM00445
RX PubMed=6617268;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00447
AC CVCL_X073
SY GM 447
DR CLO; CLO_0026105
DR Coriell; GM00447
RX PubMed=6617268;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00448
AC CVCL_X074
SY GM 448
DR CLO; CLO_0026102
DR Coriell; GM00448
RX PubMed=6617268;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00449
AC CVCL_F125
SY GM0449A; GM 0449A
DR CLO; CLO_0026103
DR Coriell; GM00449
RX PubMed=19815695;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
DI NCIt; C125704; Fanconi anemia, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00450
AC CVCL_X051
SY GM 450
DR CLO; CLO_0026107
DR Coriell; GM00450
RX PubMed=6617268;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X052 ! GM00451
SX Male
CA Finite cell line
//
ID GM00451
AC CVCL_X052
SY GM 451
DR CLO; CLO_0026108
DR Coriell; GM00451
RX PubMed=6617268;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X051 ! GM00450
SX Male
CA Finite cell line
//
ID GM00452
AC CVCL_X053
SY GM 452
DR CLO; CLO_0026106
DR Coriell; GM00452
RX PubMed=6617268;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00467
AC CVCL_J105
DR CLO; CLO_0025976
DR Coriell; GM00467
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM00468
AC CVCL_7284
DR CLO; CLO_0025975
DR Coriell; GM00468
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00469
AC CVCL_7285
DR CLO; CLO_0003511
DR CLO; CLO_0025974
DR CLDB; cl1478
DR Coriell; GM00469
DI NCIt; C3962; Adenosine deaminase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00470
AC CVCL_M921
SY GM-470; GM 470; GM17062
DR CLO; CLO_0014561
DR CLO; CLO_0025971
DR Coriell; GM00470
DR Coriell; GM17062
RX CelloPub=CLPUB00290;
RX PubMed=3017984;
CC Part of: Human variation panel.
CC Population: Mexican.
DI NCIt; C85052; Sandhoff disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00472
AC CVCL_7286
SY GM 00472; GM 472
DR CLO; CLO_0025969
DR Coriell; GM00472
RX PubMed=6451249;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00473
AC CVCL_7287
DR CLO; CLO_0025968
DR Coriell; GM00473
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00474
AC CVCL_H130
DR CLO; CLO_0025965
DR Coriell; GM00474
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00477
AC CVCL_H131
SY GM 0477
DR CLO; CLO_0025964
DR Coriell; GM00477
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00479
AC CVCL_V773
SY GM-479
DR CLO; CLO_0025958
DR Coriell; GM00479
RX PubMed=949908;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00480
AC CVCL_4N03
DR CLO; CLO_0025955
DR Coriell; GM00480
DI NCIt; C84663; Cutis laxa
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00483
AC CVCL_7288
SY GM-483
DR CLO; CLO_0003512
DR CLO; CLO_0025954
DR CLDB; cl1479
DR Coriell; GM00483
RX CelloPub=CLPUB00290;
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00486
AC CVCL_4N04
SY GM-486; GM00486C
DR CLO; CLO_0025957
DR Coriell; GM00486
RX CelloPub=CLPUB00290;
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N15 ! GM01459
SX Female
CA Finite cell line
//
ID GM00488
AC CVCL_F265
SY GM-488; GM488; GM00488C
DR CLO; CLO_0003513
DR CLO; CLO_0025956
DR CLDB; cl1480
DR Coriell; GM00488
RX CelloPub=CLPUB00290;
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00489
AC CVCL_Y985
SY GM-489; GM 489
DR CLO; CLO_0025951
DR Coriell; GM00489
RX CelloPub=CLPUB00290;
RX PubMed=9792862;
DI NCIt; C129932; Nephropathic cystinosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00490
AC CVCL_F264
DR CLO; CLO_0025950
DR Coriell; GM00490
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00492
AC CVCL_V420
DR CLO; CLO_0025953
DR Coriell; GM00492
DI NCIt; C84787; Incontinentia pigmenti
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00495
AC CVCL_7289
SY GM495; GM00104
DR CLO; CLO_0025952
DR Coriell; GM00104
DR Coriell; GM00495
RX PubMed=225015;
CC Discontinued: Coriell; GM00104; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00496
AC CVCL_X231
SY GM-0496; GM 496; GM496
DR CLO; CLO_0025949
DR Coriell; GM00496
RX PubMed=694721;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
DI NCIt; C36396; Trisomy 8
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00497
AC CVCL_9W74
DR CLO; CLO_0025944
DR Coriell; GM00497
CC Discontinued: Coriell; GM00497; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00498
AC CVCL_7290
SY GM 00498; GM498B; GM 498
DR CLO; CLO_0025943
DR Coriell; GM00498
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00499
AC CVCL_7291
DR CLO; CLO_0025948
DR Coriell; GM00499
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00500
AC CVCL_7292
SY GM 0500
DR CLO; CLO_0025947
DR Coriell; GM00500
RX PubMed=3860870;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00501
AC CVCL_V774
SY GM-0501; GM-501; GM 501
DR CLO; CLO_0025946
DR Coriell; GM00501
RX PubMed=1017322;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00502
AC CVCL_U382
SY GM-502
DR CLO; CLO_0025945
DR Coriell; GM00502
RX CelloPub=CLPUB00290;
DI NCIt; C85184; Tay-Sachs disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00503
AC CVCL_X232
SY GM 503
DR CLO; CLO_0025942
DR Coriell; GM00503
RX PubMed=6661932;
DI NCIt; C36529; Trisomy 13
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00504
AC CVCL_J106
DR CLO; CLO_0025941
DR Coriell; GM00504
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM00509
AC CVCL_L952
SY GM00250; GM-250; GM250; GM-0509; GM 509 A; GM 509
DR CLO; CLO_0025940
DR Coriell; GM00250
DR Coriell; GM00509
RX PubMed=1183234;
RX PubMed=6617268;
RX PubMed=6661932;
RX PubMed=7329430;
RX PubMed=7471105;
CC Discontinued: Coriell; GM00250; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00510
AC CVCL_L930
SY XP1PW
DR CLO; CLO_0025939
DR Coriell; GM00510
DR JCRB; KURB1057
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00512
AC CVCL_1V21
SY GM-512
DR CLO; CLO_0025934
DR Coriell; GM00512
RX CelloPub=CLPUB00290;
DI NCIt; C122782; Hurler-Scheie syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00513
AC CVCL_W541
SY HDF-FOP1
DR CLO; CLO_0025933
DR Coriell; GM00513
DI NCIt; C3040; Fibrodysplasia ossificans progressiva
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00514
AC CVCL_U383
SY GM-514
DR CLO; CLO_0025936
DR Coriell; GM00514
RX CelloPub=CLPUB00290;
DI NCIt; C85184; Tay-Sachs disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00515
AC CVCL_U384
SY GM-515
DR CLO; CLO_0025935
DR Coriell; GM00515
RX CelloPub=CLPUB00290;
DI NCIt; C85184; Tay-Sachs disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00517
AC CVCL_0R00
DR CLO; CLO_0025938
DR Coriell; GM00517
DI NCIt; C121564; Adenine phosphoribosyltransferase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00519
AC CVCL_V775
SY GM-519; GM 519
DR CLO; CLO_0025937
DR Coriell; GM00519
RX CelloPub=CLPUB00290;
RX PubMed=36611;
RX PubMed=826372;
DI NCIt; C61264; Maroteaux-Lamy syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V790 ! GM01022
OI CVCL_V821 ! GM05358
SX Female
CA Finite cell line
//
ID GM00520
AC CVCL_V776
SY GM-520
DR CLO; CLO_0025930
DR Coriell; GM00520
RX CelloPub=CLPUB00290;
RX PubMed=826372;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00521
AC CVCL_CX25
SY GM-521
DR Coriell; GM00521
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00521; probable.
DI NCIt; C61270; I-cell disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_CX24 ! GM00087
SX Male
CA Finite cell line
//
ID GM00522
AC CVCL_M231
SY XP2NBi; GM17341
DR CLO; CLO_0013745
DR CLO; CLO_0025929
DR Coriell; GM00522
DR Coriell; GM17341
CC Part of: Human variation panel.
CC Population: Africans south of the Sahara.
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00523
AC CVCL_M232
SY XP1NBi
DR CLO; CLO_0025931
DR Coriell; GM00523
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00525
AC CVCL_4Z87
SY GM-525
DR CLO; CLO_0026042
DR Coriell; GM00525
RX CelloPub=CLPUB00290;
DI NCIt; C84569; Argininosuccinic aciduria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00526
AC CVCL_X075
SY GM-0526; GM 526
DR CLO; CLO_0026043
DR Coriell; GM00526
RX PubMed=6661932;
RX PubMed=7329430;
DI NCIt; C36529; Trisomy 13
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00527
AC CVCL_U385
SY GM-527
DR CLO; CLO_0026040
DR Coriell; GM00527
RX CelloPub=CLPUB00290;
DI NCIt; C85184; Tay-Sachs disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00528
AC CVCL_1Y21
SY GM-528
DR CLO; CLO_0026041
DR Coriell; GM00528
RX CelloPub=CLPUB00290;
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00533
AC CVCL_4Z88
SY GM-533
DR CLO; CLO_0026038
DR Coriell; GM00533
RX CelloPub=CLPUB00290;
DI NCIt; C84569; Argininosuccinic aciduria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00536
AC CVCL_7293
SY GM-536; GM0536; GM536; GM17203
DR BTO; BTO:0005521
DR CLO; CLO_0013836
DR CLO; CLO_0026039
DR Coriell; GM00536
DR Coriell; GM17203
DR GEO; GSM569493
DR GEO; GSM596267
DR GEO; GSM596629
RX PubMed=16244288;
RX PubMed=20889555;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM00537
AC CVCL_L485
SY GM-537; GM 537
DR CLO; CLO_0026036
DR Coriell; GM00537
RX PubMed=180603;
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00538
AC CVCL_9W75
SY GM-538
DR CLO; CLO_0026037
DR Coriell; GM00538
RX CelloPub=CLPUB00290;
DI NCIt; C61264; Maroteaux-Lamy syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00540
AC CVCL_4Z89
SY GM-540
DR CLO; CLO_0026045
DR Coriell; GM00540
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00544
AC CVCL_L757
SY XP4LO; GM544B; GM 544
DR CLO; CLO_0026048
DR Coriell; GM00544
RX PubMed=1372102;
RX PubMed=7471106;
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00546
AC CVCL_M922
SY GM17204
DR CLO; CLO_0013835
DR Coriell; GM00546
DR Coriell; GM17204
DR GEO; GSM569628
DR GEO; GSM596268
DR GEO; GSM596630
RX PubMed=20889555;
RX PubMed=26621101;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; GM00546; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM00552
AC CVCL_CX35
SY GM-552
DR Coriell; GM00552
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00552; probable.
DI NCIt; C61264; Maroteaux-Lamy syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00558
AC CVCL_7294
SY GM-558; GM 558; GM558; GM17205
DR CLO; CLO_0013834
DR CLO; CLO_0026035
DR Coriell; GM00558
DR Coriell; GM17205
DR GEO; GSM569499
DR GEO; GSM596269
DR GEO; GSM596631
RX PubMed=6451249;
RX PubMed=20889555;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM00559
AC CVCL_AX18
SY GM-559
DR CLO; CLO_0026019
DR Coriell; GM00559
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00560
AC CVCL_CX49
SY GM-560
DR Coriell; GM00560
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00560; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00561
AC CVCL_CX50
SY GM-561
DR Coriell; GM00561
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00561; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00562
AC CVCL_X233
SY GM 562
DR CLO; CLO_0026020
DR Coriell; GM00562
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X234 ! GM00563
SX Female
CA Finite cell line
//
ID GM00563
AC CVCL_X234
SY GM 563
DR CLO; CLO_0026021
DR Coriell; GM00563
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X233 ! GM00562
SX Female
CA Finite cell line
//
ID GM00568
AC CVCL_X446
SY GM-568
DR CLO; CLO_0026022
DR Coriell; GM00568
RX CelloPub=CLPUB00290;
DI NCIt; C61273; Aspartylglycosaminuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00572
AC CVCL_1K49
SY GM-572
DR CLO; CLO_0026015
DR Coriell; GM00572
RX CelloPub=CLPUB00290;
DI NCIt; C84737; Glycogen storage disease type IV
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00573
AC CVCL_1F04
SY GM-573
DR CLO; CLO_0026016
DR Coriell; GM00573
RX CelloPub=CLPUB00290;
DI NCIt; C84736; Glycogen storage disease type III
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00574
AC CVCL_V389
SY GM-574
DR CLO; CLO_0026017
DR Coriell; GM00574
RX CelloPub=CLPUB00290;
DI NCIt; C84733; Glycogen storage disease type I
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00575
AC CVCL_1N13
SY GM-575
DR CLO; CLO_0026018
DR Coriell; GM00575
RX CelloPub=CLPUB00290;
DI NCIt; C122662; Glycogen storage disease type IX
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00576
AC CVCL_M923
SY GM-576; GM17011
DR CLO; CLO_0018025
DR CLO; CLO_0026023
DR Coriell; GM00576
DR Coriell; GM17011
RX CelloPub=CLPUB00290;
CC Part of: Human variation panel.
CC Population: Chinese.
DI NCIt; C84736; Glycogen storage disease type III
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00577
AC CVCL_1K50
SY GM-577
DR CLO; CLO_0026014
DR Coriell; GM00577
RX CelloPub=CLPUB00290;
DI NCIt; C84738; Glycogen storage disease type V
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00578
AC CVCL_1F05
SY GM-578
DR CLO; CLO_0026013
DR Coriell; GM00578
RX CelloPub=CLPUB00290;
DI NCIt; C84736; Glycogen storage disease type III
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00579
AC CVCL_CX19
SY GM-579
DR CLO; CLO_0025996
DR Coriell; GM00579
RX CelloPub=CLPUB00290;
DI NCIt; C126875; Glycogen storage disease type VI
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00583
AC CVCL_5M49
SY GM-583
DR CLO; CLO_0025997
DR Coriell; GM00583
RX CelloPub=CLPUB00290;
DI NCIt; C103968; Pyruvate dehydrogenase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00584
AC CVCL_2G96
SY GM-584
DR CLO; CLO_0025994
DR Coriell; GM00584
RX CelloPub=CLPUB00290;
DI NCIt; C84765; Homocystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00585
AC CVCL_2G97
SY GM-585
DR CLO; CLO_0025995
DR Coriell; GM00585
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00589
AC CVCL_V777
SY GM-589; GM589
DR CLO; CLO_0026000
DR Coriell; GM00589
RX PubMed=872630;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00593
AC CVCL_9W76
SY GM-593
DR CLO; CLO_0026001
DR Coriell; GM00593
RX CelloPub=CLPUB00290;
DI NCIt; C84901; Mucopolysaccharidosis type IVA
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00594
AC CVCL_0P59
SY GM-594
DR CLO; CLO_0025998
DR Coriell; GM00594
RX CelloPub=CLPUB00290;
DI NCIt; C84765; Homocystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00595
AC CVCL_AW72
SY GM-595
DR CLO; CLO_0025999
DR Coriell; GM00595
RX CelloPub=CLPUB00290;
DI NCIt; C98986; Methylmalonic acidemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00596
AC CVCL_AW73
SY GM-596
DR CLO; CLO_0028998
DR Coriell; GM00596
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00599
AC CVCL_AA10
DR CLO; CLO_0029001
DR Coriell; GM00599
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84706; Familial dysautonomia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM00600
AC CVCL_AA11
DR CLO; CLO_0029000
DR Coriell; GM00600
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM00601
AC CVCL_AA12
DR CLO; CLO_0029017
DR Coriell; GM00601
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84706; Familial dysautonomia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM00602
AC CVCL_AA13
DR CLO; CLO_0029019
DR Coriell; GM00602
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84706; Familial dysautonomia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM00603
AC CVCL_AA14
DR CLO; CLO_0029023
DR Coriell; GM00603
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM00604
AC CVCL_H133
DR CLO; CLO_0029024
DR Coriell; GM00604
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM00605
AC CVCL_X062
SY GM-0605; GM 605
DR Coriell; GM00605
RX PubMed=6451249;
RX PubMed=6617268;
RX PubMed=6661932;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; GM00605; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID GM00606
AC CVCL_IP63
SY GM0606
DR Coriell; GM00606
RX PubMed=8316623;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; GM00606; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID GM00607
AC CVCL_7295
SY GM-607; GM607; GM17206
DR CLO; CLO_0013833
DR CLO; CLO_0029006
DR Coriell; GM00607
DR Coriell; GM17206
DR GEO; GSM569508
DR GEO; GSM596270
DR GEO; GSM596740
RX PubMed=20889555;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM00608
AC CVCL_H132
DR CLO; CLO_0029008
DR Coriell; GM00608
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM00609
AC CVCL_GR91
DR CLO; CLO_0029010
DR Coriell; GM00609
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00610
AC CVCL_V778
SY GM-610
DR CLO; CLO_0028972
DR Coriell; GM00610
RX PubMed=1225500;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00612
AC CVCL_AD58
SY GM-612
DR CLO; CLO_0028969
DR Coriell; GM00612
RX CelloPub=CLPUB00290;
DI NCIt; C34806; Maple syrup urine disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00613
AC CVCL_4D18
SY GM-613
DR CLO; CLO_0028968
DR Coriell; GM00613
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00614
AC CVCL_W655
SY GM-614
DR CLO; CLO_0028967
DR Coriell; GM00614
RX CelloPub=CLPUB00290;
DI NCIt; C61260; Hunter syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00615
AC CVCL_W656
SY GM-615
DR CLO; CLO_0028992
DR Coriell; GM00615
RX CelloPub=CLPUB00290;
DI NCIt; C61260; Hunter syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00620
AC CVCL_AB42
SY GM-620
DR CLO; CLO_0028994
DR Coriell; GM00620
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00621
AC CVCL_7296
SY GM-621; GM17207
DR CLO; CLO_0013881
DR CLO; CLO_0028987
DR Coriell; GM00621
DR Coriell; GM17207
DR GEO; GSM569505
DR GEO; GSM596271
DR GEO; GSM596632
RX PubMed=20889555;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM00622
AC CVCL_5M64
DR CLO; CLO_0028991
DR Coriell; GM00622
RX PubMed=23665875;
CC Omics: CNV analysis.
DI NCIt; C3273; Neurofibromatosis type 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00624
AC CVCL_V779
SY GM-624
DR CLO; CLO_0028981
DR Coriell; GM00624
RX PubMed=1183237;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00625
AC CVCL_2G98
SY GM-625; GM0625
DR CLO; CLO_0028984
DR Coriell; GM00625
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00627
AC CVCL_M978
SY GM-627; GM17151
DR CLO; CLO_0013957
DR CLO; CLO_0028869
DR Coriell; GM00627
DR Coriell; GM17151
RX PubMed=1225502;
CC Part of: Human variation panel.
CC Population: African American.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00629
AC CVCL_0L92
SY GM-629
DR CLO; CLO_0028870
DR Coriell; GM00629
RX CelloPub=CLPUB00290;
DI NCIt; C84897; Mucopolysaccharidosis type IIIA
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00632
AC CVCL_AV85
SY GM0632
DR CLO; CLO_0028871
DR Coriell; GM00632
RX PubMed=2837086;
DI NCIt; C98944; Hereditary orotic aciduria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00633
AC CVCL_H954
DR CLO; CLO_0028872
DR Coriell; GM00633
RX PubMed=23665875;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H953 ! GM00044
SX Male
CA Transformed cell line
//
ID GM00636
AC CVCL_H162
DR CLO; CLO_0028873
DR Coriell; GM00636
DI NCIt; C84701; Fabry disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00637
AC CVCL_7297
SY GM00637B; GM00637H; GM-637; GM 637; GM637; GM637A; GM0637; HG2855
DR BTO; BTO:0003591
DR CLO; CLO_0003514
DR CLO; CLO_0028881
DR CLDB; cl1481
DR Coriell; GM00637
DR IMGT/HLA; 10615
DR TOKU-E; 4106
RX PubMed=2821020;
RX PubMed=2903889;
RX PubMed=3023120;
RX PubMed=11172010;
RX PubMed=12361951;
RX PubMed=18433479;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7270 ! GM00037
SX Female
CA Transformed cell line
//
ID GM00638
AC CVCL_7298
SY GM-638; GM 638; GM638; GM00638A; GM54VA
DR CLO; CLO_0003515
DR CLO; CLO_0028878
DR CLDB; cl1482
DR Coriell; GM00638
RX CelloPub=CLPUB00290;
RX PubMed=189310;
RX PubMed=191830;
RX PubMed=1766867;
RX PubMed=12361951;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D342 ! GM00054
SX Male
CA Transformed cell line
//
ID GM00639
AC CVCL_7299
SY GM-639; GM 639; GM639; GM52VA
DR CLO; CLO_0003516
DR CLDB; cl1483
DR Coriell; GM00639
RX PubMed=191830;
RX PubMed=1766867;
RX PubMed=3413074;
RX PubMed=9175740;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Discontinued: Coriell; GM00639; true.
ST Source(s): PubMed=11416159
ST Amelogenin: X,Y
ST D18S51: 14,16
ST D21S11: 30,31
ST D8S1179: 13
ST FGA: 23,24
ST TH01: 9.3
ST vWA: 15,17
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2779 ! CHP 4 (W.W.)
SX Male
CA Transformed cell line
//
ID GM00640
AC CVCL_6B38
SY GM-640
DR CLO; CLO_0028883
DR Coriell; GM00640
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00641
AC CVCL_CX55
SY GM-641
DR Coriell; GM00641
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00641; probable.
DI NCIt; C126561; Niemann-Pick disease, type A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00643
AC CVCL_0L93
SY GM-643
DR CLO; CLO_0028882
DR Coriell; GM00643
RX CelloPub=CLPUB00290;
DI NCIt; C84897; Mucopolysaccharidosis type IIIA
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00644
AC CVCL_CX56
SY GM-644
DR Coriell; GM00644
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00644; probable.
DI NCIt; C126561; Niemann-Pick disease, type A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00646
AC CVCL_6B23
DR CLO; CLO_0028885
DR Coriell; GM00646
DI NCIt; C125702; Fanconi anemia, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00647
AC CVCL_1L40
DR CLO; CLO_0028849
DR Coriell; GM00647
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00648
AC CVCL_K091
SY GM-648; GM648
DR CLO; CLO_0028850
DR Coriell; GM00648
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00649
AC CVCL_AD59
SY GM-649; GM00649A
DR CLO; CLO_0028853
DR Coriell; GM00649
RX CelloPub=CLPUB00290;
DI NCIt; C34806; Maple syrup urine disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00650
AC CVCL_AD60
SY GM-650
DR CLO; CLO_0028854
DR Coriell; GM00650
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00651
AC CVCL_AD61
SY GM-651
DR CLO; CLO_0028851
DR Coriell; GM00651
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00654
AC CVCL_AB43
SY GM-654
DR CLO; CLO_0028852
DR Coriell; GM00654
RX CelloPub=CLPUB00290;
DI NCIt; C84548; Alpha-mannosidosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00657
AC CVCL_V780
SY GM-0657; GM-657; GM 657
DR CLO; CLO_0028863
DR Coriell; GM00657
RX PubMed=477406;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00667
AC CVCL_DN44
DR CLO; CLO_0028861
DR Coriell; GM00667
DI NCIt; C128114; Autosomal recessive hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00671
AC CVCL_F487
SY XP8BE; Pe Ar; GM-671; GM 671
DR CLO; CLO_0028860
DR ATCC; CRL-1158
DR Coriell; GM00671
DR JCRB; KURB1058
CC Discontinued: ATCC; CRL-1158; probable.
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F488 ! GM02249
SX Male
CA Finite cell line
//
ID GM00673
AC CVCL_F492
SY XP4SL
DR CLO; CLO_0028858
DR Coriell; GM00673
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00676
AC CVCL_F489
SY XP9BE; Ge Ar; GM0676
DR CLO; CLO_0028916
DR ATCC; CRL-1161
DR Coriell; GM00676
DR JCRB; KURB1059
CC Discontinued: ATCC; CRL-1161; true.
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F490 ! GM02498
SX Male
CA Finite cell line
//
ID GM00677
AC CVCL_F491
SY XP2BE; Ja Ar; GM-677; GM 677; GM677
DR CLO; CLO_0028918
DR ATCC; CRL-1166
DR Coriell; GM00677
DR JCRB; KURB1055
CC Discontinued: ATCC; CRL-1166; probable.
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00681
AC CVCL_X132
SY GM681
DR Coriell; GM00681
RX PubMed=694721;
CC Discontinued: Coriell; GM00681; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00682
AC CVCL_X133
DR CLO; CLO_0028921
DR Coriell; GM00682
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00683
AC CVCL_CX20
SY GM-683
DR Coriell; GM00683
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00683; probable.
DI NCIt; C84736; Glycogen storage disease type III
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00690
AC CVCL_W657
SY GM-690
DR CLO; CLO_0028910
DR Coriell; GM00690
RX CelloPub=CLPUB00290;
DI NCIt; C61260; Hunter syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00692
AC CVCL_X235
SY GM-0692; GM 692
DR CLO; CLO_0028912
DR Coriell; GM00692
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00693
AC CVCL_V461
DR CLO; CLO_0028913
DR Coriell; GM00693
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00694
AC CVCL_DN45
DR CLO; CLO_0028914
DR Coriell; GM00694
DI NCIt; C128114; Autosomal recessive hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00695
AC CVCL_CX57
DR CLO; CLO_0028937
DR Coriell; GM00695
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00696
AC CVCL_DN46
DR CLO; CLO_0028936
DR Coriell; GM00696
DI NCIt; C128114; Autosomal recessive hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00697
AC CVCL_DN47
DR CLO; CLO_0028938
DR Coriell; GM00697
DI NCIt; C128114; Autosomal recessive hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00700
AC CVCL_4N05
SY GM-700
DR CLO; CLO_0028895
DR Coriell; GM00700
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00701
AC CVCL_4N06
SY GM-701; GM00701C
DR CLO; CLO_0028896
DR Coriell; GM00701
RX CelloPub=CLPUB00290;
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00705
AC CVCL_0P86
DR CLO; CLO_0028893
DR Coriell; GM00705
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00706
AC CVCL_W235
SY GM-706; GM 706; GM706
DR CLO; CLO_0028894
DR Coriell; GM00706
RX CelloPub=CLPUB00290;
RX PubMed=9792862;
DI NCIt; C129932; Nephropathic cystinosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00709
AC CVCL_M276
SY XP21RO
DR CLO; CLO_0028891
DR Coriell; GM00709
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00710
AC CVCL_F493
SY GM710A; XP25RO; XP-25
DR CLO; CLO_0028892
DR ATCC; CRL-1261
DR Coriell; GM00710
DR JCRB; KURB1039
RX PubMed=1372102;
CC Discontinued: ATCC; CRL-1261; true.
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00711
AC CVCL_0P82
DR CLO; CLO_0028889
DR Coriell; GM00711
DI NCIt; C85187; Thanatophoric dysplasia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0P83 ! GM00712
OI CVCL_0P84 ! GM00713
OI CVCL_0P85 ! GM00714
SX Male
CA Finite cell line
//
ID GM00712
AC CVCL_0P83
DR CLO; CLO_0028890
DR Coriell; GM00712
DI NCIt; C85187; Thanatophoric dysplasia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0P82 ! GM00711
OI CVCL_0P84 ! GM00713
OI CVCL_0P85 ! GM00714
SX Male
CA Finite cell line
//
ID GM00713
AC CVCL_0P84
DR CLO; CLO_0028907
DR Coriell; GM00713
DI NCIt; C85187; Thanatophoric dysplasia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0P82 ! GM00711
OI CVCL_0P83 ! GM00712
OI CVCL_0P85 ! GM00714
SX Male
CA Finite cell line
//
ID GM00714
AC CVCL_0P85
DR CLO; CLO_0028906
DR Coriell; GM00714
DI NCIt; C85187; Thanatophoric dysplasia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0P82 ! GM00711
OI CVCL_0P83 ! GM00712
OI CVCL_0P84 ! GM00713
SX Male
CA Finite cell line
//
ID GM00717
AC CVCL_H134
SY GM-717; GM 717; GM-0717A
DR CLO; CLO_0028790
DR Coriell; GM00717
RX PubMed=761484;
RX PubMed=1561323;
RX PubMed=7539412;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM00718
AC CVCL_H135
SY GM-718
DR CLO; CLO_0028798
DR Coriell; GM00718
RX PubMed=761484;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM00719
AC CVCL_7300
SY GM-719
DR CLO; CLO_0028797
DR EFO; EFO_0004922
DR Coriell; GM00719
RX PubMed=761484;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM00720
AC CVCL_2G99
SY GM-720; GM0720
DR CLO; CLO_0028796
DR Coriell; GM00720
RX CelloPub=CLPUB00290;
DI NCIt; C84765; Homocystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00721
AC CVCL_L953
SY GM-721; GM00547
DR CLO; CLO_0028795
DR Coriell; GM00547
DR Coriell; GM00721
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00547; true.
DI NCIt; C84765; Homocystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00722
AC CVCL_L954
SY GM-722; GM00548
DR CLO; CLO_0028794
DR Coriell; GM00548
DR Coriell; GM00722
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00548; true.
CC Discontinued: Coriell; GM00722; probable.
DI NCIt; C84765; Homocystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00724
AC CVCL_2H00
SY GM-724
DR CLO; CLO_0028793
DR Coriell; GM00724
RX CelloPub=CLPUB00290;
DI NCIt; C84765; Homocystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00725
AC CVCL_L955
SY GM-725
DR CLO; CLO_0028792
DR Coriell; GM00725
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00726
AC CVCL_M979
SY GM17081
DR CLO; CLO_0014483
DR CLO; CLO_0028791
DR Coriell; GM00726
DR Coriell; GM17081
CC Part of: Human variation panel.
CC Population: Southeast Asians.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00727
AC CVCL_1Y22
SY GM-727
DR CLO; CLO_0028783
DR Coriell; GM00727
RX CelloPub=CLPUB00290;
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00729
AC CVCL_V548
SY GM-729; GM 729; GM729
DR CLO; CLO_0028810
DR Coriell; GM00729
RX PubMed=7329430;
RX PubMed=7471105;
DI NCIt; C3360; Supernumerary circular chromosome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00730
AC CVCL_L944
SY GM-730; GM 730; GM730; GM0730; GM00238
DR CLO; CLO_0028809
DR Coriell; GM00238
DR Coriell; GM00730
RX PubMed=2903889;
RX PubMed=2973075;
RX PubMed=6600729;
RX PubMed=6843573;
CC Discontinued: Coriell; GM00238; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00731
AC CVCL_7301
SY GM 0731A; GM 0731
DR CLO; CLO_0028816
DR Coriell; GM00731
RX PubMed=3860870;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00732
AC CVCL_GS52
DR CLO; CLO_0028815
DR Coriell; GM00732
DI NCIt; C3501; Peripheral sensory neuropathy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00733
AC CVCL_AM61
DR CLO; CLO_0028818
DR Coriell; GM00733
DI NCIt; C34568; Ehlers-Danlos syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00734
AC CVCL_X236
SY GM 734
DR CLO; CLO_0028817
DR Coriell; GM00734
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00735
AC CVCL_X076
SY GM-0735; GM 735
DR CLO; CLO_0028812
DR Coriell; GM00735
RX PubMed=6617268;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00736
AC CVCL_J107
DR CLO; CLO_0028811
DR Coriell; GM00736
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM00737
AC CVCL_0L94
SY GM-737
DR CLO; CLO_0028814
DR Coriell; GM00737
RX CelloPub=CLPUB00290;
DI NCIt; C84898; Mucopolysaccharidosis type IIIB
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00738
AC CVCL_4J12
SY GM-738
DR CLO; CLO_0028813
DR Coriell; GM00738
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00739
AC CVCL_L471
SY GM-739; GM 739; GM739; CS1AN
DR CLO; CLO_0028821
DR Coriell; GM00739
DR JCRB; KURB1910
RX PubMed=2973075;
DI NCIt; C9460; Cockayne syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00740
AC CVCL_9W77
DR CLO; CLO_0028820
DR Coriell; GM00740
DI NCIt; C85047; Rhizomelic chondrodysplasia punctata
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00741
AC CVCL_CX36
SY GM-741
DR Coriell; GM00741
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00741; probable.
DI NCIt; C128116; Neuronal ceroid lipofuscinosis type 4B
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00743
AC CVCL_BW98
SY GM-743
DR CLO; CLO_0028819
DR Coriell; GM00743
RX CelloPub=CLPUB00290;
DI NCIt; C126738; Phosphoglycerate kinase 1 deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00744
AC CVCL_DD65
DR CLO; CLO_0028825
DR Coriell; GM00744
DI NCIt; C26837; Osteogenesis imperfecta
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00747
AC CVCL_CX01
SY GM-747
DR CLO; CLO_0028824
DR Coriell; GM00747
RX CelloPub=CLPUB00290;
DI NCIt; C84937; Glycine encephalopathy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00751
AC CVCL_2H01
SY GM-751
DR CLO; CLO_0028823
DR Coriell; GM00751
RX CelloPub=CLPUB00290;
DI NCIt; C84765; Homocystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00752
AC CVCL_2H02
SY GM-752
DR CLO; CLO_0028822
DR Coriell; GM00752
RX CelloPub=CLPUB00290;
DI NCIt; C84765; Homocystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00753
AC CVCL_2H03
SY GM-753
DR CLO; CLO_0028828
DR Coriell; GM00753
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00754
AC CVCL_CX51
SY GM-754
DR Coriell; GM00754
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00754; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00760
AC CVCL_W236
SY GM-760; GM 760; GM760
DR CLO; CLO_0028827
DR Coriell; GM00760
RX CelloPub=CLPUB00290;
RX PubMed=9792862;
DI NCIt; C129932; Nephropathic cystinosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00768
AC CVCL_H138
DR CLO; CLO_0028826
DR Coriell; GM00768
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H137 ! GM00897
SX Male
CA Finite cell line
//
ID GM00770
AC CVCL_V205
DR CLO; CLO_0028840
DR Coriell; GM00770
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00773
AC CVCL_V781
SY GM-773
DR CLO; CLO_0028839
DR Coriell; GM00773
RX PubMed=891261;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00780
AC CVCL_CV49
SY GM 780; GM780
DR Coriell; GM00780
CC Discontinued: Coriell; GM00780; probable.
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID GM00781
AC CVCL_J108
SY GM-781
DR CLO; CLO_0028842
DR Coriell; GM00781
RX PubMed=761484;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM00782
AC CVCL_4E27
DR CLO; CLO_0028841
DR Coriell; GM00782
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00783
AC CVCL_W542
SY HDF-FOP2
DR CLO; CLO_0028844
DR Coriell; GM00783
DI NCIt; C3040; Fibrodysplasia ossificans progressiva
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00798
AC CVCL_V528
SY GM-798
DR CLO; CLO_0028843
DR Coriell; GM00798
RX CelloPub=CLPUB00290;
CC Characteristics: Homozygous for the IDUA p.Trp402Ter mutation.
DI NCIt; C61261; Hurler syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00799
AC CVCL_1V09
SY GM-799
DR CLO; CLO_0028846
DR Coriell; GM00799
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00800
AC CVCL_1V10
SY GM-800
DR CLO; CLO_0028845
DR Coriell; GM00800
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00801
AC CVCL_1B69
SY GM-801
DR CLO; CLO_0028848
DR Coriell; GM00801
RX CelloPub=CLPUB00290;
DI NCIt; C61274; Fucosidosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00802
AC CVCL_1B70
SY GM-802
DR CLO; CLO_0028847
DR Coriell; GM00802
RX CelloPub=CLPUB00290;
DI NCIt; C61274; Fucosidosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00803
AC CVCL_X077
SY GM 803
DR CLO; CLO_0029645
DR Coriell; GM00803
RX PubMed=6617268;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00804
AC CVCL_H175
DR CLO; CLO_0029644
DR Coriell; GM00804
DI NCIt; C129932; Nephropathic cystinosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00806
AC CVCL_CX43
SY GM-806; GM 806
DR Coriell; GM00806
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00806; probable.
DI NCIt; C129928; Galactosialidosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IJ33 ! GM04305
SX Female
CA Finite cell line
//
ID GM00811
AC CVCL_U702
DR CLO; CLO_0029646
DR Coriell; GM00811
CC Discontinued: Coriell; GM00811; probable.
DI NCIt; C2903; Bloom syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U705 ! GM02932
SX Male
CA Finite cell line
//
ID GM00813
AC CVCL_2H04
SY GM-813
DR CLO; CLO_0029647
DR Coriell; GM00813
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00843
AC CVCL_4E23
DR CLO; CLO_0029648
DR Coriell; GM00843
DI NCIt; C85062; Sea-blue histiocyte syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00844
AC CVCL_4E24
DR CLO; CLO_0029649
DR Coriell; GM00844
DI NCIt; C85062; Sea-blue histiocyte syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00845
AC CVCL_V782
SY GM-845
DR CLO; CLO_0029652
DR Coriell; GM00845
RX PubMed=648194;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00846
AC CVCL_V783
SY GM-846
DR CLO; CLO_0029653
DR Coriell; GM00846
RX PubMed=565692;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00847
AC CVCL_7908
SY LN-SV; LNSV; GM-847; GM 847; GM847
DR CLO; CLO_0029655
DR Coriell; GM00847
RX PubMed=191830;
RX PubMed=3413074;
RX PubMed=9175740;
RX PubMed=12361951;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F127 ! GM02063
SX Male
CA Transformed cell line
//
ID GM00850
AC CVCL_7302
DR CLO; CLO_0029657
DR Coriell; GM00850
DI NCIt; C84706; Familial dysautonomia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00852
AC CVCL_8515
SY GM-852
DR CLO; CLO_0029631
DR Coriell; GM00852
RX CelloPub=CLPUB00290;
RX PubMed=19815695;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
DI NCIt; C61268; Gaucher disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00853
AC CVCL_CX47
SY GM-853
DR Coriell; GM00853
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00853; probable.
DI NCIt; C61254; Krabbe disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00854
AC CVCL_CX48
SY GM-854
DR Coriell; GM00854
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00854; probable.
DI NCIt; C61254; Krabbe disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00855
AC CVCL_CX42
SY GM-855
DR Coriell; GM00855
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00855; probable.
DI NCIt; C61268; Gaucher disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00857
AC CVCL_X237
SY GM 857
DR CLO; CLO_0029630
DR Coriell; GM00857
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
DI NCIt; C26900; Turner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00860
AC CVCL_X238
SY GM 860
DR CLO; CLO_0029629
DR Coriell; GM00860
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
CC Discontinued: Coriell; GM00860; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00861
AC CVCL_4D79
DR CLO; CLO_0029634
DR Coriell; GM00861
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00862
AC CVCL_4D19
SY GM-862
DR CLO; CLO_0029635
DR Coriell; GM00862
RX CelloPub=CLPUB00290;
DI NCIt; C61260; Hunter syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00863
AC CVCL_7303
SY GM-863
DR CLO; CLO_0003517
DR CLO; CLO_0029632
DR CLDB; cl1484
DR Coriell; GM00863
RX CelloPub=CLPUB00290;
DI NCIt; C61271; Wolman disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00864
AC CVCL_2H05
SY GM-864
DR CLO; CLO_0029633
DR Coriell; GM00864
RX CelloPub=CLPUB00290;
DI NCIt; C84765; Homocystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00865
AC CVCL_7304
SY GM-865
DR CLO; CLO_0029637
DR Coriell; GM00865
RX CelloPub=CLPUB00290;
DI NCIt; C84765; Homocystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00866
AC CVCL_2H06
SY GM-866
DR CLO; CLO_0029638
DR Coriell; GM00866
RX CelloPub=CLPUB00290;
DI NCIt; C84765; Homocystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00867
AC CVCL_2H07
SY GM-867
DR CLO; CLO_0029636
DR Coriell; GM00867
RX CelloPub=CLPUB00290;
DI NCIt; C84765; Homocystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00870
AC CVCL_V784
SY GM-0870; GM-870; GM 870
DR CLO; CLO_0029601
DR Coriell; GM00870
RX PubMed=1017321;
RX PubMed=6617268;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00876
AC CVCL_AW74
SY GM-876
DR CLO; CLO_0029600
DR Coriell; GM00876
RX CelloPub=CLPUB00290;
DI NCIt; C98986; Methylmalonic acidemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00877
AC CVCL_0R27
SY GM-877; GM877
DR CLO; CLO_0029603
DR Coriell; GM00877
RX CelloPub=CLPUB00290;
RX PubMed=2464926;
DI NCIt; C61268; Gaucher disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00878
AC CVCL_0R28
SY GM-878
DR CLO; CLO_0029602
DR Coriell; GM00878
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00879
AC CVCL_0L95
SY GM-879
DR CLO; CLO_0029618
DR Coriell; GM00879
RX CelloPub=CLPUB00290;
DI NCIt; C84897; Mucopolysaccharidosis type IIIA
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00880
AC CVCL_CX02
SY GM-880
DR CLO; CLO_0029620
DR Coriell; GM00880
RX CelloPub=CLPUB00290;
DI NCIt; C84937; Glycine encephalopathy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00881
AC CVCL_7305
SY GM-881
DR CLO; CLO_0003518
DR CLO; CLO_0029624
DR CLDB; cl1485
DR Coriell; GM00881
RX CelloPub=CLPUB00290;
DI NCIt; C84701; Fabry disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00882
AC CVCL_0Q46
SY GM-882
DR CLO; CLO_0029628
DR Coriell; GM00882
RX CelloPub=CLPUB00290;
DI NCIt; C84701; Fabry disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00883
AC CVCL_2H08
SY GM-883
DR CLO; CLO_0029610
DR Coriell; GM00883
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00885
AC CVCL_2H09
SY GM-885
DR CLO; CLO_0029611
DR Coriell; GM00885
RX CelloPub=CLPUB00290;
DI NCIt; C84765; Homocystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00886
AC CVCL_0L96
SY GM-886
DR CLO; CLO_0029585
DR Coriell; GM00886
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00887
AC CVCL_V530
SY GM-887
DR CLO; CLO_0029583
DR Coriell; GM00887
RX CelloPub=CLPUB00290;
DI NCIt; C61261; Hurler syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00888
AC CVCL_CX18
SY GM-888
DR Coriell; GM00888
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00888; probable.
DI NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00892
AC CVCL_H136
AS CVCL_H692
SY GM-0892; GM 892; GM0892; GM892; GM892A
DR CLO; CLO_0029582
DR ChEMBL-Cells; CHEMBL3308595
DR ChEMBL-Targets; CHEMBL614505
DR Coriell; GM00892
RX PubMed=6661932;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM00893
AC CVCL_7306
SY GM17208
DR CLO; CLO_0013884
DR CLO; CLO_0029581
DR Coriell; GM00893
DR Coriell; GM17208
DR GEO; GSM569509
DR GEO; GSM596272
DR GEO; GSM596633
RX PubMed=20889555;
RX PubMed=22152194;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM00897
AC CVCL_H137
DR CLO; CLO_0029580
DR Coriell; GM00897
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H138 ! GM00768
SX Male
CA Transformed cell line
//
ID GM00898
AC CVCL_CX65
SY GM-898
DR Coriell; GM00898
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00898; probable.
DI NCIt; C126561; Niemann-Pick disease, type A
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID GM00901
AC CVCL_CX32
SY GM-901
DR Coriell; GM00901
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00901; probable.
DI NCIt; C61260; Hunter syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00902
AC CVCL_CX33
SY GM-902
DR Coriell; GM00902
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00902; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00903
AC CVCL_CX34
SY GM-903
DR Coriell; GM00903
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00903; probable.
DI NCIt; C84897; Mucopolysaccharidosis type IIIA
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00904
AC CVCL_CX39
SY GM-904
DR Coriell; GM00904
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00904; probable.
DI NCIt; C84710; Farber lipogranulomatosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00905
AC CVCL_6B39
SY GM-905
DR CLO; CLO_0029598
DR Coriell; GM00905
RX CelloPub=CLPUB00290;
DI NCIt; C61251; Metachromatic leukodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00906
AC CVCL_CW98
SY GM-906
DR CLO; CLO_0029599
DR Coriell; GM00906
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00907
AC CVCL_CW99
SY GM-907
DR CLO; CLO_0029595
DR Coriell; GM00907
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00908
AC CVCL_Y986
SY GM-908
DR CLO; CLO_0029596
DR Coriell; GM00908
RX CelloPub=CLPUB00290;
DI NCIt; C129932; Nephropathic cystinosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00909
AC CVCL_Y987
SY GM-909
DR CLO; CLO_0029591
DR Coriell; GM00909
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00910
AC CVCL_Y988
SY GM-910
DR CLO; CLO_0029560
DR Coriell; GM00910
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00911
AC CVCL_4T28
SY GM-911
DR CLO; CLO_0029561
DR Coriell; GM00911
RX CelloPub=CLPUB00290;
DI NCIt; C123435; Methionine adenosyltransferase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00914
AC CVCL_5M67
DR CLO; CLO_0029562
DR Coriell; GM00914
DI NCIt; C42596; Sporadic retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00915
AC CVCL_CX53
SY GM-915
DR Coriell; GM00915
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00915; probable.
DI NCIt; C84908; Multiple sulfatase deficiency disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00918
AC CVCL_CX44
SY GM-918
DR CLO; CLO_0029563
DR Coriell; GM00918
RX CelloPub=CLPUB00290;
DI NCIt; C84739; GM1 gangliosidosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00919
AC CVCL_H176
DR CLO; CLO_0029564
DR Coriell; GM00919
DI NCIt; C84765; Homocystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00922
AC CVCL_7307
SY GM17209
DR CLO; CLO_0013875
DR CLO; CLO_0029565
DR Coriell; GM00922
DR Coriell; GM17209
DR GEO; GSM569629
DR GEO; GSM596273
DR GEO; GSM596634
RX PubMed=20889555;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM00930
AC CVCL_AW75
SY GM-930
DR CLO; CLO_0029568
DR Coriell; GM00930
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00930; probable.
DI NCIt; C98986; Methylmalonic acidemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00931
AC CVCL_4J13
DR CLO; CLO_0029567
DR Coriell; GM00931
DI NCIt; C84536; Acute intermittent porphyria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00932
AC CVCL_4J14
DR CLO; CLO_0029571
DR Coriell; GM00932
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00933
AC CVCL_4J15
DR CLO; CLO_0029570
DR Coriell; GM00933
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00934
AC CVCL_0L97
SY GM-934
DR CLO; CLO_0029541
DR Coriell; GM00934
RX CelloPub=CLPUB00290;
DI NCIt; C84897; Mucopolysaccharidosis type IIIA
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00935
AC CVCL_V785
SY GM-935
DR CLO; CLO_0029539
DR Coriell; GM00935
RX CelloPub=CLPUB00290;
RX PubMed=826372;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00936
AC CVCL_L468
DR CLO; CLO_0029540
DR Coriell; GM00936
DR JCRB; KURB1074
DI NCIt; C3967; Xeroderma pigmentosum, complementation group D
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00937
AC CVCL_W147
SY GM-937
DR CLO; CLO_0029545
DR Coriell; GM00937
RX CelloPub=CLPUB00290;
DI NCIt; C81315; Phenylketonuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00939
AC CVCL_W223
DR CLO; CLO_0029546
DR Coriell; GM00939
DI NCIt; C84536; Acute intermittent porphyria
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W224 ! GM02135
SX Female
CA Finite cell line
//
ID GM00940
AC CVCL_M925
DR CLO; CLO_0029542
DR Coriell; GM00940
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M924 ! GM02134
SX Female
CA Finite cell line
//
ID GM00941
AC CVCL_4J16
DR CLO; CLO_0029543
DR Coriell; GM00941
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4J46 ! GM02133
SX Male
CA Finite cell line
//
ID GM00942
AC CVCL_9W78
SY GM-942
DR CLO; CLO_0029552
DR Coriell; GM00942
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00943
AC CVCL_V786
SY GM-943
DR CLO; CLO_0029550
DR Coriell; GM00943
RX CelloPub=CLPUB00290;
RX PubMed=826372;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00945
AC CVCL_X078
SY GM-0945; GM 945
DR CLO; CLO_0029549
DR Coriell; GM00945
RX PubMed=6617268;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00946
AC CVCL_7308
SY GM17210
DR CLO; CLO_0013891
DR CLO; CLO_0029523
DR Coriell; GM00946
DR Coriell; GM17210
DR GEO; GSM569510
DR GEO; GSM596274
DR GEO; GSM596635
RX PubMed=20889555;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM00947
AC CVCL_4W19
DR CLO; CLO_0029524
DR Coriell; GM00947
DI NCIt; C98964; Isovaleric acidemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00948
AC CVCL_IL05
DR CLO; CLO_0029525
DR Coriell; GM00948
DI NCIt; C85061; Scleromyxedema
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IL06 ! GM00950
OI CVCL_IL07 ! GM00951
SX Male
CA Finite cell line
//
ID GM00950
AC CVCL_IL06
DR CLO; CLO_0029526
DR Coriell; GM00950
DI NCIt; C85061; Scleromyxedema
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IL05 ! GM00948
OI CVCL_IL07 ! GM00951
SX Male
CA Finite cell line
//
ID GM00951
AC CVCL_IL07
DR CLO; CLO_0029519
DR Coriell; GM00951
DI NCIt; C85061; Scleromyxedema
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IL05 ! GM00948
OI CVCL_IL06 ! GM00950
SX Male
CA Finite cell line
//
ID GM00954
AC CVCL_V029
SY GM-954
DR CLO; CLO_0029520
DR Coriell; GM00954
RX CelloPub=CLPUB00290;
DI NCIt; C84568; Argininemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V030 ! GM02011
SX Female
CA Finite cell line
//
ID GM00956
AC CVCL_X060
SY GM 956
DR Coriell; GM00956
RX PubMed=6451249;
CC Discontinued: Coriell; GM00956; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID GM00957
AC CVCL_7309
SY GM 957
DR CLO; CLO_0029521
DR Coriell; GM00957
RX PubMed=6451249;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00958
AC CVCL_9W79
SY GM-958
DR CLO; CLO_0029522
DR Coriell; GM00958
RX CelloPub=CLPUB00290;
DI NCIt; C84901; Mucopolysaccharidosis type IVA
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00959
AC CVCL_V787
SY GM-0959; GM-959; GM 959
DR CLO; CLO_0029532
DR Coriell; GM00959
RX PubMed=1017324;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00961
AC CVCL_4J17
DR CLO; CLO_0029531
DR Coriell; GM00961
DI NCIt; C27725; Porphyria cutanea tarda
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00962
AC CVCL_W225
DR CLO; CLO_0029499
DR Coriell; GM00962
DI NCIt; C84759; Hereditary coproporphyria
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W226 ! GM02302
SX Female
CA Finite cell line
//
ID GM00963
AC CVCL_1V22
SY GM-963
DR CLO; CLO_0029506
DR Coriell; GM00963
RX CelloPub=CLPUB00290;
DI NCIt; C122782; Hurler-Scheie syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00967
AC CVCL_7310
SY GM00967D
DR CLO; CLO_0029507
DR Coriell; GM00967
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X802 ! AG16504
OI CVCL_1M95 ! AG20457
OI CVCL_1M96 ! AG22339
OI CVCL_7316 ! GM01310
OI CVCL_7531 ! GM13335
OI CVCL_7532 ! GM13336
SX Male
CA Finite cell line
//
ID GM00969
AC CVCL_7311
SY GM 969A
DR CLO; CLO_0029504
DR Coriell; GM00969
RX PubMed=2837086;
RX PubMed=3745952;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00970
AC CVCL_7312
SY GM970B; GM0970; GM 0970A
DR CLO; CLO_0029505
DR Coriell; GM00970
RX PubMed=3745952;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00972
AC CVCL_H140
DR CLO; CLO_0029502
DR Coriell; GM00972
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H139 ! GM01063
SX Female
CA Finite cell line
//
ID GM00976
AC CVCL_CX00
SY GM-976
DR Coriell; GM00976
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00976; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00977
AC CVCL_4J18
DR CLO; CLO_0029503
DR Coriell; GM00977
DI NCIt; C27725; Porphyria cutanea tarda
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00978
AC CVCL_L956
SY GM00188
DR CLO; CLO_0029500
DR Coriell; GM00188
DR Coriell; GM00978
CC Discontinued: Coriell; GM00188; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00980
AC CVCL_X239
SY GM-0980; GM 980
DR CLO; CLO_0029514
DR Coriell; GM00980
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00981
AC CVCL_V829
SY GM-0981; GM-981; GM 981
DR CLO; CLO_0029478
DR Coriell; GM00981
RX PubMed=657847;
RX PubMed=6617268;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00982
AC CVCL_V788
SY GM-982
DR CLO; CLO_0029477
DR Coriell; GM00982
RX PubMed=657848;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00983
AC CVCL_X240
SY GM-0983; GM0983; GM 983
DR CLO; CLO_0029476
DR Coriell; GM00983
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00988
AC CVCL_V789
SY GM-988
DR CLO; CLO_0029475
DR Coriell; GM00988
RX PubMed=872632;
RX PubMed=23665875;
CC Omics: CNV analysis.
CC Discontinued: Coriell; GM00988; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00989
AC CVCL_CV39
DR CLO; CLO_0029474
DR Coriell; GM00989
DI NCIt; C34951; Progeria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00991
AC CVCL_CV50
SY GM 991; GM991
DR Coriell; GM00991
CC Discontinued: Coriell; GM00991; probable.
DI NCIt; C34951; Progeria
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID GM00994
AC CVCL_CX40
SY GM-994
DR Coriell; GM00994
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00994; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM00995
AC CVCL_CX41
SY GM-995
DR Coriell; GM00995
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00995; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00997
AC CVCL_V206
DR CLO; CLO_0029473
DR Coriell; GM00997
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00998
AC CVCL_V207
DR CLO; CLO_0029472
DR Coriell; GM00998
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM00999
AC CVCL_V208
DR CLO; CLO_0029471
DR Coriell; GM00999
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01000
AC CVCL_CX07
SY GM-1000
DR Coriell; GM01000
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM01000; probable.
DI NCIt; C34806; Maple syrup urine disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01011
AC CVCL_L745
DR CLO; CLO_0029470
DR Coriell; GM01011
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01012
AC CVCL_L744
SY GM1012A
DR CLO; CLO_0029469
DR Coriell; GM01012
CC Characteristics: Homozygous for the CFTR p.Phe508del mutation.
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01013
AC CVCL_V209
DR CLO; CLO_0029496
DR Coriell; GM01013
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01014
AC CVCL_V210
DR CLO; CLO_0029498
DR Coriell; GM01014
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01016
AC CVCL_6B40
DR CLO; CLO_0029497
DR Coriell; GM01016
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01017
AC CVCL_6B41
DR CLO; CLO_0029493
DR Coriell; GM01017
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C61251; Metachromatic leukodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01018
AC CVCL_M980
SY GM17072
DR CLO; CLO_0014601
DR CLO; CLO_0029492
DR Coriell; GM01018
DR Coriell; GM17072
CC Part of: Human variation panel.
CC Population: Puerto Rican.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C61251; Metachromatic leukodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01019
AC CVCL_U479
DR CLO; CLO_0029495
DR Coriell; GM01019
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01022
AC CVCL_V790
SY GM-1022; GM01022A
DR CLO; CLO_0029494
DR Coriell; GM01022
RX CelloPub=CLPUB00290;
RX PubMed=826372;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C61264; Maroteaux-Lamy syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V775 ! GM00519
OI CVCL_V821 ! GM05358
SX Female
CA Transformed cell line
//
ID GM01023
AC CVCL_V791
SY GM-1023
DR CLO; CLO_0029490
DR Coriell; GM01023
RX CelloPub=CLPUB00290;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V761 ! GM00289
SX Male
CA Transformed cell line
//
ID GM01024
AC CVCL_V792
SY GM-1024
DR CLO; CLO_0029489
DR Coriell; GM01024
RX CelloPub=CLPUB00290;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C61274; Fucosidosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V763 ! GM00291
SX Male
CA Transformed cell line
//
ID GM01025
AC CVCL_V793
SY GM-1025
DR CLO; CLO_0029491
DR Coriell; GM01025
RX CelloPub=CLPUB00290;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C61274; Fucosidosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V764 ! GM00292
SX Male
CA Transformed cell line
//
ID GM01026
AC CVCL_V794
SY GM-1026
DR CLO; CLO_0030369
DR Coriell; GM01026
RX CelloPub=CLPUB00290;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V762 ! GM00290
SX Female
CA Transformed cell line
//
ID GM01028
AC CVCL_V431
SY GM01028A
DR CLO; CLO_0030378
DR Coriell; GM01028
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V430 ! GM00440
SX Female
CA Transformed cell line
//
ID GM01029
AC CVCL_V795
SY GM01029A
DR CLO; CLO_0030377
DR Coriell; GM01029
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V771 ! GM00439
SX Female
CA Transformed cell line
//
ID GM01030
AC CVCL_0R29
DR CLO; CLO_0030376
DR Coriell; GM01030
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01031
AC CVCL_0R30
DR CLO; CLO_0030375
DR Coriell; GM01031
RX PubMed=19815695;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; GM01031; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01032
AC CVCL_M981
SY GM17021
DR CLO; CLO_0014695
DR CLO; CLO_0030374
DR Coriell; GM01032
DR Coriell; GM17021
CC Part of: Human variation panel.
CC Population: Indo Pakistani.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C122782; Hurler-Scheie syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01034
AC CVCL_1V11
DR CLO; CLO_0030373
DR Coriell; GM01034
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C61261; Hurler syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1V12 ! GM01867
SX Female
CA Transformed cell line
//
ID GM01041
AC CVCL_4J19
DR CLO; CLO_0030372
DR Coriell; GM01041
DI NCIt; C27725; Porphyria cutanea tarda
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01044
AC CVCL_U514
SY GM-1044; GM1044
DR CLO; CLO_0030371
DR Coriell; GM01044
RX PubMed=891263;
RX CelloPub=CLPUB00290;
DI NCIt; C84639; Citrullinemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U515 ! GM01204
SX Male
CA Finite cell line
//
ID GM01053
AC CVCL_V531
SY GM-1053
DR CLO; CLO_0030370
DR Coriell; GM01053
RX CelloPub=CLPUB00290;
DI NCIt; C61261; Hurler syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01056
AC CVCL_D344
SY GM01056B; GM-1056; GM1056; GM1056-A; GM17211
DR CLO; CLO_0013890
DR CLO; CLO_0030349
DR Coriell; GM01056
DR Coriell; GM17211
DR GEO; GSM569520
DR GEO; GSM596275
DR GEO; GSM596636
RX PubMed=3495441;
RX PubMed=20889555;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7499 ! GM09918
SX Male
CA Transformed cell line
//
ID GM01057
AC CVCL_H964
DR CLO; CLO_0030350
DR Coriell; GM01057
DI NCIt; C75486; Menkes disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H965 ! GM01245
SX Male
CA Finite cell line
//
ID GM01058
AC CVCL_H141
SY GM-1058
DR CLO; CLO_0030366
DR Coriell; GM01058
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H142 ! GM01206
SX Male
CA Finite cell line
//
ID GM01059
AC CVCL_X079
SY GM-1059; GM 1059
DR CLO; CLO_0030365
DR Coriell; GM01059
RX PubMed=6617268;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01061
AC CVCL_V036
SY GM01061A; GM1061
DR CLO; CLO_0030368
DR Coriell; GM01061
RX PubMed=2973075;
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V042 ! GM03642
SX Male
CA Finite cell line
//
ID GM01063
AC CVCL_H139
SY GM01063B
DR CLO; CLO_0030367
DR Coriell; GM01063
RX PubMed=23665875;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H140 ! GM00972
SX Female
CA Transformed cell line
//
ID GM01064
AC CVCL_V796
SY GM-1064; GM1064
DR CLO; CLO_0030362
DR Coriell; GM01064
RX PubMed=1017323;
RX PubMed=6293786;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01068
AC CVCL_CX37
SY GM-1068
DR Coriell; GM01068
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM01068; probable.
DI NCIt; C84701; Fabry disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01070
AC CVCL_CX38
SY GM-1070
DR Coriell; GM01070
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM01070; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01078
AC CVCL_7313
SY GM-1078; GM 1078; GM18002
DR CLO; CLO_0015992
DR CLO; CLO_0030361
DR Coriell; GM01078
DR Coriell; GM18002
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01082
AC CVCL_GS53
DR CLO; CLO_0030364
DR Coriell; GM01082
DI NCIt; C84697; Erythropoietic porphyria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01083
AC CVCL_V037
SY GM01083A
DR CLO; CLO_0030363
DR Coriell; GM01083
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V043 ! GM03643
SX Female
CA Finite cell line
//
ID GM01085
AC CVCL_V038
DR CLO; CLO_0030193
DR Coriell; GM01085
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V044 ! GM03644
SX Male
CA Finite cell line
//
ID GM01091
AC CVCL_V797
SY GM-1091
DR CLO; CLO_0030198
DR Coriell; GM01091
RX PubMed=446099;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01093
AC CVCL_DD66
DR CLO; CLO_0030195
DR Coriell; GM01093
DI NCIt; C26837; Osteogenesis imperfecta
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01094
AC CVCL_0L98
SY GM-1094
DR CLO; CLO_0030180
DR Coriell; GM01094
RX CelloPub=CLPUB00290;
DI NCIt; C84897; Mucopolysaccharidosis type IIIA
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0M02 ! GM01739
SX Female
CA Finite cell line
//
ID GM01095
AC CVCL_0L99
SY GM-1095
DR CLO; CLO_0030181
DR Coriell; GM01095
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01096
AC CVCL_0M00
SY GM-1096
DR CLO; CLO_0030184
DR Coriell; GM01096
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01098
AC CVCL_7314
SY GM1098; GM 1098; GM 1098B; CS5HO; CS2BE
DR CLO; CLO_0030186
DR Coriell; GM01098
DR JCRB; KURB1916
RX PubMed=7471106;
DI NCIt; C9460; Cockayne syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L458 ! GM01712
SX Male
CA Finite cell line
//
ID GM01099
AC CVCL_AD62
SY GM-1099
DR CLO; CLO_0030187
DR Coriell; GM01099
RX CelloPub=CLPUB00290;
DI NCIt; C34806; Maple syrup urine disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01101
AC CVCL_0P87
DR CLO; CLO_0030188
DR Coriell; GM01101
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01108
AC CVCL_1V04
SY GM-1108
DR CLO; CLO_0030189
DR Coriell; GM01108
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01109
AC CVCL_1V05
SY GM-1109
DR CLO; CLO_0030177
DR Coriell; GM01109
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01110
AC CVCL_U386
SY GM-1110; GM 1110; GM1110
DR CLO; CLO_0030175
DR Coriell; GM01110
RX CelloPub=CLPUB00290;
DI NCIt; C85184; Tay-Sachs disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01116
AC CVCL_CX46
SY GM-1116
DR Coriell; GM01116
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM01116; probable.
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01118
AC CVCL_4D80
DR CLO; CLO_0030174
DR Coriell; GM01118
DI NCIt; C3360; Supernumerary circular chromosome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01122
AC CVCL_H970
DR CLO; CLO_0030172
DR Coriell; GM01122
DI NCIt; C114769; Maturity-onset diabetes of the young
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H971 ! GM01240
SX Female
CA Finite cell line
//
ID GM01123
AC CVCL_DF14
DR CLO; CLO_0030163
DR Coriell; GM01123
CC Miscellaneous: Established from monozygotic twin of GM01131 (CVCL_DF16).
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01125
AC CVCL_DF15
DR CLO; CLO_0030166
DR Coriell; GM01125
DI NCIt; C35478; Congenital macular corneal dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01126
AC CVCL_2H10
SY GM-1126
DR CLO; CLO_0030160
DR Coriell; GM01126
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01128
AC CVCL_2H11
SY GM-1128
DR CLO; CLO_0030162
DR Coriell; GM01128
RX CelloPub=CLPUB00290;
DI NCIt; C84765; Homocystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01129
AC CVCL_2H12
SY GM-1129
DR CLO; CLO_0030168
DR Coriell; GM01129
RX CelloPub=CLPUB00290;
DI NCIt; C84765; Homocystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01131
AC CVCL_DF16
DR CLO; CLO_0030169
DR Coriell; GM01131
CC Miscellaneous: Established from monozygotic twin of GM01123 (CVCL_DF14).
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01133
AC CVCL_HF30
SY GM1133
DR Coriell; GM01133
RX PubMed=2973075;
CC Discontinued: Coriell; GM01133; probable.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID GM01137
AC CVCL_V462
SY GM-1137; GM 1137
DR CLO; CLO_0030246
DR Coriell; GM01137
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01138
AC CVCL_V798
SY GM-1138; GM 1138; GM1138
DR CLO; CLO_0030239
DR Coriell; GM01138
RX PubMed=862431;
RX PubMed=6617268;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V823 ! GM09216
SX Male
CA Finite cell line
//
ID GM01139
AC CVCL_0P88
DR CLO; CLO_0030236
DR Coriell; GM01139
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01140
AC CVCL_CX03
SY GM-1140
DR CLO; CLO_0030243
DR Coriell; GM01140
RX CelloPub=CLPUB00290;
DI NCIt; C84937; Glycine encephalopathy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01142
AC CVCL_F129
SY GM01142A; GM1142
DR CLO; CLO_0030240
DR Coriell; GM01142
DR JCRB; KURB2682
RX PubMed=2973075;
RX PubMed=3762576;
RX PubMed=6600729;
RX PubMed=7471106;
RX PubMed=23665875;
CC Omics: CNV analysis.
DI NCIt; C42596; Sporadic retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F130 ! GM01484
SX Female
CA Finite cell line
//
ID GM01150
AC CVCL_4J20
DR CLO; CLO_0030226
DR Coriell; GM01150
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01151
AC CVCL_4J21
DR CLO; CLO_0030228
DR Coriell; GM01151
DI NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01152
AC CVCL_4J22
DR CLO; CLO_0030232
DR Coriell; GM01152
DI NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01153
AC CVCL_4J23
DR CLO; CLO_0030234
DR Coriell; GM01153
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01154
AC CVCL_4J24
DR CLO; CLO_0030219
DR Coriell; GM01154
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01157
AC CVCL_4J25
DR CLO; CLO_0030218
DR Coriell; GM01157
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01158
AC CVCL_CX08
SY GM-1158
DR Coriell; GM01158
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM01158; probable.
DI NCIt; C34806; Maple syrup urine disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01159
AC CVCL_CX14
SY GM-1159
DR Coriell; GM01159
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM01159; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01161
AC CVCL_AM62
DR CLO; CLO_0030217
DR Coriell; GM01161
DI NCIt; C34568; Ehlers-Danlos syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01162
AC CVCL_CX04
SY GM-1162
DR CLO; CLO_0030215
DR Coriell; GM01162
RX CelloPub=CLPUB00290;
DI NCIt; C84937; Glycine encephalopathy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01163
AC CVCL_4J26
DR CLO; CLO_0030213
DR Coriell; GM01163
DI NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01165
AC CVCL_4J27
DR CLO; CLO_0030211
DR Coriell; GM01165
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01168
AC CVCL_1H37
DR CLO; CLO_0030210
DR Coriell; GM01168
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01169
AC CVCL_V039
DR CLO; CLO_0030206
DR Coriell; GM01169
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01171
AC CVCL_1H38
DR CLO; CLO_0030209
DR Coriell; GM01171
CC Miscellaneous: At sampling donor was not affected with Huntington disease, but at significan risk.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01176
AC CVCL_X241
SY GM 1176
DR CLO; CLO_0030203
DR Coriell; GM01176
RX PubMed=6661932;
DI NCIt; C26900; Turner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01178
AC CVCL_CV40
SY GM1178; GM 1178
DR CLO; CLO_0030204
DR Coriell; GM01178
DI NCIt; C34951; Progeria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01179
AC CVCL_4J28
DR CLO; CLO_0030262
DR Coriell; GM01179
DI NCIt; C27725; Porphyria cutanea tarda
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01183
AC CVCL_X242
SY GM 1183
DR CLO; CLO_0030263
DR Coriell; GM01183
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01187
AC CVCL_8516
DR CLO; CLO_0030264
DR Coriell; GM01187
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01188
AC CVCL_4J29
DR CLO; CLO_0030265
DR Coriell; GM01188
DI NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01192
AC CVCL_4J30
DR CLO; CLO_0030266
DR Coriell; GM01192
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01193
AC CVCL_4J31
DR CLO; CLO_0030267
DR Coriell; GM01193
DI NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01201
AC CVCL_X243
SY GM 1201
DR CLO; CLO_0030268
DR Coriell; GM01201
RX PubMed=6661932;
RX PubMed=23665875;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01202
AC CVCL_V799
SY GM-1202; GM 1202; GM1202
DR CLO; CLO_0030260
DR Coriell; GM01202
RX PubMed=6661932;
RX PubMed=23665875;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01203
AC CVCL_0P89
DR CLO; CLO_0030259
DR Coriell; GM01203
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01204
AC CVCL_U515
SY GM01204A; GM-1204
DR CLO; CLO_0030261
DR Coriell; GM01204
RX CelloPub=CLPUB00290;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84639; Citrullinemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U514 ! GM01044
SX Male
CA Transformed cell line
//
ID GM01205
AC CVCL_U512
DR CLO; CLO_0030253
DR Coriell; GM01205
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01206
AC CVCL_H142
SY GM01206A; GM-1206
DR CLO; CLO_0030254
DR Coriell; GM01206
RX CelloPub=CLPUB00290;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H141 ! GM01058
SX Male
CA Transformed cell line
//
ID GM01207
AC CVCL_F022
SY GM18003
DR CLO; CLO_0015993
DR CLO; CLO_0030251
DR Coriell; GM01207
DR Coriell; GM18003
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01208
AC CVCL_M982
SY GM-1208; GM17350
DR CLO; CLO_0013724
DR CLO; CLO_0030252
DR Coriell; GM01208
DR Coriell; GM17350
RX CelloPub=CLPUB00290;
CC Part of: Human variation panel.
CC Population: Caribbean.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01209
AC CVCL_1Y23
SY GM-1209; GM 1209
DR CLO; CLO_0030257
DR Coriell; GM01209
RX CelloPub=CLPUB00290;
RX PubMed=1766867;
CC Miscellaneous: Established from monozygotic twin of GM01210 (CVCL_1Y24).
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01210
AC CVCL_1Y24
SY GM-1210
DR CLO; CLO_0030258
DR Coriell; GM01210
RX CelloPub=CLPUB00290;
CC Miscellaneous: Established from monozygotic twin of GM01209 (CVCL_1Y23).
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01211
AC CVCL_9R16
SY GM-1211
DR CLO; CLO_0030255
DR Coriell; GM01211
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01212
AC CVCL_M983
SY GM-1212; GM17351
DR CLO; CLO_0013726
DR CLO; CLO_0030256
DR Coriell; GM01212
DR Coriell; GM17351
RX CelloPub=CLPUB00290;
CC Part of: Human variation panel.
CC Population: Caribbean.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01213
AC CVCL_1F06
DR CLO; CLO_0030250
DR Coriell; GM01213
DI NCIt; C114771; Xeroderma pigmentosum, complementation group E
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01214
AC CVCL_1B71
SY GM-1214
DR CLO; CLO_0030249
DR Coriell; GM01214
RX CelloPub=CLPUB00290;
DI NCIt; C61274; Fucosidosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01219
AC CVCL_H967
DR CLO; CLO_0030288
DR Coriell; GM01219
DI NCIt; C114769; Maturity-onset diabetes of the young
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H966 ! GM01246
SX Male
CA Finite cell line
//
ID GM01220
AC CVCL_V800
SY GM-1220; GM 1220
DR CLO; CLO_0030284
DR Coriell; GM01220
RX PubMed=891262;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01221
AC CVCL_X244
SY GM-1221; GM 1221; GM1221
DR CLO; CLO_0030285
DR Coriell; GM01221
RX PubMed=6293786;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01222
AC CVCL_4D81
DR CLO; CLO_0030286
DR Coriell; GM01222
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01224
AC CVCL_V801
SY GM-1224; GM 1224
DR CLO; CLO_0030287
DR Coriell; GM01224
RX PubMed=477416;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01225
AC CVCL_M984
SY GM17022
DR CLO; CLO_0014692
DR CLO; CLO_0030280
DR Coriell; GM01225
DR Coriell; GM17022
RX PubMed=23665875;
CC Part of: Human variation panel.
CC Population: Indo Pakistani.
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01227
AC CVCL_L459
SY GM1227
DR CLO; CLO_0030281
DR Coriell; GM01227
DR JCRB; KURB1268
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01228
AC CVCL_L957
SY GM00642
DR CLO; CLO_0030282
DR Coriell; GM00642
DR Coriell; GM01228
CC Discontinued: Coriell; GM00642; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01229
AC CVCL_7315
SY GM 1229; GM17352
DR CLO; CLO_0003519
DR CLO; CLO_0013721
DR CLO; CLO_0030283
DR CLDB; cl1486
DR Coriell; GM01229
DR Coriell; GM17352
RX PubMed=6661932;
RX PubMed=23665875;
CC Part of: Human variation panel.
CC Population: Caribbean.
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01230
AC CVCL_0P90
DR CLO; CLO_0030279
DR Coriell; GM01230
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01236
AC CVCL_V421
DR CLO; CLO_0030278
DR Coriell; GM01236
DI NCIt; C84787; Incontinentia pigmenti
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01237
AC CVCL_H969
DR CLO; CLO_0030275
DR Coriell; GM01237
DI NCIt; C114769; Maturity-onset diabetes of the young
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H968 ! GM01247
SX Male
CA Finite cell line
//
ID GM01240
AC CVCL_H971
SY GM01240A
DR CLO; CLO_0030276
DR Coriell; GM01240
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C114769; Maturity-onset diabetes of the young
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H970 ! GM01122
SX Female
CA Transformed cell line
//
ID GM01241
AC CVCL_H972
DR CLO; CLO_0030273
DR Coriell; GM01241
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C114769; Maturity-onset diabetes of the young
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H973 ! GM01486
SX Male
CA Transformed cell line
//
ID GM01242
AC CVCL_N344
DR CLO; CLO_0030274
DR Coriell; GM01242
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C114769; Maturity-onset diabetes of the young
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_N345 ! GM01435
SX Male
CA Transformed cell line
//
ID GM01243
AC CVCL_AI24
DR CLO; CLO_0030271
DR Coriell; GM01243
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C114769; Maturity-onset diabetes of the young
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AI26 ! GM01430
SX Male
CA Transformed cell line
//
ID GM01244
AC CVCL_AI25
DR CLO; CLO_0030272
DR Coriell; GM01244
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C114769; Maturity-onset diabetes of the young
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AI27 ! GM01496
SX Male
CA Transformed cell line
//
ID GM01245
AC CVCL_H965
DR CLO; CLO_0030269
DR Coriell; GM01245
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C75486; Menkes disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H964 ! GM01057
SX Male
CA Transformed cell line
//
ID GM01246
AC CVCL_H966
SY GM01246A
DR CLO; CLO_0030270
DR Coriell; GM01246
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C114769; Maturity-onset diabetes of the young
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H967 ! GM01219
SX Male
CA Transformed cell line
//
ID GM01247
AC CVCL_H968
SY GM01247A; GM01247B
DR CLO; CLO_0030932
DR Coriell; GM01247
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C114769; Maturity-onset diabetes of the young
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H969 ! GM01237
SX Male
CA Transformed cell line
//
ID GM01250
AC CVCL_W636
SY GM 1250
DR CLO; CLO_0030931
DR Coriell; GM01250
RX PubMed=6661932;
DI NCIt; C85237; XYY syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01251
AC CVCL_M985
SY GM-1251; GM17152
DR CLO; CLO_0013959
DR CLO; CLO_0030930
DR Coriell; GM01251
DR Coriell; GM17152
RX PubMed=477407;
CC Part of: Human variation panel.
CC Population: African American.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01252
AC CVCL_V802
SY GM-1252; GM 1252
DR CLO; CLO_0030929
DR Coriell; GM01252
RX PubMed=477407;
RX PubMed=6617268;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01253
AC CVCL_V803
SY GM-1253; GM 1253
DR CLO; CLO_0030936
DR Coriell; GM01253
RX PubMed=477407;
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01254
AC CVCL_1V23
SY GM-1254
DR CLO; CLO_0030935
DR Coriell; GM01254
RX CelloPub=CLPUB00290;
DI NCIt; C122782; Hurler-Scheie syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01255
AC CVCL_1V24
SY GM-1255; GM1255
DR CLO; CLO_0030934
DR Coriell; GM01255
RX CelloPub=CLPUB00290;
RX PubMed=6293786;
DI NCIt; C122782; Hurler-Scheie syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01256
AC CVCL_1V17
SY GM-1256
DR CLO; CLO_0030933
DR Coriell; GM01256
RX CelloPub=CLPUB00290;
DI NCIt; C61265; Scheie syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01257
AC CVCL_V532
SY GM-1257
DR CLO; CLO_0030938
DR Coriell; GM01257
RX CelloPub=CLPUB00290;
DI NCIt; C61261; Hurler syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01258
AC CVCL_W658
SY GM-1258
DR CLO; CLO_0030937
DR Coriell; GM01258
RX CelloPub=CLPUB00290;
DI NCIt; C61260; Hunter syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01259
AC CVCL_9W80
SY GM-1259
DR CLO; CLO_0030919
DR Coriell; GM01259
RX CelloPub=CLPUB00290;
DI NCIt; C84901; Mucopolysaccharidosis type IVA
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01260
AC CVCL_0R31
SY GM-1260; GM1260
DR CLO; CLO_0030921
DR Coriell; GM01260
RX CelloPub=CLPUB00290;
RX PubMed=2464926;
DI NCIt; C61268; Gaucher disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01261
AC CVCL_J109
SY GM-1261; GM 1261
DR CLO; CLO_0030920
DR Coriell; GM01261
RX PubMed=6661932;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01295
AC CVCL_M277
SY XP1KC
DR CLO; CLO_0030923
DR Coriell; GM01295
DI NCIt; C3967; Xeroderma pigmentosum, complementation group D
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01296
AC CVCL_0P91
SY GM1296
DR CLO; CLO_0030922
DR Coriell; GM01296
RX PubMed=6293786;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01297
AC CVCL_CX05
SY GM-1297
DR CLO; CLO_0030925
DR Coriell; GM01297
RX CelloPub=CLPUB00290;
DI NCIt; C84937; Glycine encephalopathy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01298
AC CVCL_2N27
SY GM-1298
DR CLO; CLO_0030924
DR Coriell; GM01298
RX CelloPub=CLPUB00290;
DI NCIt; C85030; Propionic acidemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01299
AC CVCL_2N28
SY GM-1299
DR CLO; CLO_0030927
DR Coriell; GM01299
RX CelloPub=CLPUB00290;
DI NCIt; C85030; Propionic acidemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01300
AC CVCL_2N29
SY GM-1300
DR CLO; CLO_0030926
DR Coriell; GM01300
RX CelloPub=CLPUB00290;
DI NCIt; C85030; Propionic acidemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01301
AC CVCL_CX09
SY GM-1301
DR CLO; CLO_0030928
DR Coriell; GM01301
RX CelloPub=CLPUB00290;
DI NCIt; C84937; Glycine encephalopathy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01302
AC CVCL_CX10
SY GM-1302
DR CLO; CLO_0030909
DR Coriell; GM01302
RX CelloPub=CLPUB00290;
DI NCIt; C84937; Glycine encephalopathy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01304
AC CVCL_4F86
DR CLO; CLO_0030910
DR Coriell; GM01304
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4F87 ! GM01305
SX Female
CA Finite cell line
//
ID GM01305
AC CVCL_4F87
DR CLO; CLO_0030918
DR Coriell; GM01305
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4F86 ! GM01304
SX Female
CA Finite cell line
//
ID GM01306
AC CVCL_4F88
SY GM01306A
DR CLO; CLO_0030917
DR Coriell; GM01306
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4F89 ! GM01307
SX Female
CA Finite cell line
//
ID GM01307
AC CVCL_4F89
DR CLO; CLO_0030916
DR Coriell; GM01307
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4F88 ! GM01306
SX Female
CA Finite cell line
//
ID GM01309
AC CVCL_F131
SY GM1309
DR CLO; CLO_0030915
DR Coriell; GM01309
DI NCIt; C125702; Fanconi anemia, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01310
AC CVCL_7316
SY GM01310B; GM17212
DR CLO; CLO_0013895
DR CLO; CLO_0030914
DR Coriell; GM01310
DR Coriell; GM17212
DR GEO; GSM569521
DR GEO; GSM596276
DR GEO; GSM596637
RX PubMed=20889555;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X802 ! AG16504
OI CVCL_1M95 ! AG20457
OI CVCL_1M96 ! AG22339
OI CVCL_7310 ! GM00967
OI CVCL_7531 ! GM13335
OI CVCL_7532 ! GM13336
SX Male
CA Transformed cell line
//
ID GM01311
AC CVCL_J110
SY GM01311A
DR CLO; CLO_0030913
DR Coriell; GM01311
CC Problematic cell line: Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_J111 ! GM01312
SX Male
CA Transformed cell line
//
ID GM01312
AC CVCL_J111
SY GM01312A; GM-1312; GM 1312; GM1312
DR CLO; CLO_0030912
DR BioSample; SAMN03151629
DR Coriell; GM01312
RX PubMed=3893568;
RX PubMed=10936422;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=20143388).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_J110 ! GM01311
SX Male
CA Transformed cell line
//
ID GM01322
AC CVCL_AB28
DR CLO; CLO_0030911
DR Coriell; GM01322
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex ambiguous
CA Finite cell line
//
ID GM01323
AC CVCL_1V18
SY GM-1323
DR CLO; CLO_0030899
DR Coriell; GM01323
RX CelloPub=CLPUB00290;
DI NCIt; C61265; Scheie syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01348
AC CVCL_V211
DR CLO; CLO_0030900
DR Coriell; GM01348
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01351
AC CVCL_HQ01
DR Coriell; GM01351
DI NCIt; C129865; Congenital contractural arachnodactyly
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01352
AC CVCL_HQ02
DR Coriell; GM01352
DI NCIt; C129865; Congenital contractural arachnodactyly
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01353
AC CVCL_4N07
DR CLO; CLO_0030901
DR Coriell; GM01353
RX PubMed=23665875;
CC Omics: CNV analysis.
DI NCIt; C84663; Cutis laxa
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01354
AC CVCL_4N08
DR CLO; CLO_0030906
DR Coriell; GM01354
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01355
AC CVCL_4N09
SY GM01355A
DR CLO; CLO_0030905
DR Coriell; GM01355
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01356
AC CVCL_V830
SY GM-1356; GM 1356
DR CLO; CLO_0030908
DR Coriell; GM01356
RX PubMed=657849;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01359
AC CVCL_X080
SY GM-1359; GM 1359
DR CLO; CLO_0030907
DR Coriell; GM01359
RX PubMed=6661932;
RX PubMed=7329430;
RX PubMed=23665875;
CC Omics: CNV analysis.
DI NCIt; C36626; Trisomy 18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01361
AC CVCL_9W81
SY GM-1361
DR CLO; CLO_0030903
DR Coriell; GM01361
RX CelloPub=CLPUB00290;
DI NCIt; C84901; Mucopolysaccharidosis type IVA
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01362
AC CVCL_L486
SY Gm 1362
DR CLO; CLO_0030902
DR Coriell; GM01362
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01363
AC CVCL_J112
DR CLO; CLO_0030904
DR Coriell; GM01363
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84536; Acute intermittent porphyria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01364
AC CVCL_D871
SY GM-1364; GM 1364
DR CLO; CLO_0030843
DR Coriell; GM01364
RX CelloPub=CLPUB00290;
DI NCIt; C34806; Maple syrup urine disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D872 ! GM01366
SX Female
CA Finite cell line
//
ID GM01366
AC CVCL_D872
SY GM-1366; GM 1366
DR CLO; CLO_0030842
DR Coriell; GM01366
RX CelloPub=CLPUB00290;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C34806; Maple syrup urine disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D871 ! GM01364
SX Female
CA Transformed cell line
//
ID GM01368
AC CVCL_GY15
DR CLO; CLO_0030847
DR Coriell; GM01368
DI NCIt; C129072; Hereditary persistence of fetal hemoglobin
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01374
AC CVCL_2H13
SY GM-1374
DR CLO; CLO_0030845
DR Coriell; GM01374
RX CelloPub=CLPUB00290;
DI NCIt; C84765; Homocystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01375
AC CVCL_2H14
SY GM-1375
DR CLO; CLO_0030829
DR Coriell; GM01375
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01376
AC CVCL_2H15
SY GM-1376
DR CLO; CLO_0030831
DR Coriell; GM01376
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01377
AC CVCL_4N10
DR CLO; CLO_0030833
DR Coriell; GM01377
DI NCIt; C84663; Cutis laxa
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01379
AC CVCL_7317
DR CLO; CLO_0030835
DR Coriell; GM01379
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7319 ! GM01381
SX Male
CA Finite cell line
//
ID GM01380
AC CVCL_7318
SY GM01380A; GM 01380; GM1380
DR CLO; CLO_0030836
DR Coriell; GM01380
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7266 ! GM00010
SX Male
CA Finite cell line
//
ID GM01381
AC CVCL_7319
SY GM01381B; GM 1381; GM1381
DR CLO; CLO_0030837
DR Coriell; GM01381
RX PubMed=7329430;
RX PubMed=7471105;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7317 ! GM01379
SX Male
CA Finite cell line
//
ID GM01385
AC CVCL_4N11
DR CLO; CLO_0030818
DR Coriell; GM01385
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01386
AC CVCL_4N12
DR CLO; CLO_0030828
DR Coriell; GM01386
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01387
AC CVCL_J114
SY GM-1387; GM 1387
DR CLO; CLO_0030825
DR Coriell; GM01387
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_J113 ! GM01388
SX Female
CA Finite cell line
//
ID GM01388
AC CVCL_J113
SY GM-1388; GM 1388
DR CLO; CLO_0030823
DR Coriell; GM01388
RX PubMed=6661932;
RX PubMed=23665875;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_J114 ! GM01387
SX Female
CA Transformed cell line
//
ID GM01389
AC CVCL_F028
DR CLO; CLO_0030821
DR Coriell; GM01389
DI NCIt; C114771; Xeroderma pigmentosum, complementation group E
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7327 ! GM01646
SX Female
CA Finite cell line
//
ID GM01390
AC CVCL_8517
DR CLO; CLO_0030813
DR Coriell; GM01390
DI NCIt; C3962; Adenosine deaminase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01391
AC CVCL_1V13
SY GM-1391
DR CLO; CLO_0030816
DR Coriell; GM01391
RX CelloPub=CLPUB00290;
DI NCIt; C61261; Hurler syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01392
AC CVCL_1V14
SY GM-1392
DR CLO; CLO_0030810
DR Coriell; GM01392
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01393
AC CVCL_1V15
SY GM-1393
DR CLO; CLO_0030812
DR Coriell; GM01393
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01396
AC CVCL_V804
SY GM-1396; GM 1396
DR CLO; CLO_0030817
DR Coriell; GM01396
RX PubMed=598254;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01399
AC CVCL_X245
SY GM-1399; GM 1399
DR CLO; CLO_0030808
DR Coriell; GM01399
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01406
AC CVCL_AV86
SY GM1406
DR CLO; CLO_0030801
DR Coriell; GM01406
RX PubMed=2837086;
DI NCIt; C98944; Hereditary orotic aciduria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01408
AC CVCL_DF17
DR CLO; CLO_0030799
DR Coriell; GM01408
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01409
AC CVCL_J115
DR CLO; CLO_0030805
DR Coriell; GM01409
DI NCIt; C114769; Maturity-onset diabetes of the young
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_J116 ! GM01410
SX Female
CA Finite cell line
//
ID GM01410
AC CVCL_J116
DR CLO; CLO_0030803
DR Coriell; GM01410
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C114769; Maturity-onset diabetes of the young
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_J115 ! GM01409
SX Female
CA Transformed cell line
//
ID GM01411
AC CVCL_0P92
DR CLO; CLO_0030790
DR Coriell; GM01411
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01413
AC CVCL_V463
SY GM-1413; GM 1413
DR CLO; CLO_0030792
DR Coriell; GM01413
RX PubMed=6661932;
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01414
AC CVCL_X246
SY GM-1414; GM 1414
DR CLO; CLO_0030794
DR Coriell; GM01414
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
DI NCIt; C26900; Turner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01415
AC CVCL_F656
SY GM01415E; GM-1415; GM 1415
DR CLO; CLO_0030796
DR Coriell; GM01415
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F657 ! GM01416
SX Female
CA Finite cell line
//
ID GM01416
AC CVCL_F657
SY GM01416B; GM-1416; GM 1416; GM1416
DR CLO; CLO_0030788
DR Coriell; GM01416
RX PubMed=6661932;
RX PubMed=23665875;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F656 ! GM01415
SX Female
CA Transformed cell line
//
ID GM01417
AC CVCL_1Y25
SY GM-1417
DR CLO; CLO_0030787
DR Coriell; GM01417
RX CelloPub=CLPUB00290;
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01418
AC CVCL_1Y26
SY GM-1418
DR CLO; CLO_0030786
DR Coriell; GM01418
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01419
AC CVCL_1Y27
SY GM-1419
DR CLO; CLO_0030784
DR Coriell; GM01419
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01421
AC CVCL_V805
SY GM-1421
DR CLO; CLO_0030782
DR Coriell; GM01421
RX PubMed=446100;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01422
AC CVCL_0P93
DR CLO; CLO_0030780
DR Coriell; GM01422
DI NCIt; C85187; Thanatophoric dysplasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01426
AC CVCL_0M01
SY GM-1426
DR CLO; CLO_0030778
DR Coriell; GM01426
RX CelloPub=CLPUB00290;
DI NCIt; C84898; Mucopolysaccharidosis type IIIB
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01428
AC CVCL_L469
SY GM-1428; GM 1428; GM1428; CS7SE
DR CLO; CLO_0030774
DR Coriell; GM01428
DR JCRB; KURB1917
RX PubMed=7471106;
DI NCIt; C9460; Cockayne syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01429
AC CVCL_X247
SY GM-1429; GM 1429
DR CLO; CLO_0030777
DR Coriell; GM01429
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01430
AC CVCL_AI26
DR CLO; CLO_0030772
DR Coriell; GM01430
DI NCIt; C114769; Maturity-onset diabetes of the young
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AI24 ! GM01243
SX Male
CA Finite cell line
//
ID GM01435
AC CVCL_N345
DR CLO; CLO_0030888
DR Coriell; GM01435
DI NCIt; C114769; Maturity-onset diabetes of the young
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_N344 ! GM01242
SX Male
CA Finite cell line
//
ID GM01436
AC CVCL_DD67
DR CLO; CLO_0030889
DR Coriell; GM01436
DI NCIt; C26837; Osteogenesis imperfecta
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01441
AC CVCL_X248
SY GM 1441
DR CLO; CLO_0030890
DR Coriell; GM01441
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01442
AC CVCL_0M09
DR CLO; CLO_0030891
DR Coriell; GM01442
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01443
AC CVCL_0M10
DR CLO; CLO_0030892
DR Coriell; GM01443
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01444
AC CVCL_0M11
DR CLO; CLO_0030894
DR Coriell; GM01444
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01445
AC CVCL_V212
DR CLO; CLO_0030897
DR Coriell; GM01445
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01446
AC CVCL_2H16
DR CLO; CLO_0030898
DR Coriell; GM01446
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01447
AC CVCL_2H17
DR CLO; CLO_0030881
DR Coriell; GM01447
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01448
AC CVCL_4N13
DR CLO; CLO_0030879
DR Coriell; GM01448
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01453
AC CVCL_AE18
DR CLO; CLO_0030868
DR Coriell; GM01453
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84525; Abetalipoproteinemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE19 ! GM10012
SX Female
CA Transformed cell line
//
ID GM01454
AC CVCL_GY16
DR CLO; CLO_0030871
DR Coriell; GM01454
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C129070; Cystathioninuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01456
AC CVCL_EJ27
DR CLO; CLO_0030869
DR Coriell; GM01456
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01458
AC CVCL_4N14
DR CLO; CLO_0030870
DR Coriell; GM01458
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01459
AC CVCL_4N15
SY GM01459B
DR CLO; CLO_0030876
DR Coriell; GM01459
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N04 ! GM00486
SX Female
CA Transformed cell line
//
ID GM01460
AC CVCL_4N16
DR CLO; CLO_0030878
DR Coriell; GM01460
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01461
AC CVCL_EJ28
DR CLO; CLO_0030873
DR Coriell; GM01461
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01463
AC CVCL_2H18
DR CLO; CLO_0030874
DR Coriell; GM01463
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01464
AC CVCL_1K51
DR CLO; CLO_0030862
DR Coriell; GM01464
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84734; Glycogen storage disease type II
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01465
AC CVCL_AA15
DR CLO; CLO_0031429
DR Coriell; GM01465
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84706; Familial dysautonomia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01466
AC CVCL_AA16
DR CLO; CLO_0031431
DR Coriell; GM01466
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84706; Familial dysautonomia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01482
AC CVCL_H974
DR CLO; CLO_0031430
DR Coriell; GM01482
DI NCIt; C27725; Porphyria cutanea tarda
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01484
AC CVCL_F130
SY GM1484
DR CLO; CLO_0031433
DR Coriell; GM01484
RX PubMed=23665875;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: CNV analysis.
DI NCIt; C42596; Sporadic retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F129 ! GM01142
SX Female
CA Transformed cell line
//
ID GM01486
AC CVCL_H973
DR CLO; CLO_0031432
DR Coriell; GM01486
DI NCIt; C114769; Maturity-onset diabetes of the young
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H972 ! GM01241
SX Male
CA Finite cell line
//
ID GM01487
AC CVCL_T811
DR CLO; CLO_0031435
DR Coriell; GM01487
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01488
AC CVCL_T809
DR CLO; CLO_0031434
DR Coriell; GM01488
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3362; Schizophrenia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T810 ! GM02497
SX Male
CA Transformed cell line
//
ID GM01489
AC CVCL_T812
DR CLO; CLO_0031437
DR Coriell; GM01489
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3362; Schizophrenia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01490
AC CVCL_T813
DR CLO; CLO_0031436
DR Coriell; GM01490
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C34387; Anorexia nervosa
DI NCIt; C3362; Schizophrenia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T814 ! GM02503
SX Female
CA Transformed cell line
//
ID GM01492
AC CVCL_7320
SY GM-1492; GM 1492; GM1492; AbRu No. 44; 44(AbRu)
DR BTO; BTO:0003590
DR CLO; CLO_0031438
DR Coriell; GM01492
RX PubMed=761484;
RX PubMed=7471105;
RX PubMed=7471106;
DI NCIt; C2903; Bloom syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01493
AC CVCL_1M67
SY GM-1493; GM 1493; GM1493; AmEl No. 57; 57(AmEl)
DR Coriell; GM01493
RX PubMed=761484;
CC Discontinued: Coriell; GM01493; probable.
DI NCIt; C2903; Bloom syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID GM01494
AC CVCL_9R61
SY GM-1494
DR CLO; CLO_0031442
DR Coriell; GM01494
RX CelloPub=CLPUB00290;
DI NCIt; C125595; Mucolipidosis type IIIA
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01496
AC CVCL_AI27
DR CLO; CLO_0031441
DR Coriell; GM01496
DI NCIt; C114769; Maturity-onset diabetes of the young
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AI25 ! GM01244
SX Male
CA Finite cell line
//
ID GM01497
AC CVCL_AI28
DR CLO; CLO_0031440
DR Coriell; GM01497
DI NCIt; C114769; Maturity-onset diabetes of the young
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AI29 ! GM01498
SX Female
CA Finite cell line
//
ID GM01498
AC CVCL_AI29
DR CLO; CLO_0031439
DR Coriell; GM01498
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C114769; Maturity-onset diabetes of the young
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AI28 ! GM01497
SX Female
CA Transformed cell line
//
ID GM01500
AC CVCL_D870
SY GM-1500; GM 1500; GM1500
DR CLO; CLO_0031446
DR Coriell; GM01500
RX PubMed=3495441;
RX PubMed=3893568;
RX PubMed=10936422;
CC Problematic cell line: Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01501
AC CVCL_9Y81
DR CLO; CLO_0031445
DR Coriell; GM01501
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C80307; Waldenstrom macroglobulinemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01503
AC CVCL_8A59
DR CLO; CLO_0031444
DR Coriell; GM01503
DI NCIt; C84814; Leigh disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01506
AC CVCL_4N17
DR CLO; CLO_0031443
DR Coriell; GM01506
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01509
AC CVCL_1F07
DR CLO; CLO_0031448
DR Coriell; GM01509
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01512
AC CVCL_0P94
DR CLO; CLO_0031447
DR Coriell; GM01512
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01516
AC CVCL_AM63
DR CLO; CLO_0031478
DR Coriell; GM01516
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01524
AC CVCL_X249
SY GM-1524; GM 1524; GM1524
DR CLO; CLO_0031474
DR Coriell; GM01524
DR GEO; GSM796
RX PubMed=6661932;
RX PubMed=9150358;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01525
AC CVCL_7321
SY AT2BI; GM-1525; GM 1525; GM1525; GM-1525C
DR CLO; CLO_0031475
DR Coriell; GM01525
DR JCRB; KURB1106
RX PubMed=761484;
RX PubMed=1561323;
RX PubMed=7539412;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Misspelling: 'GM1524' in patent US5955279.
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01526
AC CVCL_7322
SY AT8BI; GM-1526; GM 1526; GM1526; GM-1526B
DR CLO; CLO_0031476
DR BioSample; SAMN03472405
DR Coriell; GM01526
DR JCRB; JCRB3008
DR JCRB; KURB3012
RX PubMed=761484;
RX PubMed=1561323;
RX PubMed=7539412;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 12
ST D5S818: 8,11
ST D7S820: 11,12
ST TH01: 7,9.3
ST TPOX: 8,10
ST vWA: 16,18
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01528
AC CVCL_2H19
DR CLO; CLO_0031477
DR Coriell; GM01528
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01529
AC CVCL_2H20
DR CLO; CLO_0031470
DR Coriell; GM01529
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01530
AC CVCL_V213
DR CLO; CLO_0031471
DR Coriell; GM01530
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01531
AC CVCL_V214
DR CLO; CLO_0031472
DR Coriell; GM01531
RX PubMed=19359498;
CC Characteristics: Homozygous for the CFTR p.Phe508del mutation.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01532
AC CVCL_2H21
DR CLO; CLO_0031473
DR Coriell; GM01532
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84765; Homocystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01533
AC CVCL_V806
SY GM-1533; GM1533
DR CLO; CLO_0031469
DR Coriell; GM01533
RX CelloPub=CLPUB00290;
RX PubMed=2498246;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01535
AC CVCL_X250
SY GM 1535; GM1535
DR CLO; CLO_0031488
DR Coriell; GM01535
DR GEO; GSM797
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01536
AC CVCL_M986
SY GM17153
DR CLO; CLO_0013958
DR CLO; CLO_0031487
DR Coriell; GM01536
DR Coriell; GM17153
CC Part of: Human variation panel.
CC Population: African American.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01549
AC CVCL_X081
SY GM 1549
DR CLO; CLO_0031485
DR Coriell; GM01549
RX PubMed=6617268;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01550
AC CVCL_0P95
DR CLO; CLO_0031486
DR Coriell; GM01550
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01552
AC CVCL_2Z61
DR CLO; CLO_0031483
DR Coriell; GM01552
DI NCIt; C2892; Nevoid basal cell carcinoma syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2Z62 ! GM01553
SX Male
CA Finite cell line
//
ID GM01553
AC CVCL_2Z62
DR CLO; CLO_0031484
DR Coriell; GM01553
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2892; Nevoid basal cell carcinoma syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2Z61 ! GM01552
SX Male
CA Transformed cell line
//
ID GM01555
AC CVCL_V807
SY GM-1555; GM 1555; GM1555
DR CLO; CLO_0031481
DR Coriell; GM01555
RX PubMed=761480;
RX PubMed=6661932;
RX PubMed=7329430;
RX PubMed=7471105;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01557
AC CVCL_CX15
SY GM-1557
DR Coriell; GM01557
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM01557; probable.
DI NCIt; C34806; Maple syrup urine disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01558
AC CVCL_2H22
DR CLO; CLO_0031482
DR Coriell; GM01558
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01559
AC CVCL_2H23
DR CLO; CLO_0031479
DR Coriell; GM01559
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01560
AC CVCL_2H24
DR CLO; CLO_0031480
DR Coriell; GM01560
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84765; Homocystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01561
AC CVCL_V808
DR CLO; CLO_0031456
DR Coriell; GM01561
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V768 ! GM00380
SX Female
CA Transformed cell line
//
ID GM01562
AC CVCL_EJ29
DR CLO; CLO_0031458
DR Coriell; GM01562
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01564
AC CVCL_X251
SY GM 1564
DR CLO; CLO_0031457
DR Coriell; GM01564
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01565
AC CVCL_9R62
DR CLO; CLO_0031449
DR Coriell; GM01565
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C81315; Phenylketonuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01566
AC CVCL_GY17
DR CLO; CLO_0031450
DR Coriell; GM01566
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C129070; Cystathioninuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01567
AC CVCL_4N18
DR CLO; CLO_0031451
DR Coriell; GM01567
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01568
AC CVCL_1K52
DR CLO; CLO_0031452
DR Coriell; GM01568
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01570
AC CVCL_V809
SY GM-1570; GM 1570
DR CLO; CLO_0031453
DR Coriell; GM01570
RX PubMed=446098;
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01571
AC CVCL_W031
SY GM 1571
DR CLO; CLO_0031454
DR Coriell; GM01571
RX PubMed=2705456;
DI NCIt; C26798; Hypophosphatasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01575
AC CVCL_2Z63
DR CLO; CLO_0031455
DR Coriell; GM01575
DI NCIt; C2892; Nevoid basal cell carcinoma syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2Z64 ! GM01576
SX Female
CA Finite cell line
//
ID GM01576
AC CVCL_2Z64
DR CLO; CLO_0031468
DR Coriell; GM01576
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2892; Nevoid basal cell carcinoma syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2Z63 ! GM01575
SX Female
CA Transformed cell line
//
ID GM01577
AC CVCL_2Z65
SY GM01577A
DR CLO; CLO_0031467
DR Coriell; GM01577
DI NCIt; C2892; Nevoid basal cell carcinoma syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2Z66 ! GM01578
SX Male
CA Finite cell line
//
ID GM01578
AC CVCL_2Z66
DR CLO; CLO_0031466
DR Coriell; GM01578
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2892; Nevoid basal cell carcinoma syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2Z65 ! GM01577
SX Male
CA Transformed cell line
//
ID GM01579
AC CVCL_0P96
DR CLO; CLO_0031465
DR Coriell; GM01579
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01580
AC CVCL_0P97
DR CLO; CLO_0031461
DR Coriell; GM01580
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01582
AC CVCL_7323
SY GM00240
DR CLO; CLO_0031462
DR Coriell; GM00240
DR Coriell; GM01582
CC Discontinued: Coriell; GM00240; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01583
AC CVCL_D511
SY GM-1583
DR CLO; CLO_0031459
DR Coriell; GM01583
RX CelloPub=CLPUB00290;
DI NCIt; C61260; Hunter syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01584
AC CVCL_D512
DR CLO; CLO_0031460
DR Coriell; GM01584
DI NCIt; C61260; Hunter syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01586
AC CVCL_9Q87
SY GM-1586; GM01586C
DR CLO; CLO_0031463
DR Coriell; GM01586
RX CelloPub=CLPUB00290;
DI NCIt; C61270; I-cell disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01588
AC CVCL_1L41
DR CLO; CLO_0031464
DR Coriell; GM01588
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01589
AC CVCL_9Q88
SY GM-1589
DR CLO; CLO_0031544
DR Coriell; GM01589
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01590
AC CVCL_9Q89
SY GM-1590
DR CLO; CLO_0031540
DR Coriell; GM01590
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01598
AC CVCL_2Y95
DR CLO; CLO_0031543
DR Coriell; GM01598
DI NCIt; C3448; Wiskott-Aldrich syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01599
AC CVCL_AK17
DR CLO; CLO_0031537
DR Coriell; GM01599
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01600
AC CVCL_AK18
DR CLO; CLO_0031538
DR Coriell; GM01600
DI NCIt; C125694; Sitosterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01601
AC CVCL_AK19
DR CLO; CLO_0031554
DR Coriell; GM01601
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01602
AC CVCL_9W82
SY GM-1602
DR CLO; CLO_0031553
DR Coriell; GM01602
RX CelloPub=CLPUB00290;
DI NCIt; C84902; Mucopolysaccharidosis type IVB
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01603
AC CVCL_7324
SY GM01603B
DR CLO; CLO_0031551
DR Coriell; GM01603
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7325 ! GM01604
SX Male
CA Finite cell line
//
ID GM01604
AC CVCL_7325
SY GM01604A
DR CLO; CLO_0031549
DR Coriell; GM01604
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7324 ! GM01603
SX Male
CA Finite cell line
//
ID GM01605
AC CVCL_0P98
DR CLO; CLO_0031547
DR Coriell; GM01605
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01606
AC CVCL_F266
SY GM01606A
DR CLO; CLO_0003520
DR CLO; CLO_0031564
DR CLDB; cl1487
DR Coriell; GM01606
DI NCIt; C61271; Wolman disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01607
AC CVCL_7326
SY GM-1607; GM1607
DR CLO; CLO_0003521
DR CLO; CLO_0031565
DR CLDB; cl1488
DR Coriell; GM01607
RX CelloPub=CLPUB00290;
RX PubMed=2464926;
RX PubMed=19815695;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Characteristics: Heterozygous for the GBA p.Asn370Ser and p.Val394Leu mutations.
DI NCIt; C61268; Gaucher disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01610
AC CVCL_1D23
DR CLO; CLO_0031557
DR Coriell; GM01610
DI NCIt; C35133; Wolfram syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1D26 ! GM01795
SX Female
CA Finite cell line
//
ID GM01611
AC CVCL_1D24
DR CLO; CLO_0031558
DR Coriell; GM01611
DI NCIt; C35133; Wolfram syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01617
AC CVCL_IN55
DR CLO; CLO_0031561
DR Coriell; GM01617
DI NCIt; C129974; Inosine triphosphatase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IN47 ! GM01619
SX Female
CA Finite cell line
//
ID GM01619
AC CVCL_IN47
DR CLO; CLO_0031563
DR Coriell; GM01619
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C129974; Inosine triphosphatase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IN55 ! GM01617
SX Female
CA Transformed cell line
//
ID GM01621
AC CVCL_4J32
DR CLO; CLO_0031570
DR Coriell; GM01621
DI NCIt; C84536; Acute intermittent porphyria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01622
AC CVCL_4J33
DR CLO; CLO_0031569
DR Coriell; GM01622
DI NCIt; C84536; Acute intermittent porphyria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01623
AC CVCL_4J34
DR CLO; CLO_0031575
DR Coriell; GM01623
DI NCIt; C84536; Acute intermittent porphyria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01624
AC CVCL_4J35
DR CLO; CLO_0031572
DR Coriell; GM01624
DI NCIt; C84536; Acute intermittent porphyria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01625
AC CVCL_4J36
DR CLO; CLO_0031495
DR Coriell; GM01625
DI NCIt; C84536; Acute intermittent porphyria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01628
AC CVCL_DS07
DR CLO; CLO_0031490
DR Coriell; GM01628
DI NCIt; C128188; 46,XY sex reversal 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex ambiguous
CA Finite cell line
//
ID GM01629
AC CVCL_L473
SY GM1629; GM 1629; CS1BE
DR CLO; CLO_0031492
DR Coriell; GM01629
DR JCRB; KURB1918
DI NCIt; C9460; Cockayne syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01630
AC CVCL_H143
SY GM1630; XP1WI
DR CLO; CLO_0031500
DR Coriell; GM01630
DR JCRB; KURB1027
RX PubMed=1372102;
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H144 ! GM02344
SX Male
CA Finite cell line
//
ID GM01631
AC CVCL_U664
SY GM1631
DR CLO; CLO_0031501
DR Coriell; GM01631
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U665 ! GM07689
SX Male
CA Finite cell line
//
ID GM01632
AC CVCL_1F08
DR CLO; CLO_0031496
DR Coriell; GM01632
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1F23 ! GM07690
SX Female
CA Finite cell line
//
ID GM01633
AC CVCL_9Z54
DR CLO; CLO_0031498
DR Coriell; GM01633
DI NCIt; C3273; Neurofibromatosis type 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9Z57 ! GM01634
SX Male
CA Finite cell line
//
ID GM01634
AC CVCL_9Z57
DR CLO; CLO_0031512
DR Coriell; GM01634
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3273; Neurofibromatosis type 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9Z54 ! GM01633
SX Male
CA Transformed cell line
//
ID GM01635
AC CVCL_5L39
SY GM01635B
DR CLO; CLO_0031508
DR Coriell; GM01635
DI NCIt; C75122; Tuberous sclerosis 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5L40 ! GM01636
OI CVCL_5L43 ! GM01643
SX Male
CA Finite cell line
//
ID GM01636
AC CVCL_5L40
DR CLO; CLO_0031506
DR Coriell; GM01636
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C75122; Tuberous sclerosis 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5L39 ! GM01635
OI CVCL_5L43 ! GM01643
SX Male
CA Transformed cell line
//
ID GM01637
AC CVCL_5L41
DR CLO; CLO_0031520
DR Coriell; GM01637
DI NCIt; C75122; Tuberous sclerosis 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5L42 ! GM01638
OI CVCL_5L44 ! GM01644
SX Female
CA Finite cell line
//
ID GM01638
AC CVCL_5L42
DR CLO; CLO_0031521
DR Coriell; GM01638
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C75122; Tuberous sclerosis 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5L41 ! GM01637
OI CVCL_5L44 ! GM01644
SX Female
CA Transformed cell line
//
ID GM01639
AC CVCL_5M68
DR CLO; CLO_0031522
DR Coriell; GM01639
DI NCIt; C3273; Neurofibromatosis type 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5M69 ! GM01641
SX Female
CA Finite cell line
//
ID GM01641
AC CVCL_5M69
DR CLO; CLO_0031523
DR Coriell; GM01641
RX PubMed=23665875;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: CNV analysis.
DI NCIt; C3273; Neurofibromatosis type 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5M68 ! GM01639
SX Female
CA Transformed cell line
//
ID GM01643
AC CVCL_5L43
DR CLO; CLO_0031524
DR Coriell; GM01643
DI NCIt; C75122; Tuberous sclerosis 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5L39 ! GM01635
OI CVCL_5L40 ! GM01636
SX Male
CA Finite cell line
//
ID GM01644
AC CVCL_5L44
DR CLO; CLO_0031525
DR Coriell; GM01644
DI NCIt; C75122; Tuberous sclerosis 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5L41 ! GM01637
OI CVCL_5L42 ! GM01638
SX Female
CA Finite cell line
//
ID GM01646
AC CVCL_7327
DR CLO; CLO_0031526
DR Coriell; GM01646
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C114771; Xeroderma pigmentosum, complementation group E
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F028 ! GM01389
SX Female
CA Transformed cell line
//
ID GM01647
AC CVCL_4J37
DR CLO; CLO_0031527
DR Coriell; GM01647
DI NCIt; C84536; Acute intermittent porphyria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01650
AC CVCL_7328
SY GM01650A
DR CLO; CLO_0031530
DR Coriell; GM01650
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01651
AC CVCL_7329
SY GM01651A; GM01651B
DR CLO; CLO_0031528
DR Coriell; GM01651
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01652
AC CVCL_7330
SY GM01652B; GM 1652; GMO1652C
DR CLO; CLO_0030948
DR Coriell; GM01652
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01653
AC CVCL_7331
DR CLO; CLO_0030947
DR Coriell; GM01653
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01654
AC CVCL_D513
SY GM-1654; GM 1654
DR CLO; CLO_0030944
DR Coriell; GM01654
RX CelloPub=CLPUB00290;
DI NCIt; C34806; Maple syrup urine disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D514 ! GM01655
SX Female
CA Finite cell line
//
ID GM01655
AC CVCL_D514
SY GM-1655; GM 1655; GM1655
DR CLO; CLO_0030943
DR Coriell; GM01655
RX CelloPub=CLPUB00290;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C34806; Maple syrup urine disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D513 ! GM01654
SX Female
CA Transformed cell line
//
ID GM01656
AC CVCL_2Z67
SY GM01656A
DR CLO; CLO_0030946
DR Coriell; GM01656
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2892; Nevoid basal cell carcinoma syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2Z68 ! GM01657
OI CVCL_2Z69 ! GM01658
SX Male
CA Transformed cell line
//
ID GM01657
AC CVCL_2Z68
DR CLO; CLO_0030945
DR Coriell; GM01657
DI NCIt; C2892; Nevoid basal cell carcinoma syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2Z67 ! GM01656
OI CVCL_2Z69 ! GM01658
SX Male
CA Finite cell line
//
ID GM01658
AC CVCL_2Z69
DR CLO; CLO_0030940
DR Coriell; GM01658
DI NCIt; C2892; Nevoid basal cell carcinoma syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2Z67 ! GM01656
OI CVCL_2Z68 ! GM01657
SX Male
CA Finite cell line
//
ID GM01659
AC CVCL_V425
SY GM 1659
DR CLO; CLO_0030939
DR Coriell; GM01659
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01660
AC CVCL_V426
DR CLO; CLO_0030942
DR Coriell; GM01660
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01661
AC CVCL_R905
SY GM1661
DR CLO; CLO_0030941
DR Coriell; GM01661
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01662
AC CVCL_F602
SY GM01662A; GM-1662; GM 1662; GM1662
DR CLO; CLO_0030958
DR Coriell; GM01662
RX PubMed=3021482;
RX PubMed=6087154;
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F609 ! GM06804
SX Male
CA Finite cell line
//
ID GM01663
AC CVCL_V810
SY GM-1663; GM 1663; GM1663
DR CLO; CLO_0030957
DR Coriell; GM01663
RX PubMed=761481;
RX PubMed=6661932;
RX PubMed=7329430;
RX PubMed=7471105;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01664
AC CVCL_0Q00
DR CLO; CLO_0030956
DR Coriell; GM01664
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01665
AC CVCL_0Q01
DR CLO; CLO_0030955
DR Coriell; GM01665
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01667
AC CVCL_X082
SY GM 1667
DR CLO; CLO_0030954
DR Coriell; GM01667
RX PubMed=6617268;
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01671
AC CVCL_2Y86
DR CLO; CLO_0030953
DR Coriell; GM01671
DI NCIt; C61245; Cartilage hair hypoplasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01672
AC CVCL_1R60
DR CLO; CLO_0030952
DR Coriell; GM01672
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01673
AC CVCL_0D84
SY GM-1673, GM1673
DR CLO; CLO_0030951
DR Coriell; GM01673
RX CelloPub=CLPUB00290;
RX PubMed=7909321;
DI NCIt; C98986; Methylmalonic acidemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01674
AC CVCL_AW76
SY GM-1674
DR CLO; CLO_0030950
DR Coriell; GM01674
RX CelloPub=CLPUB00290;
DI NCIt; C98986; Methylmalonic acidemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01675
AC CVCL_U387
SY GM-1675; GM1675
DR CLO; CLO_0030949
DR Coriell; GM01675
RX CelloPub=CLPUB00290;
DI NCIt; C85184; Tay-Sachs disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01676
AC CVCL_9Q83
DR CLO; CLO_0030962
DR Coriell; GM01676
DI NCIt; C84940; Oculocerebrorenal syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01678
AC CVCL_0Q02
DR CLO; CLO_0030961
DR Coriell; GM01678
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01679
AC CVCL_U516
SY GM-1679; GM1679
DR CLO; CLO_0030964
DR Coriell; GM01679
RX CelloPub=CLPUB00290;
DI NCIt; C84639; Citrullinemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U518 ! GM01685
OI CVCL_U519 ! GM03056
SX Male
CA Finite cell line
//
ID GM01680
AC CVCL_7332
SY GM 1680
DR CLO; CLO_0030963
DR Coriell; GM01680
RX PubMed=3860870;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01681
AC CVCL_7333
DR CLO; CLO_0030966
DR Coriell; GM01681
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01683
AC CVCL_0Q03
DR CLO; CLO_0030965
DR Coriell; GM01683
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01684
AC CVCL_U517
SY GM-1684; GM1684
DR CLO; CLO_0030968
DR Coriell; GM01684
RX CelloPub=CLPUB00290;
DI NCIt; C84639; Citrullinemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01685
AC CVCL_U518
SY GM-1685
DR CLO; CLO_0030967
DR Coriell; GM01685
RX CelloPub=CLPUB00290;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84639; Citrullinemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U516 ! GM01679
OI CVCL_U519 ! GM03056
SX Male
CA Transformed cell line
//
ID GM01691
AC CVCL_AM86
DR CLO; CLO_0030960
DR Coriell; GM01691
DI NCIt; C125697; Ehlers-Danlos syndrome, type II
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01695
AC CVCL_V811
SY GM1695
DR CLO; CLO_0030959
DR Coriell; GM01695
RX PubMed=2498246;
RX PubMed=7438786;
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01696
AC CVCL_1D19
SY GM 1696
DR CLO; CLO_0030978
DR Coriell; GM01696
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01700
AC CVCL_1D22
DR CLO; CLO_0030973
DR Coriell; GM01700
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01701
AC CVCL_1D25
DR CLO; CLO_0030972
DR Coriell; GM01701
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1D28 ! GM01797
SX Male
CA Finite cell line
//
ID GM01702
AC CVCL_1N14
SY GM-1702
DR CLO; CLO_0030971
DR Coriell; GM01702
DI NCIt; C122662; Glycogen storage disease type IX
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01703
AC CVCL_1Y28
SY GM-1703
DR CLO; CLO_0030970
DR Coriell; GM01703
RX CelloPub=CLPUB00290;
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01704
AC CVCL_1Y29
SY GM-1704
DR CLO; CLO_0030977
DR Coriell; GM01704
RX CelloPub=CLPUB00290;
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01706
AC CVCL_7334
SY GM00237
DR CLO; CLO_0030976
DR Coriell; GM00237
DR Coriell; GM01706
CC Discontinued: Coriell; GM00237; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01707
AC CVCL_L982
SY GM01008
DR CLO; CLO_0030975
DR Coriell; GM01008
DR Coriell; GM01707
CC Discontinued: Coriell; GM01008; true.
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01708
AC CVCL_L959
SY GM01010
DR CLO; CLO_0030974
DR Coriell; GM01010
DR Coriell; GM01708
CC Discontinued: Coriell; GM01010; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01709
AC CVCL_X252
SY GM 1709
DR CLO; CLO_0030969
DR Coriell; GM01709
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01712
AC CVCL_L458
SY GM1712
DR CLO; CLO_0030988
DR Coriell; GM01712
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C9460; Cockayne syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7314 ! GM01098
SX Male
CA Transformed cell line
//
ID GM01715
AC CVCL_GS54
DR CLO; CLO_0030987
DR Coriell; GM01715
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3962; Adenosine deaminase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_GS57 ! GM02445
SX Male
CA Transformed cell line
//
ID GM01717
AC CVCL_7335
DR CLO; CLO_0030983
DR Coriell; GM01717
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01718
AC CVCL_9R63
SY GM-1718; GM01718A
DR CLO; CLO_0030984
DR Coriell; GM01718
RX CelloPub=CLPUB00290;
DI NCIt; C125596; Neuraminidase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01719
AC CVCL_9R64
SY GM-1719
DR CLO; CLO_0030985
DR Coriell; GM01719
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01720
AC CVCL_9R65
SY GM-1720
DR CLO; CLO_0030986
DR Coriell; GM01720
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01723
AC CVCL_X253
SY GM 1723
DR CLO; CLO_0030980
DR Coriell; GM01723
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X254 ! GM01724
SX Female
CA Finite cell line
//
ID GM01724
AC CVCL_X254
DR Coriell; GM01724
CC Discontinued: Coriell; GM01724; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X253 ! GM01723
SX Female
CA Finite cell line
//
ID GM01725
AC CVCL_2Z70
DR CLO; CLO_0030981
DR Coriell; GM01725
DI NCIt; C2892; Nevoid basal cell carcinoma syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2Z71 ! GM01726
SX Female
CA Finite cell line
//
ID GM01726
AC CVCL_2Z71
SY GM01726A
DR CLO; CLO_0030982
DR Coriell; GM01726
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2892; Nevoid basal cell carcinoma syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2Z70 ! GM01725
SX Female
CA Transformed cell line
//
ID GM01727
AC CVCL_X083
SY GM 1727
DR CLO; CLO_0030998
DR Coriell; GM01727
RX PubMed=6617268;
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01730
AC CVCL_1R61
DR CLO; CLO_0030997
DR Coriell; GM01730
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01734
AC CVCL_X255
SY GM 1734
DR CLO; CLO_0030996
DR Coriell; GM01734
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01736
AC CVCL_1F09
DR CLO; CLO_0030994
DR Coriell; GM01736
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01737
AC CVCL_2Z43
DR CLO; CLO_0030995
DR Coriell; GM01737
DI NCIt; C84609; Campomelic dysplasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01739
AC CVCL_0M02
SY GM-1739
DR CLO; CLO_0030992
DR Coriell; GM01739
RX CelloPub=CLPUB00290;
DI NCIt; C84897; Mucopolysaccharidosis type IIIA
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0L98 ! GM01094
SX Female
CA Finite cell line
//
ID GM01741
AC CVCL_H173
SY GM-1741
DR CLO; CLO_0030993
DR Coriell; GM01741
RX CelloPub=CLPUB00290;
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H174 ! GM01743
SX Male
CA Finite cell line
//
ID GM01742
AC CVCL_CX27
SY GM-1742
DR Coriell; GM01742
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM01742; true.
DI NCIt; C61270; I-cell disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01743
AC CVCL_H174
SY GM-1743
DR CLO; CLO_0030990
DR Coriell; GM01743
RX CelloPub=CLPUB00290;
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H173 ! GM01741
SX Male
CA Finite cell line
//
ID GM01744
AC CVCL_AD63
SY GM-1744
DR CLO; CLO_0030991
DR Coriell; GM01744
RX CelloPub=CLPUB00290;
DI NCIt; C34806; Maple syrup urine disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01746
AC CVCL_1M68
SY GM-1746; GM 1746
DR CLO; CLO_0030989
DR Coriell; GM01746
RX PubMed=761484;
DI NCIt; C62505; Fanconi anemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01750
AC CVCL_X256
SY GM-1750; GM 1750
DR CLO; CLO_0031006
DR Coriell; GM01750
DR GEO; GSM798
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01751
AC CVCL_0Q58
DR CLO; CLO_0031005
DR Coriell; GM01751
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01759
AC CVCL_9R66
SY GM-1759
DR CLO; CLO_0031008
DR Coriell; GM01759
RX CelloPub=CLPUB00290;
DI NCIt; C125595; Mucolipidosis type IIIA
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01763
AC CVCL_L960
SY GM-1763, GM00249
DR CLO; CLO_0031007
DR Coriell; GM00249
DR Coriell; GM01763
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00249; true.
DI NCIt; C114766; Carnitine palmitoyltransferase II deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01766
AC CVCL_L961
SY GM01449
DR CLO; CLO_0030999
DR Coriell; GM01449
DR Coriell; GM01766
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; GM01449; true.
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01767
AC CVCL_L963
SY GM01452
DR CLO; CLO_0031000
DR Coriell; GM01452
DR Coriell; GM01767
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; GM01452; true.
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01769
AC CVCL_L964
SY GM01021
DR CLO; CLO_0031001
DR Coriell; GM01021
DR Coriell; GM01769
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; GM01021; true.
DI NCIt; C61268; Gaucher disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01773
AC CVCL_2Z47
SY GM-1773
DR CLO; CLO_0031002
DR Coriell; GM01773
RX CelloPub=CLPUB00290;
DI NCIt; C61254; Krabbe disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01774
AC CVCL_7336
SY GM01774A
DR CLO; CLO_0031003
DR Coriell; GM01774
DI NCIt; C111802; Dyskeratosis congenita
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D515 ! GM01775
SX Male
CA Finite cell line
//
ID GM01775
AC CVCL_D515
SY GM01775A
DR CLO; CLO_0031004
DR Coriell; GM01775
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C111802; Dyskeratosis congenita
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7336 ! GM01774
SX Male
CA Transformed cell line
//
ID GM01777
AC CVCL_AA17
DR CLO; CLO_0031014
DR Coriell; GM01777
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84706; Familial dysautonomia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01778
AC CVCL_1K53
DR CLO; CLO_0031018
DR Coriell; GM01778
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01780
AC CVCL_0M03
DR CLO; CLO_0031017
DR Coriell; GM01780
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84897; Mucopolysaccharidosis type IIIA
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01781
AC CVCL_GY18
DR CLO; CLO_0031016
DR Coriell; GM01781
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C129070; Cystathioninuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01784
AC CVCL_L965
SY GM01462
DR CLO; CLO_0031015
DR Coriell; GM01462
DR Coriell; GM01784
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; GM01462; true.
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01786
AC CVCL_0G94
DR CLO; CLO_0031011
DR Coriell; GM01786
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01787
AC CVCL_0G95
DR CLO; CLO_0031012
DR Coriell; GM01787
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01788
AC CVCL_AM87
DR CLO; CLO_0031009
DR Coriell; GM01788
DI NCIt; C125697; Ehlers-Danlos syndrome, type II
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01789
AC CVCL_DD68
DR CLO; CLO_0031010
DR Coriell; GM01789
DI NCIt; C26837; Osteogenesis imperfecta
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01790
AC CVCL_AN05
DR CLO; CLO_0031013
DR Coriell; GM01790
DI NCIt; C125700; Ehlers-Danlos syndrome, type VI
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01791
AC CVCL_AN06
DR CLO; CLO_0031024
DR Coriell; GM01791
DI NCIt; C125700; Ehlers-Danlos syndrome, type VI
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01792
AC CVCL_T805
DR CLO; CLO_0031025
DR Coriell; GM01792
DI NCIt; C3362; Schizophrenia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T806 ! GM01793
SX Male
CA Finite cell line
//
ID GM01793
AC CVCL_T806
DR CLO; CLO_0031022
DR Coriell; GM01793
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3362; Schizophrenia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T805 ! GM01792
SX Male
CA Transformed cell line
//
ID GM01795
AC CVCL_1D26
SY GM01795A
DR CLO; CLO_0031023
DR Coriell; GM01795
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35133; Wolfram syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1D23 ! GM01610
SX Female
CA Transformed cell line
//
ID GM01796
AC CVCL_1D27
DR CLO; CLO_0031019
DR Coriell; GM01796
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01797
AC CVCL_1D28
DR CLO; CLO_0031020
DR Coriell; GM01797
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1D25 ! GM01701
SX Male
CA Transformed cell line
//
ID GM01799
AC CVCL_1D29
DR CLO; CLO_0031039
DR Coriell; GM01799
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35133; Wolfram syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01800
AC CVCL_1D30
DR CLO; CLO_0031037
DR Coriell; GM01800
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01801
AC CVCL_1D31
DR CLO; CLO_0031034
DR Coriell; GM01801
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01803
AC CVCL_1E87
DR CLO; CLO_0031032
DR Coriell; GM01803
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01805
AC CVCL_7337
SY GM01073; GM17213
DR CLO; CLO_0013893
DR CLO; CLO_0031046
DR Coriell; GM01073
DR Coriell; GM01805
DR Coriell; GM17213
DR GEO; GSM569542
DR GEO; GSM596277
DR GEO; GSM596638
RX PubMed=20889555;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; GM01073; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01806
AC CVCL_7338
SY GM01074; GM17214
DR CLO; CLO_0013886
DR CLO; CLO_0031047
DR Coriell; GM01074
DR Coriell; GM01806
DR Coriell; GM17214
DR GEO; GSM569518
DR GEO; GSM596278
DR GEO; GSM596741
RX PubMed=20889555;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; GM01074; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01807
AC CVCL_9R67
DR CLO; CLO_0031048
DR Coriell; GM01807
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01808
AC CVCL_2H25
DR CLO; CLO_0031040
DR Coriell; GM01808
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01810
AC CVCL_L966
SY GM01451
DR CLO; CLO_0031043
DR Coriell; GM01451
DR Coriell; GM01810
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; GM01451; true.
DI NCIt; C84525; Abetalipoproteinemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01812
AC CVCL_AM82
DR CLO; CLO_0031044
DR Coriell; GM01812
DI NCIt; C125696; Ehlers-Danlos syndrome, type I
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01813
AC CVCL_1A94
SY GM1813
DR CLO; CLO_0031045
DR Coriell; GM01813
RX PubMed=6293786;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01814
AC CVCL_7339
SY GM01072; GM17215
DR CLO; CLO_0013885
DR CLO; CLO_0031057
DR Coriell; GM01072
DR Coriell; GM01814
DR Coriell; GM17215
DR GEO; GSM569641
DR GEO; GSM596279
DR GEO; GSM596639
RX PubMed=20889555;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; GM01072; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01815
AC CVCL_7340
SY GM01075; GM18004
DR CLO; CLO_0015995
DR CLO; CLO_0031055
DR Coriell; GM01075
DR Coriell; GM01815
DR Coriell; GM18004
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; GM01075; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01829
AC CVCL_1L42
DR CLO; CLO_0031060
DR Coriell; GM01829
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01835
AC CVCL_D873
DR CLO; CLO_0031421
DR Coriell; GM01835
DI NCIt; C3362; Schizophrenia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D874 ! GM01836
SX Female
CA Finite cell line
//
ID GM01836
AC CVCL_D874
DR CLO; CLO_0031418
DR Coriell; GM01836
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3362; Schizophrenia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D873 ! GM01835
SX Female
CA Transformed cell line
//
ID GM01837
AC CVCL_AI30
DR CLO; CLO_0031419
DR Coriell; GM01837
DI NCIt; C114769; Maturity-onset diabetes of the young
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AI31 ! GM01838
SX Female
CA Finite cell line
//
ID GM01838
AC CVCL_AI31
DR CLO; CLO_0031413
DR Coriell; GM01838
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C114769; Maturity-onset diabetes of the young
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AI30 ! GM01837
SX Female
CA Transformed cell line
//
ID GM01840
AC CVCL_M987
SY GM17311
DR CLO; CLO_0013354
DR CLO; CLO_0031415
DR Coriell; GM01840
DR Coriell; GM17311
RX PubMed=23665875;
CC Part of: Human variation panel.
CC Population: South American (Brazil, Guyana, Venezuela).
CC Omics: CNV analysis.
CC Discontinued: Coriell; GM01840; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01841
AC CVCL_1L43
DR CLO; CLO_0031427
DR Coriell; GM01841
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01848
AC CVCL_X257
SY GM 1848
DR CLO; CLO_0031428
DR Coriell; GM01848
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01849
AC CVCL_X258
SY GM 1849
DR CLO; CLO_0031425
DR Coriell; GM01849
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01850
AC CVCL_M988
SY GM-1850; GM17101
DR CLO; CLO_0014894
DR CLO; CLO_0031426
DR Coriell; GM01850
DR Coriell; GM17101
DR GEO; GSM596169
RX CelloPub=CLPUB00290;
CC Part of: Human variation panel.
CC Population: African American.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01851
AC CVCL_CX23
SY GM-1851
DR Coriell; GM01851
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM01851; probable.
DI NCIt; C84548; Alpha-mannosidosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01854
AC CVCL_L461
DR CLO; CLO_0031424
DR Coriell; GM01854
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L462 ! GM01855
SX Female
CA Finite cell line
//
ID GM01855
AC CVCL_L462
DR CLO; CLO_0031402
DR Coriell; GM01855
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L461 ! GM01854
SX Female
CA Transformed cell line
//
ID GM01856
AC CVCL_F632
SY GM01856B; GM 1856B; GM 1856; GM1856; CS3BE
DR CLO; CLO_0031403
DR Coriell; GM01856
DR JCRB; KURB1908
RX PubMed=2903889;
DI NCIt; C9460; Cockayne syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F633 ! GM01857
SX Male
CA Finite cell line
//
ID GM01857
AC CVCL_F633
SY GM01857A
DR CLO; CLO_0031392
DR Coriell; GM01857
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C9460; Cockayne syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F632 ! GM01856
SX Male
CA Transformed cell line
//
ID GM01858
AC CVCL_9Z58
SY GM01858B
DR CLO; CLO_0031393
DR Coriell; GM01858
DI NCIt; C3273; Neurofibromatosis type 1
DI NCIt; C3272; Neurofibroma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9Z59 ! GM01859
OI CVCL_9Z60 ! GM01861
SX Male
CA Cancer cell line
//
ID GM01859
AC CVCL_9Z59
DR CLO; CLO_0031396
DR Coriell; GM01859
DI NCIt; C3273; Neurofibromatosis type 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9Z58 ! GM01858
OI CVCL_9Z60 ! GM01861
SX Male
CA Finite cell line
//
ID GM01861
AC CVCL_9Z60
SY GM01861A
DR CLO; CLO_0031397
DR Coriell; GM01861
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3273; Neurofibromatosis type 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9Z58 ! GM01858
OI CVCL_9Z59 ! GM01859
SX Male
CA Transformed cell line
//
ID GM01863
AC CVCL_7341
DR CLO; CLO_0031404
DR Coriell; GM01863
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01864
AC CVCL_7342
SY GM01864A
DR CLO; CLO_0031405
DR Coriell; GM01864
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01865
AC CVCL_DE31
SY GM1865
DR Coriell; GM01865
RX PubMed=7565859;
CC Discontinued: Coriell; GM01865; probable.
DI NCIt; C9460; Cockayne syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID GM01867
AC CVCL_1V12
DR Coriell; GM01867
CC Discontinued: Coriell; GM01867; probable.
DI NCIt; C61261; Hurler syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1V11 ! GM01034
SX Female
CA Finite cell line
//
ID GM01868
AC CVCL_EJ30
DR CLO; CLO_0031406
DR Coriell; GM01868
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01869
AC CVCL_4J38
DR CLO; CLO_0031407
DR Coriell; GM01869
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01870
AC CVCL_4J39
DR CLO; CLO_0032403
DR Coriell; GM01870
DI NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01871
AC CVCL_4J40
DR CLO; CLO_0032405
DR Coriell; GM01871
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01872
AC CVCL_GR92
DR CLO; CLO_0032404
DR Coriell; GM01872
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_GS11 ! GM02762
SX Female
CA Finite cell line
//
ID GM01873
AC CVCL_GR93
DR CLO; CLO_0032400
DR Coriell; GM01873
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_GS12 ! GM02763
SX Female
CA Finite cell line
//
ID GM01874
AC CVCL_CY02
DR Coriell; GM01874
DR CLO; CLO_0032399
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_CY22 ! GM02766
SX Female
CA Finite cell line
//
ID GM01875
AC CVCL_CY03
DR CLO; CLO_0032402
DR Coriell; GM01875
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_CY25 ! GM02866
SX Male
CA Finite cell line
//
ID GM01876
AC CVCL_CY04
DR CLO; CLO_0032401
DR Coriell; GM01876
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_CY24 ! GM02812
SX Male
CA Finite cell line
//
ID GM01877
AC CVCL_F076
DR CLO; CLO_0032407
DR Coriell; GM01877
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F073 ! GM03356
SX Male
CA Finite cell line
//
ID GM01878
AC CVCL_CY05
DR CLO; CLO_0032406
DR Coriell; GM01878
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_CY19 ! GM02714
SX Female
CA Finite cell line
//
ID GM01879
AC CVCL_DF18
DR CLO; CLO_0032408
DR Coriell; GM01879
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01880
AC CVCL_DF19
DR CLO; CLO_0032426
DR Coriell; GM01880
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01881
AC CVCL_V812
SY GM1881
DR CLO; CLO_0032425
DR Coriell; GM01881
RX PubMed=6777119;
DI NCIt; C84897; Mucopolysaccharidosis type IIIA
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01886
AC CVCL_4J41
DR CLO; CLO_0032424
DR Coriell; GM01886
DI NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01887
AC CVCL_4J42
DR CLO; CLO_0032423
DR Coriell; GM01887
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01888
AC CVCL_4J43
DR CLO; CLO_0032422
DR Coriell; GM01888
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01889
AC CVCL_5M70
DR CLO; CLO_0032421
DR Coriell; GM01889
DI NCIt; C86032; XX male
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01891
AC CVCL_7343
DR CLO; CLO_0032420
DR Coriell; GM01891
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01892
AC CVCL_F015
DR CLO; CLO_0032419
DR Coriell; GM01892
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01893
AC CVCL_F016
SY GM-1893; GM 1893
DR CLO; CLO_0032428
DR Coriell; GM01893
RX PubMed=6617268;
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01896
AC CVCL_F017
DR CLO; CLO_0032427
DR Coriell; GM01896
DI NCIt; C61260; Hunter syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01897
AC CVCL_F018
DR CLO; CLO_0032369
DR Coriell; GM01897
DI NCIt; C34568; Ehlers-Danlos syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01898
AC CVCL_F019
SY GM-1898; GM 01898
DR CLO; CLO_0032371
DR Coriell; GM01898
RX CelloPub=CLPUB00290;
DI NCIt; C122782; Hurler-Scheie syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01899
AC CVCL_2448
AS CVCL_D867
SY GM1899; GM 1899; GM1899A; GM1899a; RJK 906; RJK906
DR CLO; CLO_0032370
DR Coriell; GM01899
DR ECACC; 98120701
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01900
AC CVCL_L480
DR CLO; CLO_0032373
DR Coriell; GM01900
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01905
AC CVCL_GR94
DR CLO; CLO_0032372
DR Coriell; GM01905
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01907
AC CVCL_F026
SY GM-1907
DR CLO; CLO_0032375
DR Coriell; GM01907
RX CelloPub=CLPUB00290;
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D342 ! GM00054
OI CVCL_F027 ! GM02795
SX Male
CA Finite cell line
//
ID GM01908
AC CVCL_F483
SY GM-1908
DR CLO; CLO_0032374
DR Coriell; GM01908
RX CelloPub=CLPUB00290;
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2779 ! CHP 4 (W.W.)
OI CVCL_F484 ! GM02796
SX Male
CA Finite cell line
//
ID GM01909
AC CVCL_GR95
DR CLO; CLO_0032377
DR Coriell; GM01909
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_GS14 ! GM02765
SX Male
CA Finite cell line
//
ID GM01910
AC CVCL_CZ03
DR CLO; CLO_0032376
DR Coriell; GM01910
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_CZ09 ! GM03354
SX Female
CA Finite cell line
//
ID GM01911
AC CVCL_GR96
DR CLO; CLO_0032378
DR Coriell; GM01911
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_GS13 ! GM02764
SX Male
CA Finite cell line
//
ID GM01912
AC CVCL_4E25
DR CLO; CLO_0032386
DR Coriell; GM01912
DI NCIt; C85062; Sea-blue histiocyte syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4E26 ! GM01913
SX Female
CA Finite cell line
//
ID GM01913
AC CVCL_4E26
DR CLO; CLO_0032388
DR Coriell; GM01913
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C85062; Sea-blue histiocyte syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4E25 ! GM01912
SX Female
CA Transformed cell line
//
ID GM01915
AC CVCL_4N19
SY GM-1915
DR CLO; CLO_0032394
DR Coriell; GM01915
RX CelloPub=CLPUB00290;
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01920
AC CVCL_V464
SY GM-1920; GM 1920
DR CLO; CLO_0032393
DR Coriell; GM01920
RX PubMed=6617268;
RX PubMed=6661932;
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V465 ! GM01921
SX Male
CA Finite cell line
//
ID GM01921
AC CVCL_V465
SY GM01921A; GM-1921; GM 1921
DR CLO; CLO_0032392
DR Coriell; GM01921
RX PubMed=6617268;
RX PubMed=23665875;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: CNV analysis.
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V464 ! GM01920
SX Male
CA Transformed cell line
//
ID GM01927
AC CVCL_W659
SY GM-1927
DR CLO; CLO_0032391
DR Coriell; GM01927
RX CelloPub=CLPUB00290;
DI NCIt; C61260; Hunter syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01928
AC CVCL_W660
SY GM-1928
DR CLO; CLO_0032398
DR Coriell; GM01928
RX CelloPub=CLPUB00290;
DI NCIt; C61260; Hunter syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01929
AC CVCL_W661
SY GM-1929
DR CLO; CLO_0032397
DR Coriell; GM01929
RX CelloPub=CLPUB00290;
DI NCIt; C61260; Hunter syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01930
AC CVCL_L967
SY GM01802
DR CLO; CLO_0032396
DR Coriell; GM01802
DR Coriell; GM01930
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; GM01802; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01931
AC CVCL_4N20
DR CLO; CLO_0032395
DR Coriell; GM01931
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01935
AC CVCL_1K54
SY GM-1935
DR CLO; CLO_0032320
DR Coriell; GM01935
RX CelloPub=CLPUB00290;
DI NCIt; C84734; Glycogen storage disease type II
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01936
AC CVCL_1N11
SY GM-1936
DR Coriell; GM01936
RX PubMed=761484;
CC Discontinued: Coriell; GM01936; probable.
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID GM01937
AC CVCL_1N12
SY GM-1937
DR Coriell; GM01937
RX PubMed=761484;
CC Discontinued: Coriell; GM01937; probable.
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID GM01938
AC CVCL_AD64
SY GM-1938
DR CLO; CLO_0032325
DR Coriell; GM01938
RX CelloPub=CLPUB00290;
DI NCIt; C34806; Maple syrup urine disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01941
AC CVCL_X084
SY GM 1941
DR CLO; CLO_0032323
DR Coriell; GM01941
RX PubMed=6617268;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
DI NCIt; C26900; Turner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01948
AC CVCL_9W83
DR CLO; CLO_0032335
DR Coriell; GM01948
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01953
AC CVCL_7344
SY GM1953; GM01079; GM17216
DR CLO; CLO_0013888
DR CLO; CLO_0032336
DR Coriell; GM01079
DR Coriell; GM01953
DR Coriell; GM17216
DR GEO; GSM569530
DR GEO; GSM596280
DR GEO; GSM596640
RX PubMed=20889555;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; GM01079; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01954
AC CVCL_7345
SY GM01080; GM17217
DR CLO; CLO_0013887
DR CLO; CLO_0032337
DR Coriell; GM01080
DR Coriell; GM01954
DR Coriell; GM17217
DR GEO; GSM569531
DR GEO; GSM596281
DR GEO; GSM596641
RX PubMed=20889555;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; GM01080; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01955
AC CVCL_F020
DR CLO; CLO_0032338
DR Coriell; GM01955
DI NCIt; C114769; Maturity-onset diabetes of the young
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F021 ! GM01956
SX Male
CA Finite cell line
//
ID GM01956
AC CVCL_F021
DR CLO; CLO_0032332
DR Coriell; GM01956
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C114769; Maturity-onset diabetes of the young
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F020 ! GM01955
SX Male
CA Transformed cell line
//
ID GM01957
AC CVCL_0M12
DR CLO; CLO_0032333
DR Coriell; GM01957
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01958
AC CVCL_0M13
DR CLO; CLO_0032334
DR Coriell; GM01958
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01959
AC CVCL_0M14
DR CLO; CLO_0032346
DR Coriell; GM01959
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01960
AC CVCL_M989
SY GM17063
DR CLO; CLO_0014560
DR CLO; CLO_0032344
DR Coriell; GM01960
DR Coriell; GM17063
CC Part of: Human variation panel.
CC Population: Mexican.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM01972
AC CVCL_F261
DR CLO; CLO_0032341
DR Coriell; GM01972
DI NCIt; C34951; Progeria
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F262 ! AG01972
SX Female
CA Finite cell line
//
ID GM01981
AC CVCL_F589
DR CLO; CLO_0032339
DR Coriell; GM01981
DI NCIt; C75486; Menkes disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F590 ! GM01982
SX Male
CA Finite cell line
//
ID GM01982
AC CVCL_F590
DR CLO; CLO_0032357
DR Coriell; GM01982
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C75486; Menkes disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F589 ! GM01981
SX Male
CA Transformed cell line
//
ID GM01983
AC CVCL_F591
DR CLO; CLO_0032358
DR Coriell; GM01983
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F592 ! GM01984
SX Female
CA Finite cell line
//
ID GM01984
AC CVCL_F592
DR CLO; CLO_0032355
DR Coriell; GM01984
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F591 ! GM01983
SX Female
CA Transformed cell line
//
ID GM01989
AC CVCL_7346
SY GM 1989; GM01076; GM18005
DR CLO; CLO_0015997
DR CLO; CLO_0032356
DR Coriell; GM01076
DR Coriell; GM01989
DR Coriell; GM18005
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; GM01076; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM01990
AC CVCL_7347
SY GM 1990; GM01077; GM17218
DR CLO; CLO_0013921
DR CLO; CLO_0032353
DR Coriell; GM01077
DR Coriell; GM01990
DR Coriell; GM17218
DR GEO; GSM569532
DR GEO; GSM596282
DR GEO; GSM596642
RX PubMed=6661932;
RX PubMed=20889555;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; GM01077; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM01993
AC CVCL_F023
SY GM 1993
DR CLO; CLO_0032354
DR Coriell; GM01993
RX PubMed=6661932;
DI NCIt; C85237; XYY syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01995
AC CVCL_AK20
DR CLO; CLO_0032281
DR Coriell; GM01995
DI NCIt; C125694; Sitosterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01996
AC CVCL_V813
SY GM-1996; GM 1996; BH-76-506
DR CLO; CLO_0032286
DR Coriell; GM01996
RX CelloPub=CLPUB00290;
RX PubMed=891264;
RX PubMed=1766867;
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM01997
AC CVCL_CZ12
DR CLO; CLO_0032285
DR Coriell; GM01997
DI NCIt; C3962; Adenosine deaminase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_CZ84 ! GM02294
SX Male
CA Finite cell line
//
ID GM01998
AC CVCL_F024
SY GM-1998
DR CLO; CLO_0032291
DR Coriell; GM01998
RX CelloPub=CLPUB00290;
DI NCIt; C84555; Familial amyloidosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F025 ! GM01999
SX Female
CA Finite cell line
//
ID GM01999
AC CVCL_F025
DR CLO; CLO_0032288
DR Coriell; GM01999
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84555; Familial amyloidosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F024 ! GM01998
SX Female
CA Transformed cell line
//
ID GM02000
AC CVCL_1V08
SY GM-2000; GM 2000
DR CLO; CLO_0032294
DR Coriell; GM02000
RX CelloPub=CLPUB00290;
RX PubMed=6089204;
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02003
AC CVCL_X085
SY GM 2003
DR CLO; CLO_0032295
DR Coriell; GM02003
RX PubMed=6617268;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02004
AC CVCL_M278
SY XP1WA
DR CLO; CLO_0032296
DR Coriell; GM02004
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02007
AC CVCL_AM83
DR CLO; CLO_0032297
DR Coriell; GM02007
DI NCIt; C125696; Ehlers-Danlos syndrome, type I
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02008
AC CVCL_X086
SY GM 2008
DR CLO; CLO_0032298
DR Coriell; GM02008
RX PubMed=6617268;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02009
AC CVCL_L758
SY GM2009; XP1PD
DR CLO; CLO_0032301
DR Coriell; GM02009
DR JCRB; KURB1028
RX PubMed=1372102;
RX PubMed=3030788;
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02010
AC CVCL_L759
SY XP2PD
DR CLO; CLO_0032300
DR Coriell; GM02010
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02011
AC CVCL_V030
SY GM02011A
DR CLO; CLO_0032312
DR Coriell; GM02011
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84568; Argininemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V029 ! GM00954
SX Female
CA Transformed cell line
//
ID GM02013
AC CVCL_W640
SY GM-2013; GM02013D
DR CLO; CLO_0032309
DR Coriell; GM02013
RX CelloPub=CLPUB00290;
DI NCIt; C61270; I-cell disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02014
AC CVCL_M990
SY GM-2014; GM17041; GM17331
DR CLO; CLO_0013611
DR CLO; CLO_0014625
DR CLO; CLO_0032307
DR Coriell; GM02014
DR Coriell; GM17041
DR Coriell; GM17331
RX CelloPub=CLPUB00290;
CC Part of: Human variation panel.
CC Population: Middle Eastern.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02016
AC CVCL_M991
SY GM-2016; GM 02016; GM17042; GM17332
DR CLO; CLO_0013619
DR CLO; CLO_0014644
DR CLO; CLO_0032306
DR Coriell; GM02016
DR Coriell; GM17042
DR Coriell; GM17332
RX CelloPub=CLPUB00290;
RX PubMed=20889555;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Part of: Human variation panel.
CC Population: Middle Eastern.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02017
AC CVCL_M992
SY GM-2017; GM 02017; GM17333
DR CLO; CLO_0013617
DR CLO; CLO_0032316
DR Coriell; GM02017
DR Coriell; GM17333
RX CelloPub=CLPUB00290;
CC Part of: Human variation panel.
CC Population: Middle Eastern.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02018
AC CVCL_V814
SY GM-2018; GM 2018
DR CLO; CLO_0032317
DR Coriell; GM02018
RX PubMed=456042;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02022
AC CVCL_AM98
DR CLO; CLO_0032314
DR Coriell; GM02022
DI NCIt; C125699; Ehlers-Danlos syndrome, type IV
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02024
AC CVCL_M279
SY XP1JO
DR CLO; CLO_0032315
DR Coriell; GM02024
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02025
AC CVCL_V825
SY GM-2025; GM 2025; GM2025
DR CLO; CLO_0032577
DR Coriell; GM02025
RX PubMed=6617268;
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02026
AC CVCL_4J44
DR CLO; CLO_0032578
DR Coriell; GM02026
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02028
AC CVCL_CZ13
DR CLO; CLO_0032575
DR Coriell; GM02028
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02030
AC CVCL_X259
SY GM-2030; GM 2030
DR CLO; CLO_0032576
DR Coriell; GM02030
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
DI NCIt; C36396; Trisomy 8
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02032
AC CVCL_M280
SY XP2JO
DR CLO; CLO_0032571
DR Coriell; GM02032
DR JCRB; KURB1060
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M282 ! GM02035
SX Male
CA Finite cell line
//
ID GM02033
AC CVCL_L760
SY GM2033; XP3JO
DR CLO; CLO_0032572
DR Coriell; GM02033
RX PubMed=1372102;
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02034
AC CVCL_M281
SY XPH2JO
DR CLO; CLO_0032569
DR Coriell; GM02034
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02035
AC CVCL_M282
SY XP2JO
DR CLO; CLO_0032570
DR Coriell; GM02035
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M280 ! GM02032
SX Male
CA Finite cell line
//
ID GM02036
AC CVCL_7348
SY GM02036A; GMO2036A; GM 02036; GM-02036
DR CLO; CLO_0032573
DR Coriell; GM02036
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02037
AC CVCL_7349
SY GM02037C
DR BTO; BTO:0003842
DR CLO; CLO_0032574
DR Coriell; GM02037
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02038
AC CVCL_CW68
DR CLO; CLO_0032554
DR Coriell; GM02038
DI NCIt; C3362; Schizophrenia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_CW69 ! GM02039
SX Male
CA Finite cell line
//
ID GM02039
AC CVCL_CW69
DR CLO; CLO_0032555
DR Coriell; GM02039
DI NCIt; C3362; Schizophrenia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_CW68 ! GM02038
SX Male
CA Finite cell line
//
ID GM02044
AC CVCL_1D93
DR CLO; CLO_0032556
DR Coriell; GM02044
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02045
AC CVCL_CX28
SY GM-2045
DR Coriell; GM02045
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM02045; probable.
DI NCIt; C61270; I-cell disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02046
AC CVCL_L761
SY GM-2046
DR CLO; CLO_0032557
DR Coriell; GM02046
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02047
AC CVCL_L762
SY GM-2047
DR CLO; CLO_0032558
DR Coriell; GM02047
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02048
AC CVCL_M927
SY GM-2048
DR CLO; CLO_0032549
DR Coriell; GM02048
RX CelloPub=CLPUB00290;
DI NCIt; C84896; Mucolipidosis type IV
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M926 ! GM02533
SX Female
CA Finite cell line
//
ID GM02049
AC CVCL_AB44
SY GM-2049
DR CLO; CLO_0032550
DR Coriell; GM02049
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02050
AC CVCL_W641
SY GM-2050
DR CLO; CLO_0032551
DR Coriell; GM02050
RX CelloPub=CLPUB00290;
DI NCIt; C84548; Alpha-mannosidosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02051
AC CVCL_M993
SY GM-2051; GM17334
DR CLO; CLO_0013616
DR CLO; CLO_0032552
DR Coriell; GM02051
DR Coriell; GM17334
RX CelloPub=CLPUB00290;
CC Part of: Human variation panel.
CC Population: Middle Eastern.
DI NCIt; C84548; Alpha-mannosidosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02052
AC CVCL_7350
SY AT19IJE-F; GM-2052; GM2052
DR CLO; CLO_0032553
DR Coriell; GM02052
RX PubMed=761484;
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02053
AC CVCL_F593
SY GM-2053; GM2053
DR CLO; CLO_0032537
DR Coriell; GM02053
RX PubMed=761484;
RX PubMed=3030788;
DI NCIt; C62505; Fanconi anemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02054
AC CVCL_X087
SY GM 2054
DR CLO; CLO_0032538
DR Coriell; GM02054
RX PubMed=6617268;
RX PubMed=6661932;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM02055
AC CVCL_H177
SY GM 2055
DR CLO; CLO_0032535
DR Coriell; GM02055
RX PubMed=6617268;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02056
AC CVCL_X447
SY GM-2056
DR CLO; CLO_0032536
DR Coriell; GM02056
RX CelloPub=CLPUB00290;
DI NCIt; C61273; Aspartylglycosaminuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02057
AC CVCL_X448
SY GM-2057
DR CLO; CLO_0032533
DR Coriell; GM02057
RX CelloPub=CLPUB00290;
DI NCIt; C61273; Aspartylglycosaminuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02058
AC CVCL_V466
DR CLO; CLO_0032534
DR Coriell; GM02058
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02061
AC CVCL_AK21
DR CLO; CLO_0032531
DR Coriell; GM02061
DI NCIt; C125702; Fanconi anemia, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02062
AC CVCL_L763
SY XP5PD; GM2062
DR CLO; CLO_0032532
DR Coriell; GM02062
RX PubMed=1372102;
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02063
AC CVCL_F127
SY LN; GM 2063; GM-02063; GM00177; GM 177; GM-177; GM177
DR Coriell; GM00177
DR Coriell; GM02063
RX PubMed=180603;
CC Discontinued: Coriell; GM00177; probable.
CC Discontinued: Coriell; GM02063; probable.
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02064
AC CVCL_M994
SY GM2064; GM-2064; GM17342
DR CLO; CLO_0013747
DR CLO; CLO_0032529
DR Coriell; GM02064
DR Coriell; GM17342
RX PubMed=6196781;
CC Part of: Human variation panel.
CC Population: Africans south of the Sahara.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C129072; Hereditary persistence of fetal hemoglobin
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM02065
AC CVCL_9R68
SY GM-2065
DR CLO; CLO_0032530
DR Coriell; GM02065
RX CelloPub=CLPUB00290;
DI NCIt; C125595; Mucolipidosis type IIIA
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02066
AC CVCL_CW97
SY GM-2066; GM 2066
DR CLO; CLO_0032516
DR Coriell; GM02066
RX CelloPub=CLPUB00290;
RX PubMed=9792862;
DI NCIt; C129932; Nephropathic cystinosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02067
AC CVCL_V467
SY GM 2067
DR CLO; CLO_0032517
DR Coriell; GM02067
RX PubMed=6661932;
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02068
AC CVCL_1N60
DR CLO; CLO_0032518
DR Coriell; GM02068
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02074
AC CVCL_0P00
SY GM-2074
DR CLO; CLO_0032512
DR Coriell; GM02074
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02075
AC CVCL_CW70
DR CLO; CLO_0032513
DR Coriell; GM02075
DI NCIt; C2941; Chediak-Higashi syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02077
AC CVCL_1H39
DR CLO; CLO_0032514
DR Coriell; GM02077
CC Miscellaneous: At sampling donor was not affected with Huntington disease, but at significan risk.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1H40 ! GM02078
SX Female
CA Finite cell line
//
ID GM02078
AC CVCL_1H40
DR CLO; CLO_0032515
DR Coriell; GM02078
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Miscellaneous: At sampling donor was not affected with Huntington disease, but at significan risk.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1H39 ! GM02077
SX Female
CA Transformed cell line
//
ID GM02079
AC CVCL_1H41
SY GM02079A
DR CLO; CLO_0032509
DR Coriell; GM02079
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1H42 ! GM02080
SX Female
CA Finite cell line
//
ID GM02080
AC CVCL_1H42
SY GM02080A
DR CLO; CLO_0032510
DR Coriell; GM02080
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1H41 ! GM02079
SX Female
CA Transformed cell line
//
ID GM02085
AC CVCL_U703
DR CLO; CLO_0032511
DR Coriell; GM02085
DI NCIt; C2903; Bloom syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02090
AC CVCL_L764
SY GM2090; GM17343; XP4JO
DR CLO; CLO_0013734
DR CLO; CLO_0031826
DR Coriell; GM02090
DR Coriell; GM17343
RX PubMed=1372102;
CC Part of: Human variation panel.
CC Population: Africans south of the Sahara.
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02091
AC CVCL_L765
SY GM2091; XP5JO
DR CLO; CLO_0031825
DR Coriell; GM02091
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02093
AC CVCL_6B42
SY GM-2093
DR CLO; CLO_0031828
DR Coriell; GM02093
RX CelloPub=CLPUB00290;
DI NCIt; C61251; Metachromatic leukodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02094
AC CVCL_1Y44
SY GM-2094; GM 2094; GM2094A
DR CLO; CLO_0031827
DR Coriell; GM02094
RX CelloPub=CLPUB00290;
RX PubMed=3017984;
DI NCIt; C85052; Sandhoff disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1Y52 ! GM02144
SX Male
CA Finite cell line
//
ID GM02095
AC CVCL_H178
DR CLO; CLO_0031822
DR Coriell; GM02095
DI NCIt; C61251; Metachromatic leukodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02096
AC CVCL_7351
SY GM2096; GM 2096; XP1M1
DR CLO; CLO_0031821
DR Coriell; GM02096
RX PubMed=3003928;
RX PubMed=23665875;
CC Omics: CNV analysis.
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F029 ! GM02634
SX Female
CA Finite cell line
//
ID GM02098
AC CVCL_2Z72
SY GM02098A
DR CLO; CLO_0031824
DR Coriell; GM02098
DI NCIt; C2892; Nevoid basal cell carcinoma syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2Z73 ! GM02099
SX Male
CA Finite cell line
//
ID GM02099
AC CVCL_2Z73
DR CLO; CLO_0031823
DR Coriell; GM02099
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2892; Nevoid basal cell carcinoma syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2Z72 ! GM02098
SX Male
CA Transformed cell line
//
ID GM02103
AC CVCL_X260
SY GM 2103
DR CLO; CLO_0031820
DR Coriell; GM02103
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02109
AC CVCL_W621
SY GM02109B
DR CLO; CLO_0031819
DR Coriell; GM02109
DI NCIt; C61271; Wolman disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02110
AC CVCL_L962
SY GM01450
DR CLO; CLO_0031830
DR Coriell; GM01450
DR Coriell; GM02110
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; GM01450; true.
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM02123
AC CVCL_1H43
DR CLO; CLO_0031848
DR Coriell; GM02123
CC Miscellaneous: At sampling donor was not affected with Huntington disease, but at significan risk.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02124
AC CVCL_4J45
DR CLO; CLO_0031847
DR Coriell; GM02124
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84536; Acute intermittent porphyria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM02133
AC CVCL_4J46
DR CLO; CLO_0031844
DR Coriell; GM02133
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4J16 ! GM00941
SX Male
CA Transformed cell line
//
ID GM02134
AC CVCL_M924
SY GM17251
DR CLO; CLO_0014391
DR CLO; CLO_0031843
DR Coriell; GM02134
DR Coriell; GM17251
DR GEO; GSM569631
DR GEO; GSM596315
DR GEO; GSM596674
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M925 ! GM00940
SX Female
CA Transformed cell line
//
ID GM02135
AC CVCL_W224
DR CLO; CLO_0031842
DR Coriell; GM02135
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84536; Acute intermittent porphyria
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W223 ! GM00939
SX Female
CA Transformed cell line
//
ID GM02137
AC CVCL_X088
SY GM-2137; GM 2137
DR CLO; CLO_0031841
DR Coriell; GM02137
RX PubMed=6617268;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02138
AC CVCL_2Z74
DR CLO; CLO_0031840
DR Coriell; GM02138
DI NCIt; C2892; Nevoid basal cell carcinoma syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2Z75 ! GM02139
SX Female
CA Finite cell line
//
ID GM02139
AC CVCL_2Z75
SY GM02139B
DR CLO; CLO_0031849
DR Coriell; GM02139
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2892; Nevoid basal cell carcinoma syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2Z74 ! GM02138
SX Female
CA Transformed cell line
//
ID GM02144
AC CVCL_1Y52
SY GM2144
DR Coriell; GM02144
CC Discontinued: Coriell; GM02144; probable.
DI NCIt; C85052; Sandhoff disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1Y44 ! GM02094
SX Male
CA Finite cell line
//
ID GM02145
AC CVCL_CX29
SY GM-2145
DR Coriell; GM02145
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM02145; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02146
AC CVCL_H755
DR CLO; CLO_0031850
DR Coriell; GM02146
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H756 ! GM02147
SX Male
CA Transformed cell line
//
ID GM02147
AC CVCL_H756
SY GM02147A
DR CLO; CLO_0031852
DR Coriell; GM02147
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H755 ! GM02146
SX Male
CA Finite cell line
//
ID GM02148
AC CVCL_H753
DR CLO; CLO_0031851
DR Coriell; GM02148
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H754 ! GM02149
SX Female
CA Transformed cell line
//
ID GM02149
AC CVCL_H754
SY GM02149A; GM 2149; GM2149
DR CLO; CLO_0031854
DR Coriell; GM02149
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H753 ! GM02148
SX Female
CA Finite cell line
//
ID GM02150
AC CVCL_H757
DR CLO; CLO_0031853
DR Coriell; GM02150
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H758 ! GM02151
SX Female
CA Transformed cell line
//
ID GM02151
AC CVCL_H758
DR CLO; CLO_0031856
DR Coriell; GM02151
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H757 ! GM02150
SX Female
CA Finite cell line
//
ID GM02152
AC CVCL_F068
SY GM18006
DR CLO; CLO_0015998
DR CLO; CLO_0031855
DR Coriell; GM02152
DR Coriell; GM18006
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F069 ! GM02153
SX Female
CA Transformed cell line
//
ID GM02153
AC CVCL_F069
DR CLO; CLO_0031858
DR Coriell; GM02153
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F068 ! GM02152
SX Female
CA Finite cell line
//
ID GM02154
AC CVCL_1H44
SY GM02154B
DR CLO; CLO_0031857
DR Coriell; GM02154
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Miscellaneous: At sampling donor was not affected with Huntington disease, but at significan risk.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1H45 ! GM02155
SX Female
CA Transformed cell line
//
ID GM02155
AC CVCL_1H45
DR CLO; CLO_0031869
DR Coriell; GM02155
CC Miscellaneous: At sampling donor was not affected with Huntington disease, but at significan risk.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1H44 ! GM02154
SX Female
CA Finite cell line
//
ID GM02156
AC CVCL_1H46
DR CLO; CLO_0031863
DR Coriell; GM02156
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Miscellaneous: At sampling donor was not affected with Huntington disease, but at significan risk.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1H47 ! GM02157
SX Female
CA Transformed cell line
//
ID GM02157
AC CVCL_1H47
DR CLO; CLO_0031866
DR Coriell; GM02157
CC Miscellaneous: At sampling donor was not affected with Huntington disease, but at significan risk.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1H46 ! GM02156
SX Female
CA Finite cell line
//
ID GM02158
AC CVCL_1H48
DR CLO; CLO_0031885
DR Coriell; GM02158
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Miscellaneous: At sampling donor was not affected with Huntington disease, but at significan risk.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1H49 ! GM02159
SX Female
CA Transformed cell line
//
ID GM02159
AC CVCL_1H49
DR CLO; CLO_0031884
DR Coriell; GM02159
CC Miscellaneous: At sampling donor was not affected with Huntington disease, but at significan risk.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1H48 ! GM02158
SX Female
CA Finite cell line
//
ID GM02160
AC CVCL_1H50
DR CLO; CLO_0031883
DR Coriell; GM02160
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Miscellaneous: At sampling donor was not affected with Huntington disease, but at significan risk.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1H51 ! GM02161
SX Male
CA Transformed cell line
//
ID GM02161
AC CVCL_1H51
DR CLO; CLO_0031882
DR Coriell; GM02161
CC Miscellaneous: At sampling donor was not affected with Huntington disease, but at significan risk.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1H50 ! GM02160
SX Male
CA Finite cell line
//
ID GM02162
AC CVCL_1H52
DR CLO; CLO_0031888
DR Coriell; GM02162
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Miscellaneous: At sampling donor was not affected with Huntington disease, but at significan risk.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1H53 ! GM02163
SX Male
CA Transformed cell line
//
ID GM02163
AC CVCL_1H53
DR CLO; CLO_0031887
DR Coriell; GM02163
CC Miscellaneous: At sampling donor was not affected with Huntington disease, but at significan risk.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1H52 ! GM02162
SX Male
CA Finite cell line
//
ID GM02164
AC CVCL_F056
DR CLO; CLO_0031886
DR Coriell; GM02164
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F057 ! GM02165
SX Male
CA Transformed cell line
//
ID GM02165
AC CVCL_F057
DR CLO; CLO_0031757
DR Coriell; GM02165
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F056 ! GM02164
SX Male
CA Finite cell line
//
ID GM02166
AC CVCL_F054
SY GM02166B
DR CLO; CLO_0031755
DR Coriell; GM02166
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F055 ! GM02167
SX Female
CA Transformed cell line
//
ID GM02167
AC CVCL_F055
SY GM02167A
DR CLO; CLO_0031761
DR Coriell; GM02167
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F054 ! GM02166
SX Female
CA Finite cell line
//
ID GM02168
AC CVCL_F058
SY GM02168A; GM18007
DR CLO; CLO_0015999
DR CLO; CLO_0031758
DR Coriell; GM02168
DR Coriell; GM18007
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F059 ! GM02169
SX Male
CA Transformed cell line
//
ID GM02169
AC CVCL_F059
DR CLO; CLO_0031765
DR Coriell; GM02169
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F058 ! GM02168
SX Male
CA Finite cell line
//
ID GM02170
AC CVCL_1H54
DR CLO; CLO_0031766
DR Coriell; GM02170
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Miscellaneous: At sampling donor was not affected with Huntington disease, but at significan risk.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1H55 ! GM02171
SX Female
CA Transformed cell line
//
ID GM02171
AC CVCL_1H55
DR CLO; CLO_0031767
DR Coriell; GM02171
CC Miscellaneous: At sampling donor was not affected with Huntington disease, but at significan risk.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1H54 ! GM02170
SX Female
CA Finite cell line
//
ID GM02172
AC CVCL_V040
SY GM02172A
DR CLO; CLO_0031768
DR Coriell; GM02172
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V041 ! GM02173
SX Female
CA Transformed cell line
//
ID GM02173
AC CVCL_V041
SY GM02173B
DR CLO; CLO_0031763
DR Coriell; GM02173
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V040 ! GM02172
SX Female
CA Finite cell line
//
ID GM02174
AC CVCL_F070
SY GM18008
DR CLO; CLO_0015976
DR CLO; CLO_0031764
DR Coriell; GM02174
DR Coriell; GM18008
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F071 ! GM02175
SX Male
CA Transformed cell line
//
ID GM02175
AC CVCL_F071
DR CLO; CLO_0031781
DR Coriell; GM02175
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F070 ! GM02174
SX Male
CA Finite cell line
//
ID GM02176
AC CVCL_F060
DR CLO; CLO_0031780
DR Coriell; GM02176
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F061 ! GM02177
SX Male
CA Transformed cell line
//
ID GM02177
AC CVCL_F061
DR CLO; CLO_0031777
DR Coriell; GM02177
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F060 ! GM02176
SX Male
CA Finite cell line
//
ID GM02178
AC CVCL_1H56
DR CLO; CLO_0031775
DR Coriell; GM02178
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM02180
AC CVCL_1H57
DR CLO; CLO_0031774
DR Coriell; GM02180
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM02182
AC CVCL_W556
SY GM2182
DR CLO; CLO_0031787
DR Coriell; GM02182
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W557 ! GM02183
SX Female
CA Transformed cell line
//
ID GM02183
AC CVCL_W557
SY GM2183
DR CLO; CLO_0031788
DR Coriell; GM02183
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W556 ! GM02182
SX Female
CA Finite cell line
//
ID GM02184
AC CVCL_D860
SY GM02184D; GM-2184; GM 2184; GM17220
DR CLO; CLO_0014375
DR CLO; CLO_0031785
DR Coriell; GM02184
DR Coriell; GM17220
DR GEO; GSM569534
DR GEO; GSM596284
DR GEO; GSM596644
RX PubMed=6661932;
RX PubMed=20889555;
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=91
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7354 ! GM02185
SX Male
CA Transformed cell line
//
ID GM02185
AC CVCL_7354
SY GM02185B
DR CLO; CLO_0003522
DR CLO; CLO_0031786
DR CLDB; cl1489
DR Coriell; GM02185
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D860 ! GM02184
SX Male
CA Finite cell line
//
ID GM02186
AC CVCL_F050
DR CLO; CLO_0031784
DR Coriell; GM02186
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F051 ! GM02187
SX Female
CA Transformed cell line
//
ID GM02187
AC CVCL_F051
DR CLO; CLO_0032270
DR Coriell; GM02187
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F050 ! GM02186
SX Female
CA Finite cell line
//
ID GM02188
AC CVCL_F052
DR CLO; CLO_0032269
DR Coriell; GM02188
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F053 ! GM02189
SX Male
CA Transformed cell line
//
ID GM02189
AC CVCL_F053
DR CLO; CLO_0032267
DR Coriell; GM02189
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F052 ! GM02188
SX Male
CA Finite cell line
//
ID GM02190
AC CVCL_1H58
SY GM02190A
DR CLO; CLO_0032265
DR Coriell; GM02190
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Miscellaneous: At sampling donor was not affected with Huntington disease, but at significan risk.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1H59 ! GM02191
SX Female
CA Transformed cell line
//
ID GM02191
AC CVCL_1H59
DR CLO; CLO_0032264
DR Coriell; GM02191
CC Miscellaneous: At sampling donor was not affected with Huntington disease, but at significan risk.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1H58 ! GM02190
SX Female
CA Finite cell line
//
ID GM02205
AC CVCL_L968
SY GM01515; GM 2205
DR CLO; CLO_0032263
DR Coriell; GM01515
DR Coriell; GM02205
RX PubMed=6617268;
RX PubMed=23665875;
CC Omics: CNV analysis.
CC Discontinued: Coriell; GM01515; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02206
AC CVCL_L969
SY GM01514; GM 2206
DR CLO; CLO_0032262
DR Coriell; GM01514
DR Coriell; GM02206
RX PubMed=6617268;
RX PubMed=23665875;
CC Omics: CNV analysis.
CC Discontinued: Coriell; GM01514; true.
DI NCIt; C34568; Ehlers-Danlos syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02209
AC CVCL_CZ04
DR CLO; CLO_0032261
DR Coriell; GM02209
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02213
AC CVCL_4J47
DR CLO; CLO_0032260
DR Coriell; GM02213
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84536; Acute intermittent porphyria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM02214
AC CVCL_H179
DR CLO; CLO_0032259
DR Coriell; GM02214
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02217
AC CVCL_1U19
DR CLO; CLO_0032248
DR Coriell; GM02217
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C118780; Autosomal dominant torsion dystonia 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM02224
AC CVCL_CX22
SY GM-2224
DR Coriell; GM02224
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM02224; probable.
DI NCIt; C98969; Lactic acidosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02226
AC CVCL_R906
SY GM 2226; GM2226
DR CLO; CLO_0032251
DR Coriell; GM02226
RX PubMed=21335555;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02227
AC CVCL_L487
SY GM 2227
DR CLO; CLO_0032249
DR Coriell; GM02227
RX PubMed=6087154;
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02228
AC CVCL_U949
SY GM-2228
DR CLO; CLO_0032242
DR Coriell; GM02228
RX CelloPub=CLPUB00290;
DI NCIt; C84546; Alkaptonuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02229
AC CVCL_4J48
DR CLO; CLO_0032241
DR Coriell; GM02229
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM02230
AC CVCL_4J49
DR CLO; CLO_0032244
DR Coriell; GM02230
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM02232
AC CVCL_BT12
DR CLO; CLO_0032243
DR Coriell; GM02232
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C34375; Thalassemia major
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM02241
AC CVCL_GZ39
DR CLO; CLO_0032240
DR Coriell; GM02241
DI NCIt; C129302; Adrenal gland hyperplasia III
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_GZ40 ! GM02242
SX Female
CA Finite cell line
//
ID GM02242
AC CVCL_GZ40
DR CLO; CLO_0032239
DR Coriell; GM02242
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C129302; Adrenal gland hyperplasia III
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_GZ39 ! GM02241
SX Female
CA Transformed cell line
//
ID GM02246
AC CVCL_H685
SY GM2246
DR CLO; CLO_0032149
DR Coriell; GM02246
RX PubMed=8327515;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H686 ! GM10881
SX Female
CA Transformed cell line
//
ID GM02248
AC CVCL_F495
SY GM2248
DR CLO; CLO_0032155
DR Coriell; GM02248
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F494 ! GM00030
SX Male
CA Transformed cell line
//
ID GM02249
AC CVCL_F488
SY GM02249C; GM2249
DR CLO; CLO_0032156
DR Coriell; GM02249
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F487 ! GM00671
SX Male
CA Transformed cell line
//
ID GM02250
AC CVCL_F117
SY GM02250A; GM2250
DR CLO; CLO_0032150
DR Coriell; GM02250
RX PubMed=6809308;
RX PubMed=8327515;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F119 ! GM05509
SX Female
CA Transformed cell line
//
ID GM02252
AC CVCL_L460
SY GM02252A; GM2252
DR CLO; CLO_0032152
DR Coriell; GM02252
DR JCRB; KURB1044
RX PubMed=8327515;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3966; Xeroderma pigmentosum, complementation group B
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U690 ! Po Co
SX Female
CA Transformed cell line
//
ID GM02253
AC CVCL_L778
SY GM02253D; GM02253E; GM 2253; GM2253
DR CLO; CLO_0032159
DR Coriell; GM02253
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3967; Xeroderma pigmentosum, complementation group D
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3815 ! XP17BE
SX Male
CA Transformed cell line
//
ID GM02254
AC CVCL_7355
SY GM17221
DR CLO; CLO_0014377
DR CLO; CLO_0032160
DR Coriell; GM02254
DR Coriell; GM17221
DR GEO; GSM569550
DR GEO; GSM596285
DR GEO; GSM596645
RX PubMed=20889555;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM02255
AC CVCL_4N21
DR CLO; CLO_0032157
DR Coriell; GM02255
DI NCIt; C123415; Autosomal recessive torsion dystonia 2
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N22 ! GM02256
SX Female
CA Finite cell line
//
ID GM02256
AC CVCL_4N22
DR CLO; CLO_0032158
DR Coriell; GM02256
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C123415; Autosomal recessive torsion dystonia 2
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N21 ! GM02255
SX Female
CA Transformed cell line
//
ID GM02264
AC CVCL_1U20
DR CLO; CLO_0032161
DR Coriell; GM02264
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C118780; Autosomal dominant torsion dystonia 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM02266
AC CVCL_BT13
DR CLO; CLO_0032119
DR Coriell; GM02266
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C34375; Thalassemia major
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM02267
AC CVCL_BT14
SY GM-2267
DR CLO; CLO_0032120
DR Coriell; GM02267
RX PubMed=6196781;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C34375; Thalassemia major
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM02268
AC CVCL_W662
SY GM-2268
DR CLO; CLO_0032121
DR Coriell; GM02268
RX CelloPub=CLPUB00290;
DI NCIt; C61260; Hunter syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02269
AC CVCL_H180
DR CLO; CLO_0032123
DR Coriell; GM02269
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02273
AC CVCL_9Q90
SY GM-2273; GM02273G
DR CLO; CLO_0032126
DR Coriell; GM02273
RX CelloPub=CLPUB00290;
DI NCIt; C61270; I-cell disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02274
AC CVCL_CX30
SY GM-2274
DR CLO; CLO_0032128
DR Coriell; GM02274
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02290
AC CVCL_7356
SY GM02290A; GM-2290
DR CLO; CLO_0003523
DR CLO; CLO_0032129
DR CLDB; cl1490
DR Coriell; GM02290
RX PubMed=477417;
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7357 ! GM02291
OI CVCL_D868 ! GM02292
OI CVCL_D869 ! GM02338
SX Male
CA Finite cell line
//
ID GM02291
AC CVCL_7357
SY GM-2291
DR CLO; CLO_0003524
DR CLO; CLO_0032130
DR CLDB; cl1491
DR Coriell; GM02291
RX PubMed=477417;
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7356 ! GM02290
OI CVCL_D868 ! GM02292
OI CVCL_D869 ! GM02338
SX Male
CA Finite cell line
//
ID GM02292
AC CVCL_D868
SY GM-2292; GM 2292
DR CLO; CLO_0032131
DR Coriell; GM02292
RX PubMed=477417;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7356 ! GM02290
OI CVCL_7357 ! GM02291
OI CVCL_D869 ! GM02338
SX Male
CA Transformed cell line
//
ID GM02293
AC CVCL_M995
SY GM17353
DR CLO; CLO_0013723
DR CLO; CLO_0032132
DR Coriell; GM02293
DR Coriell; GM17353
CC Part of: Human variation panel.
CC Population: Caribbean.
DI NCIt; C34568; Ehlers-Danlos syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02294
AC CVCL_CZ84
DR CLO; CLO_0032206
DR Coriell; GM02294
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3962; Adenosine deaminase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_CZ12 ! GM01997
SX Male
CA Transformed cell line
//
ID GM02295
AC CVCL_4T29
SY GM-2295
DR CLO; CLO_0032204
DR Coriell; GM02295
RX CelloPub=CLPUB00290;
DI NCIt; C123437; Multicentric osteolysis, nodulosis, and arthropathy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02298
AC CVCL_5M71
DR CLO; CLO_0032205
DR Coriell; GM02298
RX PubMed=21354051;
RX PubMed=23665875;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Omics: CNV analysis.
DI NCIt; C84587; Becker's muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02299
AC CVCL_IL08
DR CLO; CLO_0032202
DR Coriell; GM02299
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IL09 ! GM02300
OI CVCL_IL10 ! GM02301
SX Female
CA Finite cell line
//
ID GM02300
AC CVCL_IL09
DR CLO; CLO_0032203
DR Coriell; GM02300
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IL08 ! GM02299
OI CVCL_IL10 ! GM02301
SX Female
CA Finite cell line
//
ID GM02301
AC CVCL_IL10
DR CLO; CLO_0032199
DR Coriell; GM02301
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IL08 ! GM02299
OI CVCL_IL09 ! GM02300
SX Female
CA Finite cell line
//
ID GM02302
AC CVCL_W226
DR CLO; CLO_0032201
DR Coriell; GM02302
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84759; Hereditary coproporphyria
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W225 ! GM00962
SX Female
CA Transformed cell line
//
ID GM02303
AC CVCL_BT15
DR CLO; CLO_0032208
DR Coriell; GM02303
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C85219; Variegate porphyria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM02304
AC CVCL_1U21
DR CLO; CLO_0032209
DR Coriell; GM02304
DI NCIt; C118780; Autosomal dominant torsion dystonia 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1U22 ! GM02305
SX Female
CA Finite cell line
//
ID GM02305
AC CVCL_1U22
DR CLO; CLO_0032207
DR Coriell; GM02305
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C118780; Autosomal dominant torsion dystonia 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1U21 ! GM02304
SX Female
CA Transformed cell line
//
ID GM02306
AC CVCL_4N23
DR CLO; CLO_0032175
DR Coriell; GM02306
DI NCIt; C123415; Autosomal recessive torsion dystonia 2
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N24 ! GM02307
SX Male
CA Finite cell line
//
ID GM02307
AC CVCL_4N24
DR CLO; CLO_0032176
DR Coriell; GM02307
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C123415; Autosomal recessive torsion dystonia 2
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N23 ! GM02306
SX Male
CA Transformed cell line
//
ID GM02314
AC CVCL_8A64
SY GM-2314
DR CLO; CLO_0032177
DR Coriell; GM02314
RX CelloPub=CLPUB00290;
DI NCIt; C84710; Farber lipogranulomatosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02315
AC CVCL_8A65
SY GM-2315; FD-1
DR BTO; BTO:0004460
DR CLO; CLO_0032178
DR Coriell; GM02315
RX PubMed=21335555;
DI NCIt; C84710; Farber lipogranulomatosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02316
AC CVCL_8A66
SY GM-2316
DR CLO; CLO_0032169
DR Coriell; GM02316
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02317
AC CVCL_8A67
SY GM-2317
DR CLO; CLO_0032170
DR Coriell; GM02317
RX CelloPub=CLPUB00290;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02324
AC CVCL_X261
SY GM02324A
DR CLO; CLO_0032172
DR Coriell; GM02324
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM02325
AC CVCL_X262
SY GM 2325
DR CLO; CLO_0032174
DR Coriell; GM02325
RX PubMed=6661932;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02327
AC CVCL_AD65
SY GM-2327
DR CLO; CLO_0032179
DR Coriell; GM02327
RX CelloPub=CLPUB00290;
DI NCIt; C34806; Maple syrup urine disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02328
AC CVCL_DD69
DR CLO; CLO_0032180
DR Coriell; GM02328
DI NCIt; C26837; Osteogenesis imperfecta
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02329
AC CVCL_X263
SY GM-2329; GM 2329
DR CLO; CLO_0033128
DR Coriell; GM02329
RX PubMed=6661932;
DI NCIt; C84282; Trisomy 9
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02330
AC CVCL_L488
DR CLO; CLO_0033123
DR Coriell; GM02330
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02331
AC CVCL_6B43
SY GM-2331
DR CLO; CLO_0033124
DR Coriell; GM02331
RX CelloPub=CLPUB00290;
DI NCIt; C61251; Metachromatic leukodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02332
AC CVCL_5L45
DR CLO; CLO_0033125
DR Coriell; GM02332
DI NCIt; C75122; Tuberous sclerosis 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5L46 ! GM02333
SX Male
CA Finite cell line
//
ID GM02333
AC CVCL_5L46
DR CLO; CLO_0033126
DR Coriell; GM02333
DI NCIt; C75122; Tuberous sclerosis 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5L45 ! GM02332
SX Male
CA Finite cell line
//
ID GM02334
AC CVCL_4J50
DR CLO; CLO_0033119
DR Coriell; GM02334
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02335
AC CVCL_X089
SY GM 2335
DR CLO; CLO_0033120
DR Coriell; GM02335
RX PubMed=6617268;
RX PubMed=23665875;
CC Omics: CNV analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02336
AC CVCL_4J51
DR CLO; CLO_0033121
DR Coriell; GM02336
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02337
AC CVCL_X090
SY GM 2337
DR CLO; CLO_0033122
DR Coriell; GM02337
RX PubMed=6617268;
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02338
AC CVCL_D869
SY GM-2338
DR CLO; CLO_0033127
DR Coriell; GM02338
RX PubMed=477417;
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7356 ! GM02290
OI CVCL_7357 ! GM02291
OI CVCL_D868 ! GM02292
SX Male
CA Finite cell line
//
ID GM02339
AC CVCL_5M72
DR CLO; CLO_0033118
DR Coriell; GM02339
RX PubMed=23665875;
CC Omics: CNV analysis.
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02340
AC CVCL_L749
DR CLO; CLO_0033117
DR Coriell; GM02340
DI NCIt; C34383; Sickle cell disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02341
AC CVCL_AA18
DR CLO; CLO_0033115
DR Coriell; GM02341
DI NCIt; C84706; Familial dysautonomia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02342
AC CVCL_AA19
DR CLO; CLO_0033116
DR Coriell; GM02342
DI NCIt; C84706; Familial dysautonomia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02343
AC CVCL_AA20
DR CLO; CLO_0033113
DR Coriell; GM02343
DI NCIt; C84706; Familial dysautonomia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02344
AC CVCL_H144
DR CLO; CLO_0033114
DR Coriell; GM02344
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H143 ! GM01630
SX Male
CA Transformed cell line
//
ID GM02345
AC CVCL_F512
SY GM02345B; GM2345B; GM 2345; GM17051
DR CLO; CLO_0014646
DR CLO; CLO_0033111
DR Coriell; GM02345
DR Coriell; GM17051
RX PubMed=8327515;
CC Part of: Human variation panel.
CC Population: Japanese.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F510 ! GM04312
SX Female
CA Transformed cell line
//
ID GM02346
AC CVCL_X091
SY GM-2346; GM 2346
DR CLO; CLO_0033112
DR Coriell; GM02346
RX PubMed=6617268;
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02347
AC CVCL_1U23
DR CLO; CLO_0033109
DR Coriell; GM02347
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C118780; Autosomal dominant torsion dystonia 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM02355
AC CVCL_L945
SY GM2355
DR CLO; CLO_0033110
DR Coriell; GM02355
DI NCIt; C3339; Familial adenomatous polyposis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02356
AC CVCL_X092
SY GM 2356
DR CLO; CLO_0033106
DR Coriell; GM02356
RX PubMed=6617268;
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02359
AC CVCL_7358
SY XP115LO; GM2359; GM02111; GM2111
DR CLO; CLO_0033108
DR Coriell; GM02111
DR Coriell; GM02359
CC Discontinued: Coriell; GM02111; probable.
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02361
AC CVCL_AK22
DR CLO; CLO_0033107
DR Coriell; GM02361
DI NCIt; C125708; Fanconi anemia, complementation group G
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02362
AC CVCL_AK23
DR CLO; CLO_0033099
DR Coriell; GM02362
DI NCIt; C125702; Fanconi anemia, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02363
AC CVCL_AK24
DR CLO; CLO_0033100
DR Coriell; GM02363
DI NCIt; C125702; Fanconi anemia, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02365
AC CVCL_1R62
SY GM02365A
DR CLO; CLO_0033101
DR Coriell; GM02365
RX PubMed=23665875;
CC Omics: CNV analysis.
DI NCIt; C84643; Coffin-Lowry syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02366
AC CVCL_U388
DR CLO; CLO_0033102
DR Coriell; GM02366
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C85184; Tay-Sachs disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM02373
AC CVCL_4N25
DR CLO; CLO_0033103
DR Coriell; GM02373
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM02380
AC CVCL_H181
SY GM 2380
DR CLO; CLO_0033104
DR Coriell; GM02380
RX PubMed=6617268;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02406
AC CVCL_W148
SY GM-2406
DR CLO; CLO_0033105
DR Coriell; GM02406
RX CelloPub=CLPUB00290;
DI NCIt; C81315; Phenylketonuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02407
AC CVCL_CX54
SY GM-2407
DR Coriell; GM02407
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM02407; probable.
DI NCIt; C84908; Multiple sulfatase deficiency disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02408
AC CVCL_F267
SY GM02408C
DR CLO; CLO_0003525
DR CLO; CLO_0033098
DR CLDB; cl1492
DR Coriell; GM02408
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02412
AC CVCL_L972
SY GM 2412; GM02412B; GM01027
DR CLO; CLO_0033097
DR Coriell; GM01027
DR Coriell; GM02412
RX PubMed=1766867;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; GM01027; true.
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L973 ! GM00441
SX Male
CA Transformed cell line
//
ID GM02415
AC CVCL_F496
SY GM02415B; GM2415; GM 2415; XP2RO; XP-2
DR CLO; CLO_0033096
DR ATCC; CRL-1259
DR Coriell; GM02415
DR JCRB; KURB1079
DR JCRB; KURB1080
RX PubMed=1376435;
RX PubMed=3030788;
CC Discontinued: ATCC; CRL-1259; true.
DI NCIt; C114771; Xeroderma pigmentosum, complementation group E
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02416
AC CVCL_8518
DR CLO; CLO_0033095
DR Coriell; GM02416
DI NCIt; C2985; Diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F066 ! GM02417
SX Female
CA Finite cell line
//
ID GM02417
AC CVCL_F066
DR CLO; CLO_0033091
DR Coriell; GM02417
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2985; Diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8518 ! GM02416
SX Female
CA Transformed cell line
//
ID GM02421
AC CVCL_H182
SY GM 2421
DR CLO; CLO_0033092
DR Coriell; GM02421
RX PubMed=6617268;
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02422
AC CVCL_H183
SY GM 2422
DR CLO; CLO_0033089
DR Coriell; GM02422
RX PubMed=6661932;
DI NCIt; C36626; Trisomy 18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02425
AC CVCL_9R69
SY GM-2425
DR CLO; CLO_0033090
DR Coriell; GM02425
RX CelloPub=CLPUB00290;
DI NCIt; C125595; Mucolipidosis type IIIA
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02426
AC CVCL_2S82
DR CLO; CLO_0033093
DR Coriell; GM02426
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02429
AC CVCL_L974
SY GM02375
DR CLO; CLO_0033094
DR Coriell; GM02375
DR Coriell; GM02429
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; GM02375; true.
DI NCIt; C84765; Homocystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM02430
AC CVCL_M996
SY GM17321
DR CLO; CLO_0013646
DR CLO; CLO_0033274
DR Coriell; GM02430
DR Coriell; GM17321
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM02431
AC CVCL_L975
SY GM02378
DR CLO; CLO_0033275
DR Coriell; GM02378
DR Coriell; GM02431
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; GM02378; true.
DI NCIt; C2941; Chediak-Higashi syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM02432
AC CVCL_M997
SY GM17252
DR CLO; CLO_0014392
DR CLO; CLO_0033283
DR Coriell; GM02432
DR Coriell; GM17252
DR GEO; GSM569642
DR GEO; GSM596316
DR GEO; GSM596675
RX PubMed=20889555;
CC Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC Part of: Human variation panel.
CC Population: Caucasian.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM02433
AC CVCL_CZ14
DR CLO; CLO_0033284
DR Coriell; GM02433
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_CZ15 ! GM02472
SX Female
CA Finite cell line
//
ID GM02434
AC CVCL_GS55
DR CLO; CLO_0033277
DR Coriell; GM02434
DI NCIt; C3962; Adenosine deaminase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_GS58 ! GM02471
SX Male
CA Finite cell line
//
ID GM02435
AC CVCL_CZ05
DR CLO; CLO_0033279
DR Coriell; GM02435
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02436
AC CVCL_GS56
DR CLO; CLO_0033293
DR Coriell; GM02436
DI NCIt; C3962; Adenosine deaminase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02437
AC CVCL_5M73
DR CLO; CLO_0033298
DR Coriell; GM02437
DI NCIt; C124844; Dyggve-Melchior-Clausen syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02438
AC CVCL_IJ35
DR CLO; CLO_0033286
DR Coriell; GM02438
DI NCIt; C129928; Galactosialidosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02439
AC CVCL_W149
SY WG406; WG0406
DR CLO; CLO_0033291
DR Coriell; GM02439
DI NCIt; C84739; GM1 gangliosidosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02440
AC CVCL_GR97
DR CLO; CLO_0033316
DR Coriell; GM02440
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02442
AC CVCL_GR98
DR CLO; CLO_0033317
DR Coriell; GM02442
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02445
AC CVCL_GS57
DR CLO; CLO_0033318
DR Coriell; GM02445
DI NCIt; C3962; Adenosine deaminase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_GS54 ! GM01715
SX Male
CA Finite cell line
//
ID GM02446
AC CVCL_D862
DR CLO; CLO_0033319
DR Coriell; GM02446
DI NCIt; C3962; Adenosine deaminase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02448
AC CVCL_9R19
DR CLO; CLO_0033322
DR Coriell; GM02448
DI NCIt; C61252; Adrenoleukodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02449
AC CVCL_AK35
SY XPPHBE
DR CLO; CLO_0033324
DR Coriell; GM02449
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM02450
AC CVCL_F497
SY GM02450F; GM2450; GM2450D; GM 2450; XP3RO
DR CLO; CLO_0033327
DR Coriell; GM02450
RX PubMed=1376435;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C114771; Xeroderma pigmentosum, complementation group E
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID GM02452
AC CVCL_GT46
DR CLO; CLO_0033330
DR Coriell; GM02452
DI NCIt; C98986; Methylmalonic acidemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02453
AC CVCL_AW77
DR CLO; CLO_0033331
DR Coriell; GM02453
DI NCIt; C98986; Methylmalonic acidemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02455
AC CVCL_9W84
DR CLO; CLO_0033335
DR Coriell; GM02455
DI NCIt; C84902; Mucopolysaccharidosis type IVB
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02456
AC CVCL_9W85
DR CLO; CLO_0033193
DR Coriell; GM02456
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID GM02469
AC CVCL_X264
SY GM 2469
DR CLO; CLO_0033194
DR Coriell; GM02469
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02470
AC CVCL_X059
SY GM-2470; GM 2470
DR Coriell; GM02470
RX PubMed=6617268;
RX PubMed=6661932;
CC Discontinued: Coriell; GM02470; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02471
AC CVCL_GS58
DR CLO; CLO_0033191
DR Coriell; GM02471
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3962; Adenosine deaminase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_GS55 ! GM02434
SX Male
CA Transformed cell line
//
ID GM02472
AC CVCL_CZ15
DR CLO; CLO_0033192
DR Coriell; GM02472
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_CZ14 ! GM02433
SX Female
CA Transformed cell line
//
ID GM02473
AC CVCL_M998
SY GM17154
DR CLO; CLO_0013961
DR CLO; CLO_0033212
DR Coriell; GM02473
DR Coriell; GM17154
DR GEO; GSM273421
DR GEO; GSM569636
DR GEO; GSM596219
DR GEO; GSM597019
CC Part of: Human variation panel.
CC Population: African American.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3721 ! HTZ17XP
SX Female
CA Transformed cell line
//
ID GM02474
AC CVCL_L477
SY GM02474A
DR CLO; CLO_0033216
DR Coriell; GM02474
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID GM02476
AC CVCL_M233
SY GM17344; XP6JO
DR CLO; CLO_0013735
DR CLO; CLO_0033207
DR Coriell; GM02476
DR Coriell; GM17344
CC Part of: Human variation panel.
CC Population: Africans south of the Sahara.
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02485
AC CVCL_7359
SY GM02485A; GM2485A
DR CLO; CLO_0033209
DR Coriell; GM02485
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3967; Xeroderma pigmentosum, complementation group D
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U669 ! Te Ko
SX Female
CA Transformed cell line
//
ID GM02486
AC CVCL_L766
SY GM 2486
DR CLO; CLO_0033202
DR Coriell; GM02486
RX PubMed=6661932;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID GM02487
AC CVCL_2S83
DR CLO; CLO_0033204
DR Coriell; GM02487
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
您正在向 biovector.net 发送关于产品 细胞株Cell Lines 22-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心 的询问
- 公告/新闻
